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This dissertation demonstrates the synthesis and application of 1-bicyclo[1.1.0]butyl 
alkylamines. The enantioselective synthesis of 1-bicyclo[1.1.0]butan-1-yl alkylamines was 
achieved by cyclopropanation to enantiomerically enriched propargyl amides. The 
enantioselective addition of alkynes to imines proceeded well for most N-diphenylphosphinyl 1-
bicyclo[1.1.0]butyl alkylamines, but the cyclopropanation suffered from the formation of 
cyclopropane byproducts. A series of silyl-substituted bicyclo[1.1.0]butanes could be 
synthesized by this methodology in high, reproducible yields. When tethered to an activated 
alkyne, the silyl-substituted bicyclo[1.1.0]butane undergoes cyclization to form a pyrrolidine.  
In the application of the 1-bicyclo[1.1.0]butyl alkylamines, a palladium(0)-catalyzed 
cycloisomerization of bicyclo[1.1.0]butanes and methylenecyclopropanes has been developed. 3-
Azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] is obtained with excellent stereoselectivity. A 
novel 2,3,3a,6a-tetrahydrocyclopenta[c]pyrrol-4(1H)-one is the product of the 
cycloisomerization and carbonylation sequence. 
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1.  ENANTIOSELECTIVE SYNTHESIS OF 1-BICYCLO[1.1.0]BUTAN-1-YL 
ALKYLAMINES 
Bicyclo[1.1.0]butane is one of the most strained small carbon ring systems, and it can 
serve as an attractive building block for the synthesis of complex organic molecules.
1,2 
Our group 
has taken advantage of this high strain energy and used bicyclo[1.1.0]butane as a precursor for 
the synthesis of pyrrolidines and azepines.
3
 New developments in this area, specifically, an 
access to enantiomerically pure 1-bicyclo[1.1.0]butan-1-yl alkylamines starting materials, would 
add significantly to the repertoire of chemical transformations of bicyclo[1.1.0]butane substrates. 
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1.1 FUNDAMENTAL PROPERTIES OF BICYCLO[1.1.0]BUTANES 
1.1.1 Structure of bicyclo[1.1.0]butanes. 
The structure of bicyclo[1.1.0]butane has been elucidated by different methods including 
microwave
4
, NMR
5
, X-ray
5
 and computations.
6-8
 These studies revealed some interesting facets 
of bicyclo[1.1.0]butane.  First, the C-C bond lengths are in agreement among different methods. 
Compared to straight-chain aliphatic (1.52-1.54Å) and cyclopropanes (1.51Å)
9
, 
bicyclo[1.1.0]butanes have a shorter C-C bond length. This observation suggests that the central 
bond of bicyclo[1.1.0]butane [C1-C3] may contain some multiple-bond character.
1
 Also, the 
bridgehead C-H bond has a similar length to a vinyl C-H bond (1.077 Å), which corresponds to 
the acidic nature of this bridgehead proton.
10
 Finally, the geometry of the bridgehead carbon 
directs the substituents on C1 and C3 into one hemisphere. 
Table 1. Structural information for bicyclo[1.1.0]butane.
5,6
 
 
 
 
 
Method
a
 α β λ C1C2 C1C3 C1H1 C2Hexo C2Hendo 
NMR 128.0 110.2 128.0 1.507 1.507 1.142 1.194 1.167 
Electron Diffraction 125.5 111.6 122.8 1.507 1.502 1.108 1.106 1.106 
Microwave 128.2 115.3 122.4 1.498 1.497 1.071 1.093 1.093 
a
Angles are given in degrees and bond lengths in Å.  
 3 
1.1.2 Frontier orbitals of bicyclo[1.1.0]butane. 
Many calculations of molecular orbitals of bicyclo[1.1.0]butane have been published 
since 1960.
7,11-14
 These studies suggest that both HOMO and LUMO are associated with a π-like 
central C-C bond (Figure 1). Ab initio calculations show that the central bond has 96% p-
character (cyclopropane 86%).
13
 
 
                              HOMO                                                               LUMO 
Figure 1. HOMO and LUMO of bicyclo[1.1.0]butane.
a
 
a
Representation of the frontier orbitals calculated at the B3LYP/6-31G* level using Spartan 14. 
1.1.3 The nature of the central bond in bicyclo[1.1.0]butane. 
To further support the hypothesis of the significant p-character of the central bond, NMR 
studies have been performed. The C1-H1 coupling constant (
1
JCH = 205 Hz) corresponds to a C-H 
bond hybrid having 40% s-character.
15
 The 
1
JCC values for C1-C3 are exceptionally low (-5.4 to 
17.5 Hz).
16
 Using some approximations, Pomerantz et al.
17
 calculated that the central bond has 
 4 
89% p-character. Additionally, Schleyer et al. used a GVB/3-21G optimized geometry to 
calculate that the central bond has ca. 4% biradical character (bicyclo[1.1.0]butane).
18
 
  
                                     A                                                  B 
Figure 2. Two 1-bicyclo[1.1.0]butyl cation conformers used in ab initio calculations. 
Because of the high π-character attributed to the C1-C3 bond, the conjugation between a 
cation and the central bond is expected to be significant. Using ab initio calculations, 
Greensburg
19
 showed that the A
+
 conformer is 32 kcal/mol more stable than the B
+
 conformer 
(Figure 3). However, the corresponding A
-
 conformer is only 0.12 kcal/mol more stable than the 
B
-
 conformer. Subsequent calculations showed that the lower stabilization energy is caused by 
poor orbital overlap in the B conformer.
20 
 
 
 
Scheme 1. Synthesis of bicyclo[1.1.0]butane dimer 2. 
Experimental evidence for the π-character of the central bond also exists. For example, 
Moore et al.
21
 synthesized a bicyclo[1.1.0]butane dimer 2 via oxidative coupling of Cu-
derivative 2 (Scheme 1). UV/VIS analysis indicated that the λmax was located at 190 nm as a 
 5 
result of a red shift from the monobicylobutane 1b. This result indicated that the two central 
bonds were conjugated.  
 
 
Figure 3. Bicyclo[1.1.0]butyl and cyclopropyl p-nitrobenzoate esters. 
Wiberg et al.
1
 have shown that solvolysis of 4 is 1000 times faster than that of the 
analogous cyclopropyl derivative 3 (Figure 3). The major solvolysis products of 4 resulted from 
an acid-catalyzed hydration of the central bond. 
1.1.4 Strain energy in bicyclo[1.1.0]butane 
Bicyclo[1.1.0]butane is one of the most strained bicyclic systems. Its strain energy ranges 
from 63.9 to 66.5 kcal/mol and depends on the substituents attached to the bicycle.
22-25
 For 
example, the central bond of bicyclo[1.1.0]butane can be in conjugation with substituents having 
a π-system, which leads to an overall stabilization of the system. 
Table 2. Strain energies for common strained molecules (in kcal/mol).
26
 
 
Bicyclo[1.1.0]butane does not follow the additivity rule for the strain of bicyclic systems; 
it has an extra 8.9 kcal/mol of strain energy generated from the fusion of the two cyclopropane 
 6 
rings. In 1976, Holloway et al.
27
 explained the extra strain energy by considering the non-
bonding 1,3-carbon/carbon interactions (Dunitz-Schomaker hypothesis
28
) in cyclobutane (18 
kcal/mol in cyclobutane). Recently, Baric and Maksic
29 
challenged this idea by indicating that 
this extra strain energy is simply caused by an increase in Baeyer strain. The high strain energy 
makes bicyclo[1.1.0]butane a reactive building block for organic synthesis. By releasing the 
strain of the bicyclo[1.1.0]butane, a diene or cyclobutene can be obtained. 
1.1.5 Bicyclo[1.1.0]butane in nature 
 
 
 
 
Figure 4. Structure of a bicyclo[1.1.0]butane fatty acid methyl ester. 
The high strain energy and acid sensitivity make bicyclo[1.1.0]butane a challenging 
structural motif for synthesis and isolation. The first compound bearing a bicyclo[1.1.0]butane 
group derived from a living organism was reported by Barsh et al.
30
 in 2007. The authors 
identified a dual-function protein encoded in the cyanobacterium Anabaena PCC 7120. They 
reconstituted this protein in E. coli in vitro and found that it could consume 9-
hydroperoxylinoleic acid and produce the bicyclo[1.1.0]butane fatty acid 5. This unique structure 
with unknown bioactivity drew the attention of the scientific community, and led chemists to 
work on its total synthesis. In 2011, the total synthesis of 5 was achieved by Sulikowski et al.
31 
in 
13 steps (Scheme 2). The sequence featured a key cascade reaction that furnished the 
bicyclo[1.1.0]butane and epoxide functionality of 5 from carboxylic acid 8 in 20% yield. 
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Scheme 2. Total synthesis of bicyclo[1.1.0]butane fatty acid 5 by Sulikowski et al. 
 
 
1.2 SYNTHESIS OF BICYCLO[1.1.0]BUTANES 
1.2.1 Retrosynthetic analysis of bicyclo[1.1.0]butanes 
 
Figure 5. Several synthetic pathways towards bicyclo[1.1.0]butane. 
As shown in Figure 5, bicyclo[1.1.0]butanes can be assembled by several different 
methods. Anionic pathways involving formation of either the central bond (A)
32-36
 or lateral bond 
 8 
(B)
37-39
 are possible. An alternative way is carbene insertion into a double bond (path C
40-41
 and 
D
42-47
). Furthermore, isomerization of a diene under photochemical conditions offers a unique 
pathway towards bicyclo[1.1.0]butane (path E)
48,49
. 
1.2.2 Synthesis of bicyclo[1.1.0]butanes by connecting the central bond 
 In 1959, Wiberg et al.
32 
reported the first synthesis of a bicyclo[1.1.0]butane. Treatment 
of 2-bromocyclobutyl methylcarboxylate with triphenylmethide led to the formation of 
bicyclo[1.1.0]butanebutyl methylcarboxylate (Scheme 3). 
 
 
 
 
Scheme 3. First synthesis of a bicyclo[1.1.0]butane. 
Hamon et al.
33
 reported that a Wurtz-type reaction could also be used in the synthesis of 
bicyclo[1.1.0]butane. Precursor 11 was treated with sodium-potassium amalgam to afford 
bicyclo[1.1.0]butane 12 (Scheme 4). 
 
 
Scheme 4. Bicyclo[1.1.0]butane synthesis by Wurtz-type reaction. 
Similar protocols using the displacement of a halogen from an activated cyclobutane 
species have been reported.
34,35 
This reaction was shown to be a stereospecific process, 
proceeding with inversion.
34 
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Scheme 5. Synthesis of 1-cyanobicyclo[1.1.0]butane. 
Recently, Tilley et al.
36
 reported that 1,3-γ-silyl elimination could furnish the 
bicyclo[1.1.0]butane system (Scheme 6). The authors stated that the electron-withdrawing 
trifluoroalkyl group on the bridgehead carbon was crucial for the formation of the desired 
bicyclo[1.1.0]butane. 
 
 
 
 
Scheme 6. Synthesis of 1-trifluoromethylbicyclo[1.1.0]butane 16. 
1.2.3 Synthesis of bicyclo[1.1.0]butanes by connecting the lateral bond 
Although connecting the central bond is the most common way to synthesize 
bicyclo[1.1.0]butanes, synthesis of the lateral bond is also an effective way to access the 
bicyclo[1.1.0]butane system. Gaoni et al.
37
 reported a highly efficient method utilizing a 
substrate bearing an epoxide and sulfonyl group (17). Treatment of 17 with n-BuLi and MsCl 
afforded cyclopropane 18. Treatment with a second equivalent of butyllithium led to 
intramolecular displacement of the mesylate to afford bicyclo[1.1.0]butane 19 in good yield. In 
another case
38
, the intramolecular nucleophilic substitution with substrate 20 can generate 21, 
even though 20 has a poor leaving group (ethoxy).  
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Scheme 7. Synthesis of bicyclo[1.1.0]butane by connecting the lateral bond. 
Carbene insertion of a cyclopropylidene generated by treatment of dibromocyclopropane 
22 with methyllithium into an adjacent CH bond is another method to connect the lateral bond 
(Scheme 8).
39
  
 
 
Scheme 8. Synthesis of bicyclo[1.1.0]butane by carbene insertion into a CH-bond. 
1.2.4 Synthesis of bicyclo[1.1.0]butanes by simultaneous formation of lateral and central 
bonds 
Another popular method for constructing the bicyclo[1.1.0]butane system is the addition 
of carbenes to alkenes. Ganem et al.
40
 obtained bicyclo[1.1.0]butane ester 25a as a byproduct 
when they treated the substituted α-diazoester 24a with rhodium(II) acetate to provide the 
corresponding cis-enoate 26a.  
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Scheme 9. Synthesis of bicyclo[1.1.0]butane by cyclopropanation to a CC-double bond. 
In 2013, Davies group
41
 published an advanced enantioselective synthesis protocol of 2-
arylbicyclo[1.1.0]butane carboxylates 25. With a low catalyst loading (0.01 mol%), product 25 
can be obtained with up to 94% ee. Furthermore, this rhodium-catalyzed reaction can be 
controlled by alternating the rhodium catalysts to afford cyclohexene 28 with high levels of 
diastereoselectivity (Scheme 9). 
In 2013, Fox et al.
42
 independently reported an similar enantioselective cyclopropanation 
of α-diazoesters 24 that gave various enantiomerically enriched bicyclo[1.1.0]butanes 25. The 
new catalyst 29 eliminated the formation product 26 and greatly increased the yield of 25. It is 
worth mentioning that 25 can subsequently engage in a homoconjugate and enolate trapping 
sequence to afford functionalized cyclobutanes 30 with high diastereoselectivity (Scheme 10). 
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 Scheme 10. Enantioselective synthesis of 26 and cyclobutane 30. 
 
1.2.5 Synthesis of bicyclo[1.1.0]butanes by carbene addition 
 
 
 
 
 
Scheme 11. Synthesis of bicyclo[1.1.0]butane via carbene addition to cyclopropene. 
The addition of carbenes to alkynes or cyclopropenes is the most straightforward method 
to synthesize bicyclo[1.1.0]butanes, and this method  provides the most possibilities for the 
synthesis of functionalized bicyclo[1.1.0]butanes. Some reactions utilize carbenes formed by the 
decomposition of diazo compounds
41
 under thermal
44
 or UV conditions
45
 (Scheme 11). 
Unfortunately, this type of carbene addition is not a stereospecific process. The products formed 
are mixtures of endo- and exo-isomers (Scheme 12).
46 
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Scheme 12. Synthesis of bicyclo[1.1.0]butane by carbene addition to alkyne. 
Other carbene sources such as the common Simmons-Smith zinc carbenoid were also 
explored. Schwartz et al.
47
 treated 1-methoxy 1-butyne with zinc carbenoid. Only a mixture of 
cyclopropanated products was obtained under these conditions, and no formation of 
bicyclo[1.1.0]butane was observed. The result was explained by the isomerization of the 
corresponding cyclopropene 36 and bicyclo[1.1.0]butane 37 (Scheme 13). 
 
 
 
 
 
 
Scheme 13. Proposed mechanism for the cyclopropanation of 35. 
The potential of Simmons-Smith reagents for the synthesis of bicyclo[1.1.0]butanes was 
explored by our group.
48
 As shown in Scheme 14, the “CH2” unit is delivered after the addition 
of Schwartz reagent to the propargyl imine. The corresponding bicyclo[1.1.0]butane and 
dicyclopropylmethylamines were obtained in good yield.  
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Scheme 14. One-pot synthesis of bicyclo[1.1.0]butane and dicyclopropylmethylamines. 
The formation of the two products 46 and 47 depended on the steric environment at the 
α-position of the propargyl amide (Scheme 14). Only disubstituted alkyne 45b was able to 
undergo this transformation effectively to afford bicyclo[1.1.0]butane 51-53. The rearranged 
product 47 resulted from the addition of two additional methylene groups to 46 under the 
Simmons-Smith cyclopropanation conditions. 
 
 
 
 
 
Scheme 15. Different products obtained depending on the steric environment at the α-position of the propargyl 
amide. 
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1.2.6 Synthesis of bicyclo[1.1.0]butanes by photochemical activation of diene 
 
 
 
 
 
 
Scheme 16. Photochemical activation of dienes 55 and 57. 
Photochemical activation of a diene is a unique route to synthesize the 
bicyclo[1.1.0]butane skeleton. This reaction is substrate dependent, and it is rarely used as a 
synthetic method. As shown in Scheme 16, two similar dienes 55 and 57 give completely 
different products.
49,50 
 
1.2.7 Bicyclo[1.1.0]butyllithium reagent 
Due to the high s-character of the bridgehead carbon of bicyclo[1.1.0]butane, the lithium-
bromide exchange reaction of 61 should be facile. Because bromide 61 is air-sensitive and 
volatile, a one-pot reaction for formation of 61 followed by a lithium-bromide exchange reaction 
and trapping with a suitable electrophile is the best solution for these problems.
51
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Scheme 17. Synthesis of bicyclo[1.1.0]butane by a one-pot halogen exchange reaction. 
In 1985, Szeimies et al.
51
 reported a one-pot reaction for formation of 
bicyclo[1.1.0]butane ethyl ester 27a (Scheme 17). They treated dibromocyclopropane with 1 
equivalent of methyllithium, which formed 1-bromobicyclo[1.1.0]butane 61. The product was 
subsequently treated with tert-butyllithium followed by the addition of ethyl chloroformate to 
afford the bicyclo[1.1.0]butane ethyl ester 27a in good yield. 
 
 
 
 
 
 
 
Scheme 18. Synthesis of cyclobutanone from bicyclo[1.1.0]butane. 
In 1999, Brinker et al.
52
 used 1-bromobicyclo[1.1.0]butane 61 as a precursor to 
cyclobutanone, which is difficult to obtain using other methods. The mechanism of this 
transformation is shown in Scheme 18.  
Our group explored the one-pot formation of bicyclo[1.1.0]butanes from 
dibromocyclopropanes extensively and found this method to be one of the most effective ways to 
access the bicyclo[1.1.0]butane system (Figure 6). By utilizing several different electrophiles and 
 17 
various substitutions on the dibromocyclopropane, a series of bicyclo[1.1.0]butanes could be 
obtained in good yields.
53
 
 
 
 
 
 
 
 
Figure 6. Several bicyclo[1.1.0]butanes synthesized from the halogen exchange reaction. 
 
 
1.3 RESULTS AND DISCUSSION  
Previously, our group has utilized bicyclo[1.1.0]butane derivatives in the synthesis of 
complex molecules.
3,54
 However, all methodologies involved racemic bicyclo[1.1.0]butane-
containing starting materials and consequently afforded racemic products. In order to make 
bicyclo[1.1.0]butane a more useful synthetic tool for organic synthesis, we sought to develop an 
effective way to access optically active bicyclo[1.1.0]butane derivatives. 
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1.3.1 Enantioselective alkynyl addition to imines. 
Because the direct addition of bicyclo[1.1.0]butyllithium to imines suffers from low 
enantioselectivity,
53
 we decided to apply dicarbene addition to an enantiomerically enriched 
propargyl amine as our new strategy towards the enantiomerically enriched bicylo[1.1.0]butanes 
(Scheme 19). 
 
 
 
Scheme 19. Dicarbene addition of enantiomerically enriched amine. 
Recently, propargyl amines have been used as precursors of many useful intermediates 
towards pharmaceutical compounds.
55-57
 Traditional synthetic methods usually involve 
deprotonation of the alkyne by a strong base such as butyllithium or an organomagnesium 
compound. The resulting alkynyllithium or magnesium reagent will undergo nucleophilic 
addition to imines. Drawbacks to this methodology are fast background addition processes and 
the incompatibility of strong bases with certain substrates.
58 
 
 
 
 
 
Scheme 20. Enantioselective synthesis of DPC 963 using chiral ligand 77. 
There are a few examples of alkynyllithium reagents undergoing enantioselective 
additions to ketimines. Nugent reported a procedure using 4-β-morpholinocaran-3α-ol 77 as a 
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chiral ligand to control the addition of lithium cyclopropylacetylide to an unprotected N-
acylketimine 76 (Scheme 20). The product of this reaction, DPC 963, is an anti-HIV drug 
candidate.
59
 In 2014, Collum et al.
60
 revealed that cubic tetramers 79 are the dominant forms in 
various lithium amino alkoxides and responsible for high enantioselectivities of the nucleophilic 
additions. 
 
 
 
 
 
Scheme 21. Total synthesis of (S)-(-)-homolaudanosine. 
Most enantioselective processes reported to date involve copper (I) species. Knochel and 
coworkers
61
 established a method using a copper (I) catalyst for the addition of an alkyne to an 
imine. Schreiber et al.
62
 found that ligands such as Quinap 82 yielded propargyl amines in high 
yields and ee’s. This reaction later was applied to the total synthesis of (S)-(-)-homolaudanosine 
(Scheme 21).  
In 2014, Ma et al.
63
 developed a high enantioselective synthesis of tetrahydroquinoline 
synthesis utilizing 1,2-unsubstituted tetrahydroquinolines with N-pinap 85 as the chiral ligand. 
This methodology utilized an in situ iminium-ion-isomerization process and opened up an 
efficient entry to many tetrahydroisoquinoline alkaloids. 
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Scheme 22. Ma’s synthesis of tetrahydroquinoline. 
Besides the numerous copper catalysts used for the asymmetric addition of alkynes, 
Hoveyda et al.
64
 utilized a peptide-based ligand in combination with a zirconium species to 
catalyze the addition of a mixed alkynyl zinc reagent to various N-aryl aromatic imines.  
 
 
 
 
 
 
 
Scheme 23. Hoveyda’s methodology using a peptide-based ligand and Zr catalyst. 
The majority of examples for the enantioselective addition of alkynes involve the use of 
unactivated imines, which have a slow background reaction and can be effectively 
enantiomerically catalyzed. Recently, many successful cases utilizing activated imines were also 
described.
65-67 
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Wu and Chong reported that binaphthol-based alkynylboronates could undergo 
enantioselective addition to N-acylamine 88. In this case, both boronate reagent and the imine 
have to be prepared and purified prior to the reaction (Scheme 24).
65
 
 
 
 
 
 
Scheme 24. Binaphthol-based alkynylboronate addition to N-acetylamine. 
Alkynyl zinc reagents have been used extensively for the enantioselective addition to 
electron-deficient imines, including N-sulfonyl, N-acetyl and N-phosphonyl imines. Pedro et al. 
described an approach using binol-type ligand 91 as chiral catalyst in combination with an 
alkynyl zinc reagent to afford N-sulfonyl propargyl amines 93 with high yields and ee’s (Scheme 
25).
66
 In 2012, they applied this strategy to the synthesis of chiral N-Cbz protected amines.
67 
These enantiomerically enriched  propargylamines 95 are highly valuable synthetic intermediates. 
 
 
 
 
 
Scheme 25. Enantioselective alkynyl zinc addition to N-tosyl and N-Cbz imine. 
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A similar approach using a proline-based ligand was reported by Wang et al.
67
 As part of 
their methodology, they examined a series of different proline-type ligands and found that the 
C2-symmetric ligand 96 catalyzed the addition of alkynyl zinc reagents to N-phosphinoyl imines 
in good yields and ee’s.68 
 
 
Scheme 26. Enantioselective alkynyl zinc addition to N-phosphinoyl imine. 
1.3.2 Enantioselective alkynyl addition to N-DPP imine. 
We previously obtained favorable results when exploring the cyclopropanation of an N-
DPP propargyl amide; therefore, we decided to use this method to access enantiomerically 
enriched bicyclo[1.1.0]butane substrates. A set of different ligands was examined for the 
addition of alkynyl zinc to imines. Diethyl zinc, p-trifluoromethyl phenyl acetylene and ligand 
were stirred for 2-6 h before the addition of the imine. After the addition of the imine, the 
mixture was stirred for another 12-48 h and quenched with saturated ammonium chloride 
solution. The products were then separated and analyzed by SFC (Chiralpak IA) (Scheme 27). 
 
 
 
 
Scheme 27. Alkynyl zinc addition to N-phosphinoyl imine. 
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Table 3. Enantioselective alkynyl zinc addition to N-phosphinoyl imine. 
Entry Conditions Yield (%) e.r.
a 
(S:R)
b
 
1 ZnMe2, rt, 48 h 86 - 
2 ZnMe2, 91 20 mol%, rt, 48 h 15 53:47 
3 ZnMe2, 98 10 mol%, rt, overnight 61 48:52 
4 ZnEt2, 99 60 mol%, rt, overnight 65 93:7 
a
Enantiomeric ratio was determined by SFC analysis using a Chiralpak IA column. 
b
Configurations were assigned 
according to the original paper.
68
  
The results in Table 3 show that ligand 99 gave acceptable yield and enantiomeric ratio. 
We decided to use the commercially available ligand 99 as a chiral catalyst for the 
enantioselective additions of alkynes to imines.  
Table 4. Enantioselective alkynyl zinc addition to N-phosphinoyl imine. 
 
 
Entry Product R1 R2 Conditions Yield (%) e.r.
a 
(S:R)
b
 
1 102 i-Pr p-CF3C6H4 12 h 78 93:7 
2 103 Ph m-ClC6H4 12 h 91 92:8 
3 104 Ph c-C6H11 48 h 67 69:31 
4 105 i-Pr p-BrC6H4 6 h 84 94:6 
5 106 i-Pr TIPS 24 h 84 92:8 
6 107 PhCH2CH2 p-CF3C6H4 24 h 82 98:2
c
(86:14) 
a
Enantiomeric ratio was determined by SFC analysis using a Chiralpak IA column. 
b
Configurations were tentatively 
assigned according to the original paper.
67
  
c
E.r. was determined after recrystallization. 
We further explored the substrate scope of this reaction. We used the imine tosyl adduct 
101a-c instead of the imine because some alkyl imines are not stable. The results are summarized 
in Table 4. As we expected, aromatic-substitued (entries 1, 2, and 4) and silyl-substituted alkyne 
(entry 5) gave good to excellent yield. Various substituents on the phenyl ring did not affect the 
e.r.. Alkyl-substituted alkyne (entry 3) only gave moderate yield and decreased enantioselectivity 
(69:31). When a smaller phenylethyl group was used (entry 6), a lower e.r. was observed. 
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However, we were able to increase the enantiomerical ratio to 98:2 by recrystallizing 104 in 
hexanes/dichloromethane.  
1.3.3 Cyclopropanation of enantiomerically enriched propargyl amide. 
As stated in the introduction, our group has studied the cyclopropanation of alkynes 
(Scheme 28). However, the substrate scope of this reaction is limited to cases where the starting 
material is a conjugated propargyl phosphonyl amide with electron withdrawing substituents on 
the aryl group.
26 
 
 
 
Scheme 28. Carbene addition of propargyl amides. 
After obtaining the enantiomerically enriched propargyl amide 100 (Scheme 29), we 
subsequently treated 100 with a Simmons-Smith carbenoid to give bicyclo[1.1.0]butane 112 in 
34% yield. After analysis by SFC using a chiral stationary phase the enantiomeric ratio of the 
bicyclo[1.1.0]butane product was equivalent to the propargyl amide starting material.  
 
 
 
 
Scheme 29. Determination of e.r. after cyclopropanation. 
a
Enantiomeric ratio was determined by SFC analysis using a Chiralpak IA column. 
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Although the chiral center was retained after cyclopropanation, this process still suffers 
from low and irreproducible yields. As shown in Scheme 30, substrate 102 undergoes 
cyclopropanation to form the bicyclo[1.1.0]butane products 113 in 46% yield. The yield was a 
slight improvement from substrate 100,  
 
 
 
 
Scheme 30. Cyclopropanation of substrates 102. 
The reason for the low reaction yield is that the bicyclo[1.1.0]butane can undergo a 
subsequent carbenoid addition, which forms skipped diene 117. Usually the skipped diene 117 
cannot be observed in the product; it will be attacked by another equivalent of carbenoid to form 
products 118 and 119. The mechanism of this transformation is shown in Scheme 31. 
 
 
 
 
 
 
 
 
 
Scheme 31. Cyclopropanation of bicyclo[1.1.0]butane. 
In 1985, Jackson et al.
69
 described their studies on the cyclopropanation of 
bicyclo[1.1.0]butane. The author stated that if the mechanism is step-wise, 122 should be the 
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main product of the first step. Since 123 and 125 would form more substituted alkenes, 130 
should be the main product of this reaction. Instead of the two suggested step-wise pathways, the 
author proposed another concerted route, the “two bond pluck”, in which the central and lateral 
bonds open simultaneously. The concerted pathway was supported by the 70% yield of product 
130 from the cyclopropanation of 1,2,2-trimethylbicyclo[1.1.0]butane (Scheme 32). 
 
 
 
 
 
 
 
 
 
Scheme 32. Mechanism study of cyclopropanation of bicyclo[1.1.0]butane 110. 
First of all, we hoped that modifications of the cyclopropanation reaction would provide 
us with a more reliable access to bicyclo[1.1.0]butane-containing compounds. In 2004, Shi and 
co-workers
70
 developed a novel class of zinc carbenoid reagents that offered efficient 
cyclopropanation of olefins. With the combination of Lewis acid catalyst such as TiCl4, SnCl4, 
AlCl3 and AlEtCl2, the reactivity of zinc reagents (ROZnCH2I) increased dramatically. The 
mechanism of the acceleration is that Lewis acid can complex with oxygen to break the 
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aggregated zinc reagents (ROZnCH2I) and increase the electrophilicity of the generated zinc 
carbenoid.
71
 
 
 
 
 
 
Scheme 33. Modification of cyclopropanation conditions of bicyclo[1.1.0]butane 100. 
The cyclopropanation of alkynes required excess reagent usage and had low conversion. 
Thus we examined the combination that increases the reactivity of zinc carbenoid the most, 
namely AlEt2Cl and CF3CH2OH. Despite the differences between simple olefins
70
 and 
propagylic amines, the use of diethyl aluminum chloride and trifluoroethanol as additives gave a 
more consistent yield. We decided to use this condition for further reaction optimization 
(Scheme 33).  
Table 5. Cyclopropanation of carbonyl-protected propargyl amides. 
 
 
 
 
 
Entry Starting Material R Product 
1 131 Ph 135 
2 132 tBu NR. 
We next tested a series of carbonyl protecting groups under the optimized conditions. As 
shown in the Table 5, N-benzoyl amide 131 generated only rearranged products. N-Pivaloyl 
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amide 132 was unreactive under the reaction conditions. Because substrates with carbonyl 
protecting groups gave lower yields than the original propargyl amide, we continued to develop 
our methodology using DPP-protected starting materials. 
Finally, we decided to test if the temperature could affect the selectivity of 
bicyclo[1.1.0]butane formation in the presence of other functional groups that are reactive 
toward carbenoids (Table 6). Cyclopropanation of both allyl and propargyl amides could be 
carried out above -40 ºC. At -30 ºC, the allyl amide was more reactive than the propargyl 
functionality and 138 could be obtained exclusively. At higher temperatures, 138, 139 and 140 
were obtained as an inseparable mixture, which means that the bicyclo[1.1.0]butane product has 
similar reactivity to the starting material propargyl amide. In summary, these results suggested 
that bicyclo[1.1.0]butane formation is difficult to perform in a selective fashion. 
Table 6. Cyclopropanation of styrenal propargyl amide at different temperatures. 
 
 
 
 
Entry Conditions Product Yield 
1 rt 140, 141 (1:10) 81%
a
 
2 -20 °C 138, 139, 140 (~1:1:1) 62%
b
 
3 -30 °C 138 86% 
4 -40 °C - - 
a
140 and 141 were obtained as an inseparable mixture, the ratio was determined by NMR. 
b
138 and 139 
were obtained as an inseparable mixture, the yield was determined by NMR. 
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1.3.4 Cyclopropanation of silyl-substituted propargyl amide. 
In 1.3.3, we managed to use modified zinc reagents to solve the low conversion problem 
in the cyclopropanation of propagylic alkynes. but failed to keep the generated 
bicyclo[1.1.0]butane from reacting with excessive zinc carbenoids. In this section, we sought to 
design some substrates in order to solve the latter problem.  
 
Scheme 34. Different product distribution in the one-pot cyclopropanation of propargylic amine. 
As stated in 1.2.5, our group investigated the cyclopropanation of N-DPP propargyl 
amides and found that the steric hindrance at the α-position was crucial for a selective formation 
of cyclopropanation products.
48
 A simple structral change from hydrogen atom (47) to ethyl 
group (46) at β-position alternated the product distribution dramtically. In other word, the ethyl 
group blocked the resulting bicyclo[1.1.0]butane from reacting further with zinc carbenoid. 
These results implied that Simmons-Smith cyclopropanation of bicyclo[1.1.0]butanes is very 
sensitive to steric hindrance (Scheme 33) . 
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We decided to test substrates with larger steric hindrance, namely, alkynes bearing a 
TIPS protecting group. The results of the reaction of TIPS-protected propargyl amides are 
summarized in Scheme 34. Surprisingly, TIPS-substituted 106 gave the cyclopropene product 
142 exclusively even at room temperature. Cyclopropene 142 is not decomposed upon storage at 
-20 ºC for 6 months. The result indicated that the TIPS group imparts too much steric hindrance 
for cyclopropene 142, which makes 142 resistant from reacting with zinc carbenoids to obtain a 
bicyclo[1.1.0]butane. 
 
 
 
 
Scheme 35. Modification of cyclopropanation conditions of bicyclo[1.1.0]butane 100. 
Next, we reduced both the size of the substituents (Table 7). By reducing the size of the 
iso-propyl group to a smaller phenethyl group, we observed the formation of 
bicyclo[1.1.0]butanes. Furthermore, the reaction proceeded to the bicyclo[1.1.0]butanes and 
stopped without reacting further. For alkynes 143-147, these reactions showed only one spot by 
TLC and gave excellent yields (75-92%). The reaction tolerated many silyl groups with sizes 
from trimethylsilyl to tert-butyldimethylsilyl. We also tested substrates with trimethylsilylmethyl 
(148) or hydrogen (149) substituents, which conveyed a similar electronic environment to other 
silyl alkynes. However, these substrates gave only decomposition products, suggesting a 
dominant role for steric effects in the cyclopropanation process. 
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Table 7. Cyclopropanation of a series of different silyl-substituted propargyl amides. 
 
 
 
Starting materials Products Yield (%) 
  
91 
  
76 
  
86 
  
75 
  
92 
  
-
a
 
  
-
a
 
a
Products afforded as a messy mixture. 
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To our knowledge, this is the first case of a cyclopropanation reaction furnishing 
bicyclo[1.1.0]butane products with such high degree of selectivity. The combination of our 
modified reagents and substrate designs provided us an efficient route to these unique silyl-
substituted bicyclo[1.1.0]butanes. 
 
 
 
 
 
 
 
 
 
Figure 7. X-ray structure of 153. 
We managed to obtain an X-ray structure of our silyl-substituted bicyclo[1.1.0]butane 
153. Detailed structural information for several bicyclo[1.1.0]butane derivatives is summarized 
in Table 8.
53 
As we stated in 1.1.1, the substituents on the bicyclo[1.1.0]butane (C10 and C12) 
are restricted in the same hemisphere. As a result, we observed a strong interaction between the 
two substituents (trimethylsilyl and 3-phenyl-1-propyl DDP amide) on the bridgehead carbons 
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(Figure 7). Comparing to a similar bicyclo[1.1.0]butane bearing a hydrogen atom and a α-benzyl 
tosyl amide (157), the bond angles were enlarged by ~10 degrees each. Comparing to a 
conjugated bicyclo[1.1.0]butane 158, the angle was increased by 23 degrees. We believed that 
this angle change along with the increased size of the substituent on C12 blocked the access to 
the p-orbital of the central bond and prevented the bicyclo[1.1.0]butane from further reaction 
with zinc carbenoids.  
Table 8. Bond angles and lengths of 153, 157
53
 and 158
53
. 
 C-C Bond parameters 
   
 C1-C10-C12 (º) 137.4 127.0 131.1 
 Si1-C12-C10 (º) 140.4 129.4 117.0 
 C10-C12 (Å) 1.505 1.456 1.518 
Besides the bond angle, we also observed that the bond length of C10-C12 was expanded 
due to the interaction between C10 and C12 substituents, which again demonstrated the steric 
hindrance of the silyl group.  
 
1.3.5 Ene reaction of silyl-substituted bicyclo[1.1.0]butane. 
In 2006, our group reported a pericyclic cascade reaction using bicyclo[1.1.0]butane 
containing starting materials.
54 
Depending on the substituent on the allyl bromide, the product 
was formed as a spirocyclic butene or tricyclic pyrrolidine system (Scheme 35). When the R 
group is an alkyl group, intermediate 159 has a short lifetime and undergoes H-abstraction to 
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form the spirocyclic butene 160-162. However, when the R group is aromatic (163-165), 
intermediate 159 undergoes a radical recombination to form a C-C bond. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 36. Thermal ene reactions of bicyclo[1.1.0]butanes.
54
 
We subsequently tried the cascade conditions with several allyl bromides and silyl-
substituted bicyclo[1.1.0]butanes. The alkylated products were formed, but no cyclized products 
were found (Scheme 37). Subjecting the alkylated products to high temperatures or microwave 
conditions did not promote the cascade reactions. Furthermore, rhodium catalysts and radical 
initiators did not facilitate this reaction (Scheme 38).
3,53
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Scheme 37. Phase transfer alkylation of bicyclo[1.1.0]butanes 150-153. 
Since these silyl-substituted bicyclo[1.1.0]butanes have different HOMO/LUMO 
energies to the bicyclo[1.1.0]butanes with aromatic substitutions on the bridgehead carbon, the 
inertness of 167-170 was not unexpected. On the other hand, as we discussed in 1.3.4, the X-ray 
structure revealed our silyl-substituted bicyclo[1.1.0]butane possessed strong steric hindrance 
that possibly blocked the anti-obital of the central bond of the fused ring system, which could 
also be detrimental to the pericyclic cascade reaction.  
 
 
 
 
Scheme 38. Cyclization failure with prolonged heating or different catalysts. 
Previously, our group developed the cyclization methodology using unactivated 
bicyclo[1.1.0]butane substrates such as 157 (Scheme 39).
53
 Treatment of substrate 157 with 
sodium hydride in anhydrous dimethylformamide led to the formation of an alkylated amide that 
is converted to the cyclized product 172. We expected silyl-substituted bicyclo[1.1.0]butanes to 
have properties similar to 157. 
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Scheme 39. [2+2] ene reaction with unactivated bicyclo[1.1.0]butane. 
However, when we attempted to carry out the reaction with compound 153, we did not 
observe the formation of any alkylated or cyclized product. The decomposition of methyl 4-
bromocrotonate indicated that the alkylation process was problematic. We sought to solve this 
issue by applying a 3-step (alkylation/deprotection/oxidation) strategy towards the synthesis of 
the activated propargyl functionality. 
 
 
 
 
 
 
Scheme 40. [2+2] ene reaction with bicyclo[1.1.0]butane 174.
 
a
Structure assigned by comparing to X-ray structure a similar compound
 
180.  
This method involved a protected alcohol that can be easily oxidized to the aldehyde, 
which in turn can activate the conjugated propargyl alkyne.
53
 Alkylation of amide 153 with TBS 
protected propargyl bromide using phase transfer conditions affords 173 in good yield (Scheme 
40). The TBS group could be removed in nearly quantitative yield without any decomposition of 
the 1-trimethylsilyl bicyclo[1.1.0]butane. Subsequently, treating the propargyl alcohol with 
Dess-Martin reagent afforded the cyclized product 174 in high yield. It is worth mentioning that 
the ene-reaction happened simultaneously at 0 degrees, without the isolation of propargyl 
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aldehyde. We planned to obtain a crystal structure of 174. Unfortunately, 174 slowly 
decomposed at room temperature and failed to crystallize.  
 
Scheme 41. [2+2] ene reaction with silyl-substituted bicyclo[1.1.0]butane. 
An alternative strategy with dinitrophenyl hydrazine was applied with substrate 175. The 
alkyne addition provided TMS-substituted bicyclo[1.1.0]butane 176. Switching the phenylethyl 
group to a smaller ethyl group did not affect the outcome of cyclopropanation. TMS-substituted 
bicyclo[1.1.0]butane 177 was obtained in 62% yield as the only product. The following 
alkylation/deprotection/ene reaction sequence produced the aldehyde 179 in high yield and as a 
single diastereomer. Hydrazone 181 was synthesized upon stirring 179 with (2,4-
dinitrophenyl)hydrazine (181) in methanol at room temperature (Scheme 41).  
The product was recrystallized from dichloromethane and hexanes to afford an orange 
crystal. As shown in Figure 8, we observed bond length differences between the double bond 
(1.343 Å) and the single bond (1.536 Å) on the cyclobutene ring. The ethyl group is located on 
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the same side with the double bond on the cyclobutene ring. This suggests that this reaction is a 
stereospecific formal ene reaction.  
 
Figure 8. X-ray structure of 181. 
1.3.6 Hiyama cross-coupling of silyl-substituted bicyclo[1.1.0]butane 
The high π-character of the central bond of bicyclo[1.1.0]butane has been highlighted in 
the first chapter. We expected this compound to have similar reactivity to a vinyl silane, which 
undergoes a Hiyama coupling in the presence of a fluoride activator and a palladium species. 
 
 
Scheme 42. Hiyama coupling protocol using aryl silane and alkyl bromide. 
Hundreds of protocols for Hiyama couplings utilizing mild conditions and different 
silicon species have been reported in the last decade.
72
 For example, a room-temperature Hiyama 
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cross-coupling of arylsilanes with alkyl bromides and iodides was reported by Fu et al. (Scheme 
42).
73
 Silicon functionalities such as dimethyl(2-thienyl)silyl have also been used in Hiyama-
coupling partners (Scheme 43).
 
 
 
 
Scheme 43. Hiyama coupling using a dimethyl(2-thienyl)silyl group. 
We began our explorations of the use of silyl-substituted bicyclo[1.1.0]butanes as 
Hiyama coupling partners using substrate 154 (Scheme 44). Unfortunately, subjecting compound 
154 to Hiyama coupling conditions led to the decomposition. An explanation is that the 
palladium catalyst opens the bicyclo[1.1.0]butane ring and formed a palladium-carbene complex 
that decomposes under the reaction conditions.  
 
 
 
Scheme 44. Hiyama coupling using a dimethyl(2-thienyl)silyl bicyclo[1.1.0]butane. 
1.4 CONCLUSION 
This chapter describes our methodologies for the enantioselective synthesis of 1-
bicyclo[1.1.0]butan-1-yl alkylamines. Initial trials with the enantioselective addition of 
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bicyclo[1.1.0]butyllithium reagent to imines were unsuccessful. We developed an alternative 
route using cyclopropanation to enantiomerically enriched propargyl amides. The 
enantioselective addition of alkynes to imines proceeded well for most N-DPP amides. The 
cyclopropanation went well for conjugated propargyl amides with the stereocenter retained. This 
methodology enabled us an access to enantiomerically enriched 1-bicyclo[1.1.0]butan-1-yl 
alkylamines. 
A series of silyl-substituted bicyclo[1.1.0]butanes could be synthesized by double 
cyclopropanation from propargyl amides without observation of byproduct. To our knowledge, 
this is the first case of a cyclopropanation reaction furnishing bicyclo[1.1.0]butane products in 
such high, reproducible yields. When tethered to an activated alkyne, the silyl-substituted 
bicyclo[1.1.0]butanes underwent cyclization to form pyrrolidines. This methodology also enables 
an unique pathway for the synthesis of multi-functional cyclobutene compound. 
Cyclobutane/cyclobutene-containing alkaloids have shown anticancer, antibiotical and other 
activities and may serve as potential lead drug candidates.
74 
Despite various well-known 
methodologies developed for cyclobutane/cyclobutene synthesis, highly-substituted cyclobutenes 
remain challenging synthesis target
75
. However, our oxidation/pericyclic cascade reaction 
furnished a quaternary center in the cyclobutene at ease. This methodology could pave a unique 
pathway for the synthesis of multi-functional cyclobutene compounds such as welwitindolinone 
A isonitrile.
76-78
 
 
Figure 9. Welwitindolinone A isonitrile. 
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2. PALLADIUM-CATALYZED CYCLOISOMERIZATION OF 1-
BICYCLO[1.1.0]BUTAN-1-YL ALKYLAMINES 
Transition metals have been at the center of strained cyclopropane methodology 
development in the last few decades. For example, metal-catalyzed methylenecyclopropene 
(MCP) reactions have proven multifunctional and versatile in organic synthesis. Utilizing this 
transformation on bicyclo[1.1.0]butanes reveals some interesting reactivity of these species. This 
chapter will demonstrate some fundamental aspects of these transformations as well as 
applications of these strategies for bicyclo[1.1.0]butane derivatives.  
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2.1 FUNDAMENTAL PROPERTIES OF METHYLENECYCLOPROPANE 
2.1.1 Transformation patterns of MCP  
Similar to bicyclo[1.1.0]butane, MCP is a highly strained four-carbon unit that can 
undergo a variety of reactions by releasing its strain energy.
22
 Metal catalysts can utilize the  
character of the cyclopropane bond and the high thermodynamic driving force provided by the 
ring strain to initiate many fascinating transformations. This type of rearrangement reaction 
usually results in significant increase in structural complexity.
79
 
 
Figure 10. Metal-catalyzed MCP reaction pathways. 
As shown in Figure 10, there are three major reaction patterns for MCP. The first pattern 
arises from the reactivity of the double bond in MCP. It can undergo carbometallation followed 
by β-elimination to afford the homoallylic or allylic compounds.80 Alternatively, the double bond 
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may also react as a component in a Pauson-Khand,
81
 Diels-Alder
82
 or [3+2] dipolar 
cycloaddition
83
, which furnish many spirocyclic compounds without cyclopropane ring opening. 
The second reaction pattern relies on the formation of a metallacyclobutane species or a metal 
trimethylenemethane (TMM) complex 188. These highly reactive intermediates are produced by 
the insertion of the transition metal into the distal (189) or the proximal (190) bond, respectively. 
Finally, MCPs can undergo metal-catalyzed cycloisomerization to afford the cyclobutene.
84,85 
The following sections review several representative examples of metal-catalyzed MCP  
cycloaddition/isomerization reactions.  
2.1.2 Cycloadditions with the conservation of cyclopropane ring 
 
Scheme 45. Intramolecular Pauson-Khand reaction of enyne.  
The Pauson-Khand reaction (PKR) is a cobalt/rhodium-mediated [2+2+1] cyclization of 
an alkyne, an alkene and a carbon monoxide that yields a cyclopentenone. In 2005, de Meijere 
and co-workers applied MCP moieties as alkenes in PKR precursors 1,6- and 1,7-enynes, which 
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furnished spirocyclopropanated bicyclo[3,3,0]octenone or bicyclo[4,3,0]nonenone in good 
yields.
86
 Additionally, the authors found that a chiral auxiliary led an asymmetric induction in the 
cyclization step. Spiro(cyclopropanebicylo[3,3,0]octantenone) 194 can be obtained in 
enantiomerically pure form (Scheme 45). 
 
Scheme 46. 1,3-Dipolar addition of MCP with nitrones and acid-mediated ring contraction. 
In 2000, Brandi et al investigated the 1,3-dipolar addition of MCP with various nitrones, 
providing 1,5-isoxazolidines in moderate yield.
87
 An acid led these resulting isoxazolidines to 
form valuable β-lactams by ethylene extrusion. (Scheme 46) 
 
Scheme 47. 1,3-Dipolar addition of BCP with nitrones and transformation of the adducts. 
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This cascade reaction was applied to bicyclopropylidene 198 (BCP) for the synthesis of 
α-spirocyclopropane-β-lactam.88,89 Upon microwave heating in presence of NaOAc, the adducts 
of BCP and nitrone (in situ generated from aldehyde) gave cyclopropanated β-lactam 200 in 
good yield. Interestingly, pyrrolidine derivatives afforded α-cyclopropanated-β-homoprolines 
due to the instability of carbapenam skeleton in 202. Additionally, the authors showed that these 
highly functionalized homoprolines were incorporated in the synthesis of a pseudotripeptide 
(Scheme 47).
90
 
 
Scheme 48. Total synthesis of gelsemoxonine. 
In 2013, Carreira’s group published a 21-step total synthesis of gelsemoxonine, a natural 
product isolated from traditional Chinese medicine.
91
 The author utilized Brandi’s 1,3-dipolar 
addition and acid-promoted ring contraction sequence to obtain β-lactam 208, which ultimately 
elaborated into the azetidine in 209. A mechanistic study indicated that the reaction proceeds via 
a concerted pathway.
92
 In 2015, Carreira et al. reported a full account of their studies on 
gelsemoxonine as well as an enantioseletive synthesis of key intermediate 206.
93
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2.1.3 Metal-catalyzed MCP [3+2] cycloaddition reactions  
The metal-catalyzed [3+2] cycloaddition of MCP and double bonds has been studied 
extensively since the pioneering studies of Noyori’s and Binger’s group in 1970s.94-96 
Motherwell and Nakamura independently reported examples of intramolecular [3+2] 
cycloaddition between MCPs with alkenes and alkynes in 1988.
97-98
 These methodologies served 
as great procedures to construct highly functionalized cyclopentanes. (Figure 11) 
 
Figure 11. Metal-catalyzed MCP reaction pathways. 
Generally, there are two different pathways for the [3+2] cycloaddition between MCP 
and double bonds. An oxidative insertion of the distal bond (C2-C3) would generate 
metallacyclobutane 210. The carbonmetalation with double bonds and reductive elimination 
forms cyclopentane 211. Alternatively, the proximal bond cleavage between C1 and C2 would 
lead to the formation of regioisomer 213 (Figure 11). 
Mascareñas and co-workers published a series of papers on the [3+2] cycloaddition of  
alkyne/alkene/allene tethered MCPs in the presence of palladium catalysts.
99-103
 In 2003, they 
found that the cyclization of 214 afforded 215 in good yield when treated with a palladium-
phosphite complex.
99
 Later they discovered that a Ruthenium-based catalyst was capable of 
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catalyzing the reaction in a similar fashion.
100
 DFT studies suggested that these cyclizations are 
initiated by an oxidative insertion into the distal bond and followed by an isomerization via a 
TMM-Pd complex to give a palladacyclobutane intermediate 216.
101
 Intramolecular addition into 
the alkyne and reductive elimination leads to the formation of 218. Additionally, the authors 
managed to combine the alkylation with the cycloaddition to a one-pot synthesis, which is a 
more simple and practical process
 
(Scheme 49) .
102
 
        
Scheme 49. Palladium-catalyzed [3+2] MCP cyclization with alkynes. 
The electron-deficient alkene tethered MCP 221 furnished 222 in a highly 
diastereoselective fashion through a similar mechanism to alkynes.
102
 On the other hand, the 
authors found the allene 223 could perform the cycloaddition with less catalyst loading (Scheme 
50).
103
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Scheme 50. Palladium-catalyzed [3+2] MCP cyclization with alkenes/allenes. 
2.1.4 Heterocycle synthesis from MCP [3+2] cycloaddition  
 
Scheme 51. Palladium-catalyzed [3+2] MCP cyclization with CO2. 
A C=X (X = N, O) double bond can also react with MCP in the presence of metal 
catalysts. An interesting example is Binger’s lactone synthesis by a palladium-catalyzed 
cycloaddition between MCP and carbon dioxide.
104
 However, this process afforded a mixture of 
regioisomers (227 and 228) and diastereomers. In 2011, Shi et al. published an optimized 
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procedure to synthesize spirocycliclactones 230 with complete regioselectivity.
105
 This 
methodology offers a straightfoward strategy to these highly-substituted lactones, which usually 
took several steps to synthesize from ketones. 
 
Scheme 52. Heat-induced [3+2] cycloaddition of o-aniline-tethered MCP. 
Shi et al. developed a series of novel and efficient protocols utilizing intramolecular 
cycloadditions of o-aniline-tethered MCP.
106-108
 In 2009, they reported a thermo-induced [3+2] 
cyclization from cyclopropane opening of in situ genertated imine 232. Notably, many 
biologically active natural products possesses the same functionalized pyrrolo[1,2-a]indole core 
as 233.
106
 (Scheme 52)  
 
Scheme 53. Heat-induced [3+2] synthesis of furoquinoline 236 and thienoquinoline 237. 
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In 2016, their group published an approach for facile access to furoquinoline and 
thienoquinoline scaffolds from 231.
107
 Mechanistically, the starting anilines were transformed 
into isocyanates in situ. Next, the isocyanate-tethered 234 underwent a 6π-electrocyclization to 
form intermediate 235, which further rearranged to product 236 through cleavage of the 
cyclopropane ring. Potential applications of products 236 and 237 were still under investigation. 
 
Scheme 54. Rh(II)-catalyzed indole-fused azetidine synthesis. 
Another rhodium(II)-catalyzed protocol that converts othro-MCP-tethered phenyl azide 
into indole-fused azetidines was discovered by Shi and co-workers in 2016.
108
 When the radical 
trapping reagent TEMPO was applied, the authors found the yield of 239 was dramatically 
diminished. This suggested a SET (single-electron-transfer) mechanism might be involved. The 
authors proposed a mechanism based on the experimental results and DFT studies. Upon the 
coordination of Rh2(esp)2, 238 releases N2 and produces nitrene 240. Subsequent SET and 
addition generates radical 241, which is rearranged to give indole intermediate 242. Another SET 
regenerates rhodium catalyst and furnishes indole-fused azetidines 239 as final product (Scheme 
54). 
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2.1.5 Metal-catalyzed MCP [3+2+2] cycloaddition reactions  
 
Scheme 55. Nickel-catalyzed [3+2+2] MCP cyclization with alkynes. 
In 2004, Saito et al. first discovered a intermolecular [3+2+2] cycloaddition between 
MCP and alkynes.
109
 The resulting seven-member ring carbocycles are prevalent among many 
nature products. Interestingly, nickel was used in this case and the product distribution was 
distinctively different from palladium-catalyzed cycloadditions because nickel prefers the 
proximal insertion to the distal insertion. Recently, this reaction was further developed as a 3-
component reaction (2 different alkynes) with a good yield of a single regioisomer (Scheme 
55).
110 
 
 
Scheme 56. Mechanisms of nickel-catalyzed [3+2+2] MCP cyclization with alkynes. 
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In 2015, a follow-up DFT study from Saito’s group suggested two possible pathways 
depending on the different substitutions on the alkynes.
111
 Alkyl-substituted alkynes prefer 
pathway A, and the regioselectivity is determined by the second insertion of acetylene (246). A 
bulkier R would generate 3,5-substituted 247a, while a smaller R would afford a mixture of 247a 
and 247b. For pathway B, electron-deficient alkynes would couple with the nickel catalyst to 
form 248, which ultimately determines regioselectivity of the 2,5-substituted 250. These 
reactions provide a facile synthesis of 7-member ring carbocycles with decent regioselectivity. 
(Scheme 56) 
 
Scheme 57. Rhodium-catalyzed [3+2+2] MCP cyclization with alkynes. 
In 2008, Evans et al. explored an intra/intermolecular [3+2+2] process for the preparation 
of cis–fused bicycloheptadienes 252 catalyzed by a rhodium phosphite complex.112 The study 
was noteworthy for the fast stereospecific generation of three new stereogenic centers and the 
control of the regiochemistry. In 2015, the same authors published another [3+2+2] 
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cycloaddition utilizing allenes as a component to generate tri- or tetrasubstituted exocyclic 
olefins 254, which provided a new route to the guaiane family of sesquiterpenes (Scheme 57).
113
 
2.1.6 Metal-catalyzed MCP cycloisomerization reactions  
De Meijere et al. developed a novel [3+1] ring expansion reaction that produces 
methylenecyclobutanones under mild conditions.
114
 The carbonylation could be carried out under 
1 atmosphere of CO (balloon) with 5 mol% of [Co2(CO)8]. Other metal carbonyls such as  
[W(CO)6], [Mo(CO)6], [Fe(CO)5] and [Cr(CO)6] gave poor yield. Notably, this is the first 
example of a cobalt catalyst effectively activating the δ bonds of a cyclopropane. (Scheme 58) 
 
Scheme 58. Cobalt-catalyzed carbonylation of MCP. 
In 2006, Fürstner reported a PtCl2-catalyzed cycloisomerization of MCP into cyclobutene 
in moderate to good yield.
84
 Shi et al. independently published the same ring-expansion 
transformation utilizing Pd(OAc)2 and CuBr2.
85
 In 2009, Marek and co-workers proved that the 
rearrangement of enantiomerically pure MCP completely conserved the quaternary stereocenter 
with high regioselectivity (Scheme 59).
115
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Scheme 59. Pd/Pt-catalyzed cycloisomerization of MCP. 
2.2 RESULTS AND DISSCUSSION 
2.2.1 Pd-catalyzed cycloisomerization of bicyclo[1.1.0]butane and MCP 
In the last several sections, we have discussed the reactivities of MCP extensively. 
Inspired by these fascinating examples, we planned to explore the interaction between MCP and 
bicyclo[1.1.0]butane. With the highly strained nature of both moieties, a great potential in 
organic synthesis can be envisioned. 
 
Scheme 60. Proposed palladium-catalyzed cycloisomerization of MCP and bicyclo[1.1.0]butane. 
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We imagined that the central bond of bicyclo[1.1.0]butane in 263 would serve as an 
alkene functionality to perform a formal [3+2] cycloaddition with MCP. A palladium catalyst 
could insert into the distal bond of MCP and isomerize to palladacyclobutane 264. Next, the 
addition of bicyclo[1.1.0]butane and reductive elimination would afford our desired 
bicyclo[3.1.1]heptane 265. On the other hand, 263 could also undergo a formal [2+2] 
cycloaddition to product cyclopropanated bicyclo[3.1.1]heptane 266.  
 
Scheme 61. Initial attempt of a palladium-catalyzed MCP cyclization. 
Our initial attempt was carried out with substrate 263, which was prepared from the 
Mistunobu reaction between 157 and 2-cyclopropylideneethanol. As shown in Scheme 61, A 
solution of 263 in dioxane was heated at reflux in the presence of 10 mol% Pd2(dba)3 and 40 
mol% triisopropylphosphite. Surprisingly, we obtained 268 in 65% yield as the only product 
without the observation of 265 or 266. Instead of forming the Pd-TMM complex with MCP, the 
palladium catalyst might open the bicyclo[1.1.0]butane ring into a carbene intermediate to 
provide the product 268. 
 
Scheme 62. Rhodium(I)-catalyzed cycloisomerization of 269. 
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We were intrigued by this result because our group previously reported a rhodium-
catalyzed cycloisomerization of bicyclo[1.1.0]butanes.
3
 As depicted in Scheme 62, by tuning the 
ligands on the rhodium catalyst, bicyclo[1.1.0]butane 269 can generate two rhodium carbine 
species 270 and 272. Subsequently, cyclopropanations produced pyrrolidine 271 or azepine 273, 
respectively.  
 
Figure 12. X-ray structure of 268. 
Recrystallization of 268 in dichloromethane and hexanes afforded a fine colorless crystal. 
The X-ray structure of 268 is displayed in Figure 12. The highly-strained spirocyclopropane ring 
is perpendicular to the pyrrolidine. Notably, the phenyl and allyl group are in a trans relationship. 
We observed a cis orientation of these groups in our previous rhodium-catalyzed 
cycloisomerization.  
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Having confirmed the structure of spirocyclopropane 268, we further examined the 
reaction with substrate 269, which provided 274 under our standard conditions. Interestingly, 
274 is the opposite diastereomer of our previous rhodium-catalyzed cycloisomerization product 
271. On the other hand, we did not detect any azepine-type (273) product under our conditions. 
We noticed very similar H-NMR spectra of these two compounds except for the protons located 
in the pyrrolidine ring. The assignment of these protons are depicted in Figure 13. 
 
  
 
Figure 13. NMR spectra of diastereomers 271 and 274. 
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First of all, we assigned Hb and Hb’ by examing the vicinal H-H coupling between Hb/Hb’ 
and Hc. 
3
JHH of Hb/Hc (271) and Hb’/Hc (274) were close to 0 Hz so the dihedral angles of these  
C-H bond should be ~90º. Second of all, Hb’ in 271 and 274 were both around 3.7 ppm because 
they adopted a similar equatorial position. Comparing to 274, two axial protons (Ha and Hb) in 
271 shifted downfield. The shielding effect of cyclopropane rings should be responsible for this 
shift.
115
 In 271
 
both protons were cis to the cyclopropane ring and much closer than the protons 
that were trans to the cyclopropane ring in 274. Additionally, in 271 Ha shifted downfield due to 
the anisotropic effect of the trans allyl group.
116
 This explains why Ha had a larger Δδ value (0.6 
ppm for Ha, 0.4 ppm for Hb). Finally, we also observed the shielding effect of the phenyl ring to 
the protons located at the cyclopropanes.
117 
As shown in Figure 12, the phenyl ring in 274 was 
perpendicular to the pyrrolidine ring and adjacent to the endo proton Hd.
 
Comparing to 271, The 
current on the phenyl ring shifted Hd downfield (0.6 ppm) and Hd’ upfield (-0.3 ppm).  
We next optimized the reaction conditions (Table 9). When the palladium (II) catalysts 
were applied, no product was observed. (entry 1). The yield was lower with palladium catalyst 
such as Pd(PPh3)4 (entry 2). 275 and triphenylphosphite reduced the yield dramatically (entries 3 
and 4). When the phosphine ligand DPPP or P(nBu)3 was used, the yield was also diminished 
(entries 5 and 6). Addition of the bulkier P(iPr)3 improved the yield of 274 to 81% (entry 7).  By 
reducing the catalyst and ligand loading to 10 mol%, the yield remained excellent (entry 8). The 
reaction was completed in less than 45 min in a microwave reactor. When only 5% catalyst was 
applied, a high concentration (0.1 M) was required to generate 274 in a high yield (entry 9). 
Finally, the bulkier P(tBu)3 ligand had a detrimental effect, while the smaller ligand PCy3 gave 
82% of 274 (entries 10 and 11). Additionally, solvents such as toluene and DMF provided no 
improvement. 
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Table 9. Reaction conditions optimizations for the cycloisomerization of 224. 
 
Entry[a] Catalyst Ligand Yield[b] 
1 20 mol % PdCl2 40 mol % P(OiPr)3 0% 
2 20 mol % Pd(PPh3)4 - 35% 
3 10 mol % Pd2(dba)3 40 mol % P(OPh)3 0% 
4 20 mol % Pd(dba)2 40 mol % 226 15% 
5 20 mol % Pd(dba)2 20 mol % DPPP 42% 
6 20 mol % Pd(dba)2 40 mol % PnBu3 34% 
7[c,d] 20 mol % Pd(dba)2 40 mol % PiPr3 81% 
8[c] 10 mol % Pd(dba)2 20 mol % PiPr3 82% 
9[c,d] 5 mol % Pd(dba)2 10 mol % PiPr3 84% 
10[c,e] 5 mol % Pd(PtBu3)2 - 0% 
11[c,e] 5 mol % Pd(PCy3)2 - 82% 
[a] Reaction was heated to reflux in 1,4-dioxanes for 2 h, concentration = 0.02M. [b] All yields are 
isolated yields. [c] Reaction was heated at 130 °C in a microwave reactor for 30-45 min. [d] 
Concentration = 0.1 M. [e] Concentration = 0.05 M. 
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Scheme 63. Precursor synthesis of various bicyclo[1.1.0]butanes 263a-i. 
After identifying optimized conditions, we synthesized a set of 1-bicyclo[1.1.0]butan-1-yl 
alkylamines 157a-i through the addition of bicyclo[1.1.0]butyllithium reagent in moderate to 
good yields (Scheme 63). Due to the high volatility of 2-cyclopropylideneethanol, we applied a 
Tsuji-Trost type reaction for the alkylation of 157a-i. The vinylcyclopropyl tosylate formed a π-
allyl-Pd(II) complex and attacked by the tosyl amide to generate 263a-i in excellent yields. 
Morever, we also prepared methyl-susbstituted 263i in 94% yield.  
Table 10. Palladium-catalyzed isomerization of various bicyclo[1.1.0]butanes.
[a]
 
 
[a] Reaction was heated to 130 °C with microwave reactor in 1,4-dioxanes for 30 min at 0.05 M concentration.  [b] 
Condition A = 10 mol % Pd(dba)2, 20 mol % PiPr3. [c] Condition B = 10 mol % Pd(dba)2, 20 mol % P(OiPr)3. [d] 
Reaction was carried out in toluene. [e] concentration = 0.1 M. 
We next explored the scope of the methodology using substrates 263a-i. (Table 11). All 
reactions proceeded in excellent stereoselectivity (268a-i were obtained as a single diastereomer). 
The yield decreased considerably as the substituent on the aromatic group moved closer to the 
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bicyclo[1.1.0]butane (268a-d). The aliphatic substrates generally formed spirocyclopropanes in 
good yield under the original conditions rather than our optimized conditions (entries 268e-i). 
The yield of these substrates decreased dramatically when the size of -group was too large or 
too small (268e and 268h). Only 268f and 268g gave moderate yields. We were surprised that 
the methyl-substituted biyclo[1.1.0]butane underwent the cyclopropanation with good yield, 
despite having a very hindered bicyclo[1.1.0]butane core (268i).  
 
Figure 14. Proposed reaction pathway. 
Our proposed palladium-induced reaction pathway of the bicyclo[1.1.0]butane is 
illustrated in Figure 14. Precomplexation of MCP 263 and palladium catalyst gave intermediate 
276 or 276’. Although palladium could cleave the lateral bond in MCP, the bicyclo[1.1.0]butane 
core was released probably due to a much higher strain energy (66 kcal/mol). And palladium 
catalyst was unable to activate 276’ due to steric hindrance between bicyclo[1.1.0]butane and 
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MCP. The central bond and lateral bond of bicyclo[1.1.0]butane in 276 rearranged to form the 
allyl-carbene intermediate 277. The highly reactive palladium-carbene reacts with MCP 
spontaneously and leads to the formation of 279. Alternatively, the unproductive hydride 
migration pathway provides the side-product diene 278. 
 
Scheme 64. Proposed mechanism for the formation of two diastereomers. 
Furthermore, we rationalized the origin of diastereoselectivities of Pd and Rh catalysts in 
Scheme 64. Since the reaction led to the pyrrolidine without forming any azepine isomers, the 
palladium catalyst could not generate an external metal-carbene complex like our previous 
rhodium-catalyzed cycloisomerization process. One interpretation from this is that the 
coordination between palladium and MCP/allyl was essential for the generation of palladium-
carbene species 277. However, rhodium catalysts can insert into bicyclo[1.1.0]butanes and 
provide rhodium-carbene species 270’ without such directing groups.118-119 The selectivity of 
rhodium catalyst can be explained by thermodynamic stability of conformer 270’. On the other 
hand, the coordination of MCP and palladium directed the bicyclo[1.1.0]butane opening. And the 
less sterically hindered intermediate 276 produced palladium-carbene 277 which furnished 268 
simultaneously. Thus 268 can be considered as a kinetically-controlled product.  
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2.2.2 Rhodium-catalyzed carbonylation of spiropentanes 
Intrigued by the formation of spiropentanes, we further explored the utility of the 3-
azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] scaffold. Most of the methodologies of 
spiropentanes demand a heteroatom or an activating group on the cyclopropane. However, 
Murakami et al. developed a rhodium-catalyzed carbonylation reaction involving two 
consecutive -bond cleavages (C1-C3 and C4-C5) of inactivated spiropentane.120 As depicted in 
Scheme 65, the carbonylation protocol provided gem-di-substituted products (281a-c) in good 
yield but cyclooctane-fused (281d and 281e) and tri-substituted (281f) products in moderate to 
low yield.  
 
Scheme 65. Murakami’s rhodium-catalyzed carbonylation of spiropentanes. 
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Scheme 66. Rhodium-catalyzed carbonylation of spiropentane 223. 
Our concern for the reaction was that 268 is a tri-substituted and cyclopentane-fused 
spirocyclopentane, which might give a poor yield according to Murakami’s substrate scope. 
Another concern was that the allyl group in 268 might coordinate with rhodium and fail to 
activate the spirocyclopropane because the allyl group was in the opposite position of 
spirocyclopropane.  
We decided to test the reaction with hydrogenated product 282 to avoid the potential 
detrimental effect of the allyl to the carbonylation sequence. The hydrogenation with platinum 
dioxide at low temperature (0 ºC) gave 282 almost quantitatively without the hydrogenation of 
the spirocyclopropanes. Refluxing 282 in presence of rhodium catalyst under one atmosphere 
carbon monoxide furnished cyclopentenone 283 in decent yield (Scheme 66). 
Mechanistically, the rhodium catalyst opens C4-C5 bond in spirocyclopentane 282 to 
generate rhodacyclobutane 284. Next, the migrations of C1 and C2 lead to the formation of 285 
and 288, respectively. Since C2 possesses more steric hindrance than C1, 285 is the predominant 
intermediate. Carbonyl insertion and reductive elimination produces 287, which further 
isomerizes to furnish our final product 283. On the other hand, due to excessive steric on tertiary 
C2, the carbonylation does not occur on 288 (Scheme 67) . 
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Scheme 67. Proposed pathways for rhodium-catalyzed carbonylation of spiropentane 282. 
Murakami obtained an excellent yield on the gem-di-substituted substrates because the 
large steric hindrance on C2 drove the migration to occur at C1 almost entirely. For other 
substrates however, there were no such dramatic differences between C1 and C2, which led to 
the formation of many C1-migration by-products. We believed that the cis phenyl group in 282 
provided extra steric hindrance to force C1 migration over C2 migration, which benefited the 
overall yield of our product 283. 
Recrystallization of 283 from dichloromethane and hexanes provided a fine colorless 
crystal. The butterfly-shape X-ray structure confirmed our proposed structure of 283 (Figure 15). 
The orientation of n-propyl and phenyl group remained the same during the carbonylation 
process.  
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Figure 15. X-ray structure of 283. 
Additionally, 268 can also afford carbonylation product 289 with a decent yield (55%). 
The coordination of the allyl group did not affect the carbonylation process.  
 
Scheme 68. Rhodium-catalyzed carbonylation of spiropentane 268. 
2.3 CONCLUSION 
We have developed a palladium-catalyzed cycloisomerization reaction of 
bicyclo[1.1.0]butane and MCP. The unique pathway gave spiropentanes as single diastereomers 
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which happens to be the opposite diastereomer of our previous rhodium-catalyzed process. These 
methodologies enabled a diastereoselective access to a variety of 3-azabicyclo[3.1.0]hexane 
scaffolds that possessed a quaternary stereocenter. This demonstrates that 1-bicyclo[1.1.0]butan-
1-yl alkylamines could be applied into the synthesis of multifunctional molecules and potentially 
served as precursors to pharmacologically active heterocycles such as indolizomycin
121
, 
boceprevir
122
, cycloclavine
123-127
 or duocamycin A
128
 (Figure 16). 
 
Figure 16. Examples of several biologically active compounds with a 3-azabicyclo[3.1.0]hexane core. 
The cycloisomerization and carbonylation sequences allow a rapid synthesis of a 
multifunctionalized 3-azabicyclo[3.3.0]octane scaffold. This carbonylation process benefited 
from the extra steric hindrance provided by the substitutions on the pyrrolidine ring. Finally, this 
methodology enables a brand new pathway towards the synthesis of complex natural product 
such as paucidisine
129
, mubironine C
130
, lycopalhine A
131-133
 and obscurinine
134
. 
 
Figure 17. Examples of several natural products with a 3-azabicyclo[3.3.0]octane core. 
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3.  EXPERIMENTAL SECTION 
 
General. All reactions were performed under an Argon atmosphere and all glassware 
was dried in an oven at 140 °C for 2 h prior to use. Reactions carried out at -78 °C employed a 
CO2/acetone bath. THF and Et2O were distilled over sodium/benzophenone ketyl, (-)-sparteine 
was distilled from CaH2, and CH2Cl2 and toluene were purified using an alumina column 
filtration system. 
Reactions were monitored by TLC analysis (pre-coated silica gel 60 F254 plates, 250 
staining with a PMA solution (5 g of phosphomolybdic acid in 100 mL of 95% EtOH), p- 
anisaldehyde solution (2.5 mL of p-anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 
100 mL of 95% EtOH), Vaughn’s reagent (4.8 g of (NH4)6Mo7O24•4H2O and 0.2 g of Ce(SO4)2 
in 100 mL of a 3.5 N H2SO4 solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 
in 100 mL of a 0.1% NaOH solution). Flash chromatography on SiO2 was used to purify the 
crude reaction mixtures. 
1
H spectra were obtained at 400 or 500 MHz in CDCl3 unless otherwise noted. Chemical 
shifts were reported in parts per million with the residual solvent peak used as an internal 
standard. 
1
H NMR spectra were obtained and are tabulated as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), number of protons, 
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and coupling constant(s). 
13
C NMR spectra were run at 100 or 125 MHz using a proton-
decoupled pulse sequence with a d1
 
of 3 sec, and are tabulated by observed peak. SFC analyses 
were performed using a Mettler-Toledo Model Analytix SFC. 
 
 
P,P-Diphenyl-N-(1-phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-yn-1-yl)phosphinic amide 
(100). To a solution of dimethyl zinc (29 mg, 0.30 mmol) in anhydrous toluene (1.0 mL) was 
added 4-(trifluoromethyl)phenylacetylene (0.068 g, 0.40 mmol) and (S)-(-)-1-benzyl-2-
pyrrolidinemethanol (0.012 g, 0.06 mmol). The mixture was stirred at room temperature for 1 h 
and added a solution of imine (306 mg, 0.10 mmol) in toluene (2.0 mL). The reaction was stirred 
at rt overnight and quenched by NH4Cl. The mixture was extracted with EtOAc, washed with 
brine and dried (Na2SO4). The organic layers were concentrated and purified by chromatography 
on SiO2 (EtOAc: hexanes = 4:1) to afford 100 (30.9 mg, 65%) as a white solid: IR (ATR) 3125.7, 
3086.1, 2905.8, 1591.5, 1574.8, 1446.2, 1313.8, 1174.1, 1159.2, 1149.8, 1075.3, 1026.9, 997.0, 
943.0, 719.4, 700.7, 691.4 cm
-1
; Mp 195  C; e.r.= 93:7 (S:R), SFC condition: Chiralpak IA 
column, sc CO2/MeOH = 70/30, flow rate = 2.5 mL/min, wavelength = 240 nm, tR = 2.7 min (S) 
and 3.1 min (R); [α]D -43 (c 1.40, CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 8.07-8.03 (m, 2 H), 
7.88-7.83 (m, 2 H), 7.65 (d, 2 H, J = 7.6 Hz), 7.56 (d, 2 H, J = 8.0 Hz), 7.54-7.32 (m, 11 H), 5.42 
(t, 1 H, J = 9.6 Hz), 3.54 (dd, 1 H, J = 8.4, 9.2 Hz);
 13
C NMR (100 MHz, CDCl3) δ 139.9 (d,  J = 
5 Hz), 132.3 (d,  J = 10, 78 Hz), 132.1 (d,  J = 3 Hz), 132.0, 128.8, 128.6 (d,  J = 2, 13 Hz), 
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128.2, 127.3, 126.5, 125.1 (q,  J = 4 Hz), 91.5, 84.3, 47.1; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for 
C28H21NOF3P 498.1211, found 498.1209. 
 
N-(4-Methyl-1-(4-(trifluoromethyl)phenyl)pent-1-yn-3-yl)-P,P-diphenylphosphinic amide 
(102). To a solution of diethyl zinc (75 mg, 0.60 mmol) in anhydrous toluene (1.0 mL) was 
added 4-(trifluoromethyl)phenylacetylene (0.102 g, 0.6 mmol) and (S)-(-)-1-benzyl-2-
pyrrolidinemethanol (0.012 g, 0.06 mmol). The mixture was stirred at room temperature for 1 h 
and added a solution of imine tosyl adduct 101b (0.046 g, 0.1 mmol) in toluene (2.0 mL). The 
reaction was stirred at room temperature for 12 h and quenched by NH4Cl. The mixture was 
extracted with EtOAc, washed with brine and dried (Na2SO4). The organic layers were 
concentrated and purified by chromatography on SiO2 (EtOAc: hexanes = 4: 1) to afford 102 
(34.5 mg, 78%) as a white solid: IR (ATR) 3172.3, 2959.8, 1612.2, 1437.0, 1327.1, 1185.4, 
1122.0, 1103.4, 1066.1, 838.7, 749.3, 723.2, 693.4 cm
-1
; Mp 196-199  C; e.r.= 93:7 (S:R), SFC 
condition: Chiralpak IB column, sc CO2/MeOH = 91/9, flow rate = 3.5 mL/min, wavelength = 
240 nm, tR = 3.2 min (S) and 3.9 min (R); [α]D -83.4 (c 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3) 
δ 8.09-8.01 (m, 2 H), 7.92-7.86 (m, 2 H), 7.58-7.45 (m, 10 H), 4.08 (dt, 1 H, J = 9.6, 4.8 Hz), 
3.30 (app t, 1 H, J = 10.0 Hz ), 2.10 (m, 1 H), 1.12 (d, 3 H, J = 6.8 Hz), 1.06 (d, 3 H, J = 6.8 Hz);
 
13
C NMR (100 MHz, CDCl3) δ 132.4 (dd,  J = 78, 127 Hz), 132.3 (d,  J = 10, 110 Hz), 132.0 (t, J 
= 3 Hz), 131.9, 129.9 (q,  J = 32 Hz), 128.5 (dd,  J = 13, 1 Hz), 126.8, 125.1 (q,  J = 4 Hz),  
124.0 (q,  J = 271 Hz), 91.3 (d,  J = 6 Hz), 83.2, 49.7, 34.8 (d, J = 4 Hz), 19.4, 17.3; HRMS (ESI) 
m/z: [M + Na]
+ 
Calcd for C25H23NOF3P 464.1367, found 464.1354. 
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N-(3-(3-Chlorophenyl)-1-phenylprop-2-ynyl)-P,P-diphenylphosphinic amide (103). To a 
solution of diethyl zinc (75 mg, 0.60 mmol) in anhydrous toluene (1.0 mL) was added 3-
chlorophenylacetylene (81.5 mg, 0.6 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (0.012 g, 
0.06 mmol). The mixture was stirred at room temperature for 1 h and added a solution of imine 
tosyl adduct 101a (0.046 g, 0.1 mmol) in toluene (2.0 mL). The reaction was stirred at room 
temperature for 12 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed 
with brine and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc: hexanes = 4: 1) to afford 103 (39.8 mg, 91%) as a white solid: 
IR (ATR) 3144.3, 2855.4, 2848.0, 1589.9, 1560.0, 1472.4, 1450.1, 1435.2, 1185.4, 1123.9, 
1107.1, 1060.5, 991.6, 784.7,  747.4, 725.0, 695.2, 680.3 cm
-1
;  Mp 165-166  C; e.r.= 92:8 (S:R), 
SFC condition: Chiralpak IA column, sc CO2/MeOH = 75/25, flow rate = 2.5 mL/min, 
wavelength = 240 nm, tR = 3.5 min (S) and 4.0 min (R); [α]D -50.8 (c 1.24, CHCl3); 
1
H NMR 
(400 MHz, CDCl3) δ 8.11-8.06 (m, 2 H), 7.90-7.85 (m, 2 H), 7.70-7.67 (d, 2 H, J = 8 Hz), 7.58-
7.49 (m, 4 H), 7.44-7.37 (m, 4 H),  7.34-7.23 (m, 5 H), 5.43 (t, J = 9.6 Hz ), 3.61 (t, J = 9.6, 4.8 
Hz ); 
13
C NMR (100 MHz, CDCl3) δ 140.04 (d,  J = 5 Hz), 134.1, 132.2 (dd, J = 49, 129 Hz), 
132.1 (t. J = 3 Hz), 131.6, 131.3 (dd, J = 10, 88 Hz), 129.8, 129.5, 128.8, 128.7, 128.6 (d, J = 13 
Hz), 128.1, 127.3, 124.4, 90.1 (d, J = 5 Hz), 84.2, 47.1; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for 
C27H21NOClP 464.0947, found 464.0967. 
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N-(3-Cyclohexyl-1-phenylprop-2-ynyl)-P,P-diphenylphosphinic amide (104). To a solution 
of diethyl zinc (75 mg, 0.6 mmol) in anhydrous toluene (1.0 mL) was added cyclohexylacetylene 
(64.6 mg, 0.6 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (12 mg, 0.06 mmol). The 
mixture was stirred at room temperature for 1 h and added a solution of imine tosyl adduct 101a 
(0.046 g, 0.1 mmol) in toluene (2.0 mL). The reaction was stirred at room temperature for 48 h 
and quenched by NH4Cl. The mixture was extracted with EtOAc, washed with brine and dried 
(Na2SO4). The organic layers were concentrated and purified by chromatography on SiO2 
(EtOAc: hexanes = 4: 1) to afford 104 (27.7 mg, 67%) as a white solid: IR (ATR) 3153.6, 3054.9, 
2926.3, 2849.8, 1491.1, 1448.2, 1437.0, 1260.0, 1187.3, 1148.1, 1123.9, 1109.0, 1092.2, 1068.0, 
1053.1, 1027.0, 997.2, 930.1, 900.2, 889.1, 825.7, 803.3, 749.3, 738.1, 723.2, 695.2 cm
-1
; Mp 
158-159  C; e.r.= 69:31 (S:R), SFC condition: Chiralpak IB column, sc CO2/MeOH = 90/10, flow 
rate = 4.0 mL/min, wavelength = 220 nm, tR = 5.3 min (S) and 6.0 min (R); [α]D -12.6 (c 1.12, 
CHCl3); 
1
H NMR (500 MHz, CDCl3) δ 8.11-8.06 (m, 2 H), 7.86-7.81 (m, 2 H), 7.65 (d, 2 H, J = 
8 Hz), 7.56-7.54 (m, 1 H), 7.52-7.47 (m, 3 H), 7.43-7.40 (m, 2 H), 7.37-7.34 (m, 2 H), 7.29-7.26 
(m, 2 H), 5.18 (t, J = 8.0 Hz ), 3.43 (t, J = 7.6 Hz ), 2.45 (m, 1 H), 1.93-1.81 (m, 2 H), 1.74-1.72 
(m, 2 H), 1.56-1.53 (m, 1 H), 1.50-1.46 (m, 2 H), 1.46-1.32 (m,3 H); 
13
C NMR (100 MHz, 
CDCl3) δ 141.08 (d,  J = 4 Hz), 132.5 (dd, J = 130, 76 Hz), 132.3 (d, J = 10, 104 Hz), 131.9 (dd, 
J = 7, 3 Hz), 128.5 (d, J = 2 Hz), 128.4, 127.7, 127.3, 90.3, 79.7 (d, J = 7 Hz), 46.8, 32.6, 25.9, 
24.9; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for C27H28NOP 436.1806, found 436.1806.  
 73 
 
N-(1-(4-Bromophenyl)-4-methylpent-1-yn-3-yl)-P,P-diphenylphosphinic amide (105). To a 
solution of diethyl zinc (75 mg, 0.60 mmol) in anhydrous toluene (1.0 mL) was added 4-
bromophenylacetylene (109 mg, 0.6 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (0.012 g, 
0.06 mmol). The mixture was stirred at room temperature for 1 h and added a solution of imine 
tosyl adduct 101b (0.043 g, 0.1 mmol) in toluene (2.0 mL). The reaction was stirred at room 
temperature for 6 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed 
with brine and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc: hexanes = 4: 1) to afford 105 (37.9 mg, 84%) as a white solid: 
IR (ATR) 3159.2, 2956.1, 2868.5, 1483.6, 1437.0, 1187.3, 1122.0, 1109.0, 1068.0, 1010.2, 922.6, 
892.8, 823.8, 749.3, 723.2, 697.1 cm
-1
; Mp 194-195  C; e.r.= 94:6 (S:R), SFC condition: 
Chiralpak IB column, sc CO2/MeOH = 90/10, flow rate = 4.0 mL/min, wavelength = 240 nm, tR 
= 5.4 min (S) and 6.0 min (R); [α]D -101.2 (c 1.03, CHCl3); mp 194-195; 
1
H NMR (400 MHz, 
CDCl3) δ 8.06-8.00 (m, 2 H), 7.91-7.86 (m, 2 H), 7.53-7.43 (m, 8 H), 7.23 (d, 2 H, J = 8.4 Hz), 
4.04 (ddd,1 H, J = 6.4, 5.2, 4.8 Hz ), 3.28 (dd, J = 10.4, 8.8 Hz ), 2.12-2.08 (m, 1 H), 1.10 (d, 3 H, 
J = 6.8 Hz), 1.04 (d, 3 H, J = 6.8 Hz);
 13
C NMR (100 MHz, CDCl3) δ 133.1, 132.4 (dd,  J = 129, 
95 Hz), 132.2 (d, J = 10, 96 Hz), 132.0, 131.5, 128.6 (dd, J =13, 2 Hz), 122.4, 121.9, 89.8 (d, J = 
6 Hz), 83.5, 49.8, 34.9 (d, J = 4 Hz), 19.4, 17.2; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for 
C24H23NOPBr 474.0598, found 474.0598. 
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N-(4-Methyl-1-(triisopropylsilyl)pent-1-yn-3-yl)-P,P-diphenylphosphinic amide (106). To a 
solution of diethyl zinc (75 mg, 0.60 mmol) in anhydrous toluene (1.0 mL) was added 
triisopropylsilylacetylene  (110 mg, 0.6 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol 
(0.012 g, 0.06 mmol). The mixture was stirred at 5 ºC for 1 h and added a solution of imine tosyl 
adduct 101b (0.043 g, 0.1 mmol) in toluene (2.0 mL). The reaction was stirred at rt for 24 h and 
quenched by NH4Cl. The mixture was extracted with EtOAc, washed with brine and dried 
(Na2SO4). The organic layers were concentrated and purified by chromatography on SiO2 
(EtOAc: hexanes = 4: 1) to afford 106 (38.1 mg, 84%) as a white solid: IR (ATR) 3183.5, 3056.7, 
2954.2, 2939.3, 2862.9, 2165.8, 2158.3, 1461.3, 1437.0, 1383.0, 1189.1, 1123.9, 1109.0, 1071.7, 
1027.0, 1017.7, 997.2, 883.5, 751.1, 747.4, 723.2, 693.4, 678.4 cm
-1
; Mp 86-87  C; e.r.= 92:8 
(S:R), SFC condition: Chiralpak IA column, sc CO2/MeOH = 90/10, flow rate = 4.0 mL/min, 
wavelength = 220 nm, tR = 2.1 min (R) and 2.6 min (S); [α]D -89.0 (c 0.87, CHCl3); 
1
H NMR 
(400 MHz, CDCl3) δ 8.09-8.02 (m, 2 H), 7.89-7.82 (m, 2 H), 7.56-7.43 (m, 6 H), 3.86 (dt,1 H, J 
= 10.4, 4.8 Hz ), 3.22 (t, J = 10.4 Hz ), 2.06-2.00 (m ,1 H), 1.11(m, 21 H), 1.06 (d, 3 H, J = 6.8 
Hz), 1.00 (d, 3 H, J = 6.8 Hz);
 13
C NMR (100 MHz, CDCl3) δ 132.6 (dd, J = 154, 126 Hz), 132.3 
(d, J = 10, 121 Hz), 131.9 (t, J = 3 Hz), 128.5 (dd, J = 13, 4 Hz), 106.9 (d, J = 9 Hz), 84.8, 50.2, 
34.9 (d, J = 2 Hz), 19.4, 18.6, 16.8, 11.2; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for C27H40NOPSi 
476.2515, found 476.2511. 
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P,P-Diphenyl-N-(5-phenyl-1-(4-(trifluoromethyl)phenyl)pent-1-yn-3-yl)phosphinic amide 
(107). To a solution of diethyl zinc (75 mg, 0.60 mmol) in anhydrous toluene (1.0 mL) was 
added 4-(trifluoromethyl)phenylacetylene (102 mg, 0.6 mmol) and (S)-(-)-1-benzyl-2-
pyrrolidinemethanol (0.012 g, 0.06 mmol). The mixture was stirred at room temperature for 1 h 
and added a solution of imine tosyl adduct 101c (0.049 g, 0.1 mmol) in toluene (2.0 mL). The 
reaction was stirred at room temperature for 24 h and quenched by NH4Cl. The mixture was 
extracted with EtOAc, washed with brine and dried (Na2SO4). The organic layers were 
concentrated and purified by chromatography on SiO2 (EtOAc: hexanes = 4: 1) to afford 107 
(41.3 mg, 82%) as a white solid: IR (ATR) 3144.3, 2928.1, 2859.2, 1614.1, 1437.0, 1328.9, 
1321.5, 1185.4, 1163.0, 1123.9, 1110.9, 1103.4, 1094.1, 1081.0, 1068.0, 1015.8, 965.5, 840.6, 
749.3, 725.0, 698.9, 693.4 cm
-1
; Mp 188-189  C; e.r.= 98:2 (S:R) (after recrystallization), SFC 
condition: Chiralpak IB column, sc CO2/MeOH = 85/15, flow rate = 3.5 mL/min, wavelength = 
240 nm, tR = 4.2 min (S) and 5.1 min (R); [α]D -47.0 (c 0.84, CHCl3) (70% ee sample); 
1
H NMR 
(500 MHz, CDCl3) δ 7.99-7.95 (m, 2 H), 7.87-7.83 (m, 2 H), 7.59-7.57 (m, 2 H), 7.54-7.43 (m, 8 
H), 7.28-7.26 (m, 2 H), 7.20-7.18 (m , 3 H), 4.25-4.20 (m, 1 H), 3.34 (dd, J = 10.5, 7.5 Hz), 2.92-
2.85 (m, 2 H), 2.27- 2.16 (m, 2 H);
 13
C NMR (125 MHz, CDCl3) δ 140.9, 132.2 (dd, J = 10, 93 
Hz), 132.2 (dd, J = 129, 85 Hz), 132.1 (t, J = 2.5 Hz), 131.9, 130.0 (q, J = 45 Hz), 128.6 (dd, J = 
12.5, 1.3 Hz), 128.5 (overlap), 126.6, 126.1, 125.2 (q, J = 3.8 Hz), 123.9 (q, J = 270 Hz), 92.4 (d, 
J = 6.3 Hz), 82.9, 43.7, 40.0 (d, J = 3.8 Hz), 32.1; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for 
C30H25NOF3P 526.1524, found 526.1524. 
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P,P-Diphenyl-N-(phenyl(3-(4-(trifluoromethyl)phenyl)bicyclo[1.1.0]butan-1-yl)methyl) 
phosphinic amide (112). To a cold solution of 100 (220 mg, 0.46 mmol) in anhydrous CH2Cl2 
(6 mL) was added Me2Zn (44 mg, 0.46 mmol) in anhydrous CH2Cl2 (1 mL). The reaction 
mixture was stirred at 0 ºC for 1 h, cooled to -50 ºC and added a cold solution of Et2Zn (114 mg, 
0.93 mmol) in anhydrous DCM (5 mL). The mixture was stirred for 10 min and added CH2I2 
(501 mg, 1.85 mmol). The reaction was stirred at -30 ºC overnight, quenched with saturated 
NH4Cl and extracted with DCM. The combined organic layers were washed with water and brine 
and dried (MgSO4). The product was concentrated and purified by chromatography on SiO2 
(EtOAc: hexanes = 4: 1) to afford 112 (74 mg, 32%) as a white solid: IR (ATR) 3285.6, 3086.1, 
3067.5, 3054.5, 3037.7, 3030.2, 1647.4, 1626.9, 1591.5, 1574.8, 1559.8, 1446.2, 1313.8, 1272.8, 
1203.9, 1174.1, 1159.2, 1149.8, 1075.3, 1026.9, 997.0, 943.0, 935.5, 916.9, 864.7, 812.5, 764.1, 
719.4, 700.7, 691.4 cm
-1
; Mp 124-126  C; e.r.= 93:7 (S:R), SFC condition: Chiralpak IA column, 
sc CO2/MeOH = 75/25, flow rate = 2.5 mL/min, wavelength = 240 nm, tR = 3.1 min (S) and 3.9 
min (R);  [α]D -28.5 (c 1.0, CHCl3);  
1
H NMR (400 MHz, CDCl3) δ 7.91-7.86 (m, 2 H), 7.64-7.59 
(m, 2 H), 7.53-7.40 (m, 4 H), 7.46-7.28 (m, 4 H), 7.18-7.10 (m, 3 H), 6.95 (d, 2 H, J = 8.0 Hz), 
6.76 (d, 2 H, J = 8.4 Hz), 4.64 (t, 1 H, J = 8.4 Hz), 3.46 (dd, 1 H, J = 7.2, 4.8 Hz), 2.24 (d, 1 H, J 
= 6.8, 5.6 Hz), 2.00 (d, 1 H, J = 6.4 Hz), 1.03 (s, 1 H), 0.95 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) 
δ 140.7, 139.9 (d, J = 6 Hz), 132.6 (dd, J = 128, 88 Hz), 132.0 (dd, J = 18, 9 Hz), 131.8 (t, J = 3 
Hz), 128.4 (dd, J = 12, 7 Hz), 128.2, 127.5, 126.9, 125.6, 124.9 (q, J = 4 Hz), 55.1, 34.2, 31.5, 
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30.0 (q, J = 5 Hz), 20.4; HRMS (ESI) m/z: [M + Na]
+ 
Calcd for C30H25NOF3P 526.1524, found 
526.1525. 
 
 
N-(2-Methyl-1-(3-(4-(trifluoromethyl)phenyl)bicyclo[1.1.0]butan-1-yl)propyl)-P,P-
diphenylphosphinic amide (113). To a cold solution of 102 (34.5 mg, 0.08 mmol) in anhydrous 
CH2Cl2 (6 mL) was added Me2Zn (7.5 mg, 0.08 mmol) in anhydrous CH2Cl2 (1 mL). The 
reaction mixture was stirred at 0 ºC for 1 h, cooled to -50 ºC and added a solution of Et2Zn (19 
mg, 0.16 mmol) in anhydrous DCM (5 mL). The mixture was added CH2I2 (84.5 mg, 0.31 mmol) 
in this temperature. The reaction mixture was stirred at -30 ºC overnight, quenched with 
saturated NH4Cl and extracted with DCM. The combined organic layers were washed with water 
and brine and dried (MgSO4). The product was concentrated and purified by chromatography on 
SiO2 (EtOAc: hexanes = 4: 1) to afford 113 (17.0 mg, 46%) as a yellowish solid: IR (ATR) 
3204.0, 3190.9, 3183.5, 2957.9, 2926.3, 2883.4, 2870.3, 1614.1, 1437.0, 1323.3, 1185.4, 1163.0, 
1118.3, 1062.4, 842.5, 751.1, 723.2, 697.1, 685.9 cm
-1
; Mp 117-118  C; 1H NMR (400 MHz, 
CDCl3) δ 7.61-7.36 (m, 13 H), 7.49-7.38 (m, 1 H), 3.25 (ddd, J = 10.4, 6.4, 3.2 Hz), 2.76 (dd, 1 
H, J = 10.8, 2.8 Hz), 2.32 (d, 1 H, J = 6.8 Hz), 2.20-2.12 (m, 1 H), 2.13 (d, 1 H, J = 6.4 Hz), 1.21 
(s, 1 H), 1.12 (s, 1 H), 1.00 (d, 3 H, J = 6.8 Hz), 0.95 (d, 3 H, J = 6.8 Hz);
 13
C NMR (125 MHz, 
CDCl3) δ 142.2, 132.2 (dd, J = 134, 130 Hz), 132.0 (d, J = 10, 30 Hz), 131.8 (dd, J = 10, 3 Hz), 
128.3 (dd, J =13, 7 Hz), 127.2 (q, J = 32 Hz), 126.1, 125.2, (q, J = 4 Hz), 124.5 (q, J = 270 Hz), 
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54.8, 34.9 (d, J = 3 Hz), 33.3, 30.6, 29.0 (d, J = 10 Hz), 19.0, 17.4, 17.1; HRMS (ESI) m/z: [M + 
Na]
+ 
Calcd for C27H27NOPF3 492.1680, found 492.1666. 
 
 
N-(1-(3-(4-Bromophenyl)bicyclo[1.1.0]butan-1-yl)-2-methylpropyl)-P,P-diphenylphosphinic 
amide (114). To a cold solution of 105 (32 mg, 0.07 mmol) in anhydrous CH2Cl2 (6 mL) was 
added Me2Zn (6.8 mg, 0.07 mmol) in anhydrous CH2Cl2 (1 mL). The reaction mixture was 
stirred at 0 ºC for 1 h, cooled to -50 ºC and added a solution of Et2Zn (17.5 mg, 0.14 mmol) in 
anhydrous DCM (5 mL). The mixture was added CH2I2 (77 mg, 0.28 mmol) in this temperature. 
The reaction mixture was stirred at -30 ºC overnight, quenched with saturated NH4Cl and 
extracted with DCM. The combined organic layers were washed with water and brine and dried 
(MgSO4). The product was concentrated and purified by chromatography on SiO2 (EtOAc: 
hexanes = 4: 1) to afford 114 (22.3 mg, 66%) as a yellowish solid: IR (ATR) 3198.4, 3058.6, 
2956.1, 2926.3, 2868.5, 1589.9, 1481.8, 1437.0, 1187.3, 1122.0, 1107.1, 1069.9, 1008.3, 904.0, 
829.4, 751.1, 723.2, 697.1 cm
-1
; Mp 121-123  C; 1H NMR (500 MHz, CDCl3) δ 7.65-7.60 (m, 2 
H), 7.49-7.38 (m, 10 H), 7.15 (d, 2 H, J = 8.5 Hz), 3.25 (ddd, J = 10.0, 6.4, 3.2 Hz), 2.73 (dd, 1 
H, J = 10.0, 2.8 Hz), 2.21 (d, 1 H, J = 7.0 Hz), 2.21-2.15 (m, 1 H), 2.05 (d, 1 H, J = 7.0 Hz), 1.14 
(s, 1 H), 1.05 (s, 1 H), 1.01 (d, 3 H, J = 7.0 Hz), 0.94 (d, 3 H, J = 7.0 Hz);
 13
C NMR (125 MHz, 
CDCl3) δ 136.6, 133.6, 132.3 (d, J = 10 Hz), 132.0 (d, J = 10 Hz), 128.4 (t, J = 10 Hz), 127.6, 
126.3, 118.8, 54.9, 34.9, 33.1, 30.1, 27.3 (d, J = 10 Hz), 19.1, 17.3, 16.5; HRMS (ESI) m/z: [M + 
H]
+ 
Calcd for C26H28NOBrP 480.1092, found 480.1082. 
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N-(1-Phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-ynyl)benzamide (131). To an ice-cooled 
MeOH (5.0 mL) was added AcCl (0.71 mL, 10 mmol). The colorless solution was stirred at 0 ºC 
for 15 min, warmed to room temperature, and stirred for a further 5 min. The resulting solution 
of 2 N HCl in MeOH was added 100 (144 mg, 0.30 mmol), stirred at room temperature for 12 h, 
and concentrated to dryness. The residue was dissolved in CH2Cl2 (5.0 mL) and concentrated to 
dryness, and the residue was dissolved in CH2Cl2 (1.0 mL) and treated with PhCOCl (80 μL, 
0.69 mmol), (iPr)2NEt (0.18 mL, 1.0 mmol) and DMAP (6.0 mg, 0.048 mmol). The reaction 
mixture was stirred at room temperature for 1 h, concentrated to 0.5 mL, and purified by column 
chromatography on SiO2 (EtOAc: hexanes = 1: 9) to afford 131 (96.6 mg, 85%) as a white solid: 
IR (ATR) 3284.1, 3064.2, 1634.6, 1522.8, 1487.4, 1319.6, 1166.8, 1123.9, 1105.3, 1066.1, 
1015.8, 840.6, 693.4 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.81 (d, 2 H, J = 7.2 Hz), 7.59 (d, 2 H, 
J = 7.2 Hz), 7.49 (s, 4 H), 7.43 (m 1 H), 7.37-7.30 (m, 5 H), 6.47 (d, 1 H, J = 8.4 Hz);
 13
C NMR 
(100 MHz, CDCl3) δ 166.6, 138.6, 133.6, 132.1, 131.9, 130.3 (q, J = 33 Hz), 128.9, 128.6, 128.3, 
127.4, 127.2, 126.4, 125.2 (q, J = 4 Hz), 89.8, 83.6, 45.6; HRMS (ESI) m/z: [M + H]
+ 
Calcd for 
C23H17NOF3 380.1262, found 380.1275. 
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N-(1-Phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-ynyl)pivalamide (132). To an ice-cooled 
MeOH (5.0 mL) was added AcCl (0.71 mL, 10 mmol). The colorless solution was stirred at 0 ºC 
for 15 min, warmed to room temperature, and stirred for a further 5 min. The resulting solution 
of 2 N HCl in MeOH was added 100 (144 mg, 0.30 mmol), stirred at room temperature for 12 h, 
and concentrated to dryness. The residue was dissolved in CH2Cl2 (5.0 mL) and concentrated to 
dryness, and the residue was dissolved in CH2Cl2 (1.0 mL) and treated with PivCl (86 μL, 0.69 
mmol), (iPr)2NEt (0.18 mL, 1.0 mmol) and DMAP (6.0 mg, 0.048 mmol). The reaction mixture 
was stirred at room temperature for 1 h, concentrated to 0.5 mL, and purified by column 
chromatography on SiO2 (EtOAc: hexanes = 1: 9) to afford 132 (99.1 mg, 92%) as a white solid: 
IR (ATR) 3297.2, 2965.4, 2632.7, 1517.2, 1319.6, 1202.2, 1181.7, 1164.9, 1157.5, 1123.9, 
1101.5, 1064.3, 1015.8, 842.5, 745.5, 736.2, 719.4, 697.1 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.56 (s, 4 H), 7.54-7.53 (d, 2 H, J =  8.0 Hz), 7.40-7.37 (m, 2 H), 7.34-7.33-7.32 (m, 1 H), 6.29 
(m, 2 H), 1.24 (s, 9 H); 
13
C NMR (125 MHz, CDCl3) δ 177.3, 132.1, 130.2 (q, J = 32.5 Hz), 
128.8, 128.2, 126.9, 126.4, 125.2 (q, J = 3.8 Hz), 123.9 (q, J = 270 Hz), 89.8, 83.3, 45.0, 38.8, 
27.4; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C21H21NOF3 360.1575, found 360.1582. 
 
 
N-(2-Methyl-1-(2-(triisopropylsilyl)cycloprop-1-en-1-yl)propyl)-P,P-diphenylphosphinic 
amide (142). To a cooled solution of 106 (45 mg, 0.10 mmol) in anhydrous CH2Cl2 (2.0 mL) 
was added Me2Zn (19 mg, 0.20 mmol) in anhydrous CH2Cl2 (1.0 mL). The reaction mixture was 
stirred at 0 ºC for 1 h, cooled to -50 ºC and added a cold solution of Et2Zn (50 mg, 0.40 mmol) 
and trifluoroethanol (29 µL, 0.40 mmol) in anhydrous dichloromethane (5 mL). Then, diethyl 
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aluminum chloride (0.012 mL, 0.012 mmol) and CH2I2 (107 mg, 0.40 mmol) was added at this 
temperature. The reaction mixture was stirred at 0 ºC overnight, quenched with saturated NH4Cl 
and extracted with dichloromethane (3×10 mL). The combined organic layers were washed with 
water and brine and dried (MgSO4). The product was concentrated and purified by 
chromatography on SiO2 to afford 142 as a white semisolid (37 mg, 79%): IR (ATR) 2954.2, 
2939.3, 2862.9, 1785.6, 1589.9, 1461.3, 1437.0, 1383.0, 1191.0, 1122.0, 1109.0, 1069.9, 1010.2, 
997.2, 881.6, 749.3, 723.2, 695.2, 678.4 cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 7.87-7.80 (m, 4 H), 
7.51-7.38 (m, 6 H), 4.18-4.12 (m, 1 H), 3.29 (t, 1 H, J = 7.6 Hz), 2.15-2.07 (m, 1 H), 1.01-0.94 
(m, 23 H), 0.84-0.82 (m, 5 H), 0.83 (d, 1 H, J = 8.0 Hz); 
13
C NMR (100 MHz, CDCl3) δ 132.7 
(dd, J = 126, 137 Hz), 132.1 (dd, J = 10, 91 Hz), 131.8 (dd, J = 3, 6 Hz), 131.7, 128.4 (d, J = 13 
Hz), 104.9, 55.4, 34.6 (d, J = 3 Hz), 19.2, 18.8, 18.7, 18.2, 11.5, 7.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C28H43NOSiP 468.2852 found 468.2845. 
 
 
N-(1-(tert-Butyldimethylsilyl)-5-phenylpent-1-yn-3-yl)-P,P-diphenylphosphinicamide (143). 
To a solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added (tert-
butyldimethylsilyl)acetylene (0.17 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (24 
mg, 0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 
101c (0.10 g, 0.20 mmol) in anhydrous toluene (2.0 mL). The reaction was stirred at room 
temperature for 24 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed 
with brine and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 143 (35 mg, 36%) as a colorless oil: 
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1
H NMR (400 MHz, CDCl3) δ 7.86-7.81 (m, 2 H), 7.72-7.66 (m, 2 H), 7.39-7.29 (m, 6 H), 7.14-
7.11 (m, 2 H), 7.09-7.03 (m, 3 H), 3.87-3.79 (m, 1 H), 3.04 (t, 1 H, J = 9.2 Hz), 2.72-2.63 (m, 2 
H), 2.02-1.88 (m, 2 H), 0.84 (s, 9 H), 0.01 (s,  6 H). 
 
 
P,P-Diphenyl-N-(5-phenyl-1-(triethylsilyl)pent-1-yn-3-yl)phosphinic amide (144). To a 
solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added 
triethylsilylacetylene  (0.17 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (24 mg, 
0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 101c 
(0.10 g, 0.20 mmol) in anhydrous toluene (2.0 mL). The reaction was stirred at room temperature 
for 24 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed with brine and 
dried (Na2SO4). The organic layers were concentrated and purified by chromatography on SiO2 
(EtOAc : hexanes = 4 :1 ) to afford 144 (45 mg, 47%) as a colorless oil: 
1
H NMR (400 MHz, 
CDCl3) δ 7.99-7.94 (m, 2 H), 7.84-7.79 (m, 2 H), 7.52-7.41 (m, 6 H), 7.25-7.21 (m, 2 H), 7.17-
7.14 (m, 3 H), 3.97-3.95 (m, 1 H), 3.17 (t, 1 H, J = 10.0 Hz), 2.85-2.76 (m, 2 H), 2.13-2.03 (m, 1 
H), 2.03-2.00 (m, 1 H), 1.02 (t, 9 H, J = 8.0 Hz), 0.61 (q, 6 H, J = 8.0 Hz); 
13
C NMR (100 MHz, 
CDCl3) δ 141.3, 132.4 (dd, J = 130, 135 Hz), 132.1 (dd, J = 10, 105 Hz), 128.5 (d, J = 11, 12 Hz), 
128.5, 128.4, 125.9, 101.7 (d, J = 8 Hz), 85.8, 44.1, 40.6 (d, J = 2 Hz), 32.1, 7.53, 4.4; 
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N-(1-(Dimethylsilyl)-5-phenylpent-1-yn-3-yl)-P,P-diphenylphosphinic amide (145). To a 
solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added 
phenyldimethylsilylacetylene  (0.20 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (24 
mg, 0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 
101c (0.10 g, 0.20 mmol) in anhydrous toluene (2.0 mL). The reaction was stirred at room 
temperature for 24 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed 
with brine and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 145 (67 mg, 66%) as a colorless oil: 
IR (ATR) 3144.8, 3055.3, 2954.6, 2921.1, 2857.7, 1452.2, 1437.2 ,1427.9, 1247.1, 1187.4, 
1122.2, 1111.0, 1092.4, 1071.9, 837.0, 816.5, 779.2, 749.4, 725.1, 697.2 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.97-7.92 (m, 2 H), 7.83-7.76 (m, 2 H), 7.65-7.62 (m, 2 H), 7.49-7.45 (m, 2 H), 
7.40-7.38 (m, 6 H), 7.26-7.20 (m, 3 H), 7.16-7.14 (m, 3 H), 4.02-3.98 (m, 1 H), 3.26 (t, 1 H, J = 
9.6 Hz), 2.85-2.77 (m, 2 H), 2.16-2.12 (m, 1 H), 2.07-2.01 (m, 1 H), 0.43 (s, 6 H); 
13
C NMR (100 
MHz, CDCl3) δ 141.9, 137.8, 134.6, 133.1 (t, J = 128 Hz), 133.1 (dd, J = 10, 100 Hz), 132.9, 
130.4, 129.4 (d, J = 13 Hz), 129.4, 129.3, 128.8, 126.8, 109.1 (d, J = 7 Hz), 87.5, 44.9, 41.1 (d, J 
= 2 Hz), 32.9, 0.1, 0.0; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C31H33NOSiP (M+H) 494.2069, 
found 494.2077. 
 
 
P,P-Diphenyl-N-(5-phenyl-1-(trimethylsilyl)pent-1-yn-3-yl)phosphinic amide (146). To a 
solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added 
trimethylsilylacetylene  (0.12 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (24 mg, 
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0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 
hydrocinnamyl substrate 101c (0.10 g, 0.20 mmol) in anhydrous toluene (2.0 mL). The reaction 
was stirred at room temperature for 24 h and quenched by NH4Cl. The mixture was extracted 
with EtOAc, washed with brine and dried (Na2SO4). The organic layers were concentrated and 
purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 146 (54 mg, 61%) as a 
colorless oil: IR (ATR) 3056.7, 2954.2, 2920.7, 2167.7, 2160.2, 1437.0, 1246.9, 1185.4, 1122.0, 
1109.0, 1090.4, 1071.7, 840.6, 749.3, 723.2, 695.2 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.80-
7.75 (m, 2 H), 7.66-7.61 (m, 2 H), 7.29-7.25 (m, 6 H), 7.08-7.03 (m, 2 H), 7.00-6.94 (m, 3 H), 
3.79-3.71 (m,1 H), 2.98 (t, 1 H, J = 9.6 Hz), 2.65-2.56 (m, 2 H), 1.93-1.82 (m, 2 H), 0.00 (s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 141.2, 132.4 (d, J = 124, 129 Hz), 132.2 (d, J = 10, 102 Hz), 
132.0, 128.6, 128.5. 128.4 (d, J = 3 Hz), 126.0, 106.5 (d, J = 7 Hz), 88.6, 43.9, 40.3 (d, J = 3 Hz), 
32.0, 0.0; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C26H31NOSiP 432.1913, found 432.1912. 
 
 
N-(1-(Dimethyl(thiophen-2-yl)silyl)-5-phenylpent-1-yn-3-yl)-P,P-diphenylphosphinic amide 
(147). To a solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added 
dimethyl(2-thienyl)silylacetylene (0.20 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol 
(24 mg, 0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 
101c (0.10 g, 0.20 mmol) in anhydrous toluene (2.0 mL). The reaction was stirred at room 
temperature for 24 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed 
with brine and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 147 (64.3 mg, 63%) as a colorless 
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oil: IR (ATR) 2954.6, 2921.1, 3150.4, 3055.3, 2169.8, 2160.5, 1452.2, 1437.2, 1405.6, 1249.0, 
1211.7, 1187.4, 1122.2, 1109.2, 1086.8, 1071.9, 995.4, 835.1, 810.9, 781.1, 747.5, 723.3, 697.2 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.97-7.92 (m, 2 H), 7.84-7.79 (m, 2 H), 7.65 (d, 1 H, J = 4.8 
Hz), 7.48 (t, 2 H, J = 7.6 Hz), 7.43-7.37 (m, 5 H), 7.23-7.20 (m, 3 H), 7.17-7.14 (m, 3 H), 4.00-
3.95 (m, 1 H), 3.22 (bs, 1 H), 2.83-2.76 (m, 2 H), 2.16-2.12 (m, 1 H), 2.07-2.03 (m, 1 H), 0.47 (s, 
6 H); 
13
C NMR (100 MHz, CDCl3) δ 140.8, 136.1, 135.0, 132.0 (dd, J = 10, 99 Hz), 131.8 (d, J = 
12 Hz), 131.2, 128.3 (d, J = 13 Hz), 128.3, 128.2, 128.1, 125.7, 108.0 (d, J = 7 Hz), 86.0, 43.8, 
39.9, 31.7, 0.0 (d, J = 4 Hz); HRMS (ESI) m/z: [M + H]
+ 
Calcd for C29H31NOSSiP 500.1633, 
found 500.1628. 
 
 
P,P-Diphenyl-N-(1-phenyl-6-(trimethylsilyl)hex-4-yn-3-yl)phosphinic amide (148). To a 
solution of diethyl zinc (0.15 g, 1.2 mmol) in anhydrous toluene (1.0 mL) was added 
propargyltrimethylsilane (0.14 g, 1.2 mmol) and (S)-(-)-1-benzyl-2-pyrrolidinemethanol (24 mg, 
0.12 mmol). The mixture was stirred at room temperature for 1 h and added a solution of 101c 
(0.1 g, 0.2 mmol) in anhydrous toluene (2.0 mL). The reaction was stirred at room temperature 
for 24 h and quenched by NH4Cl. The mixture was extracted with EtOAc, washed with brine and 
dried (Na2SO4). The organic layers were concentrated and purified by chromatography on SiO2 
(EtOAc : hexanes = 4 :1 ) to afford 148 (68 mg, 76%) as a yellowish oil: 
1
H NMR (400 MHz, 
CDCl3) δ 7.97-7.92 (m, 2 H), 7.86-7.81 (m, 2 H), 7.49-7.241 (m, 6 H), 7.26-7.21 (m, 2 H), 7.17-
7.14 (m, 3 H), 3.95-3.86 (m,1 H), 3.11 (t, 1 H, J = 9.2 Hz), 2.82-2.71 (m, 2 H), 2.10-2.08 (m, 1 
H), 1.99-1.96 (m, 1 H), 1.49 (d, 2 H, J = 2.0 Hz), 0.13 (s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 
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141.4, 132.5 (dd, J = 100, 127 Hz), 132.0 (dd, J = 9, 68 Hz), 131.8, 128.4 (dd, J = 4, 13 Hz), 
128.4, 128.3, 125.8, 82.3, 79.4 (d, J = 9 Hz), 44.0, 41.1 (d, J = 3 Hz), 32.1, 7.1, -2.0. 
 
 
P,P-Diphenyl-N-(5-phenylpent-1-yn-3-yl)phosphinic amide (149). To a solution of amide 146 
(50 mg, 0.11 mmol) in THF was added TBAF (1 M in THF, 0.24 mL, 0.24 mmol). The mixture 
was stirred at room temperature for 2 h, quenched with water, and extracted with EtOAc for 3 
times. The organic layers were washed with brine and dried (Na2SO4). The product was 
concentrated to afford 149 as a yellowish oil (38 mg, 91%) without further purification: 
1
H NMR 
(400 MHz, CDCl3) δ 7.96-7.91 (m, 2 H), 7.87-7.82 (m, 2 H), 7.52-7.42 (m, 6 H), 7.25-7.21 (m, 2 
H), 7.18-7.15 (m, 3 H), 3.95-3.88 (m, 1 H), 3.18 (t, 1 H, J = 9.6 Hz), 2.82-2.75 (m, 2 H), 2.38 (s, 
1 H), 2.14-2.05 (m, 2 H); 
 
N-(1-(3-(tert-Butyldimethylsilyl)bicyclo[1.1.0]butan-1-yl)-3-phenylpropyl)-P,P-diphenyl-
phosphinic amide (150). To a cooled solution of amide 143 (35 mg, 0.07 mmol) in anhydrous 
CH2Cl2 (2.0 mL) was added Me2Zn (14 mg, 0.15 mmol) in anhydrous CH2Cl2 (1.0 mL). The 
reaction mixture was stirred at 0 ºC for 1 h, cooled to -30 ºC and added a cold solution of Et2Zn 
(36 mg, 0.30 mmol) and trifluoroethanol (22 µl, 0.29 mmol) in anhydrous dichloromethane (5.0 
mL). Then, diethyl aluminum chloride (1 M in hexanes, 0.0090 mL, 0.0090 mmol) and CH2I2 
(79 mg, 0.29 mmol) was added at this temperature. The reaction mixture was stirred overnight, 
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quenched with saturated NH4Cl and extracted with dichloromethane (3×10 mL). The combined 
organic layers were washed with water and brine and dried (MgSO4). The product was 
concentrated and purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 150 as 
a colorless oil slowly solidified (33 mg, 91%): IR (ATR) 3215.6, 3057.2, 2949.0, 2924.8, 2852.1, 
1707.5, 1452.2, 1437.2, 1249.0, 1183.7, 1122.2, 1109.2, 1092.4, 1071.9, 829.5, 807.2, 768.0, 
749.4, 723.3, 697.2 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.97-7.87 (m, 4 H), 7.52-7.42 (m, 6 H), 
7.26-7.22 (m, 2 H), 7.17-7.15 (m, 3 H), 3.68-3.60 (m, 1 H), 2.97-2.88 (m, 2 H), 2.78-2.74 (m, 1 
H), 1.81-1.73 (m, 2 H), 1.26 (d, 1 H, J = 6.4 Hz), 1.03 (d, 1 H, J = 6.4 Hz), 0.88 (s, 9 H), 0.23 (s, 
1 H), 0.19 (s, 1 H), -1.05 (s, 6 H); 
13
C NMR (100 MHz, CDCl3) δ 141.2, 132.3 (dd, J = 10, 52 
Hz), 131.8, 128.7, 128.5, 128.4, 128.3, 125.8, 50.8, 33.6, 32.3, 29.7, 26.4, 17.8, 0.0, -1.0, -6.0, -
6.6; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C31H41NOSiP 502.2695, found 502.2707. 
 
 
P,P-Diphenyl-N-(3-phenyl-1-(3-(triethylsilyl)bicyclo[1.1.0]butan-1-yl)propyl)phosphinic 
amide (151). To a cooled solution of amide 144 (45 mg, 0.096 mmol) in anhydrous CH2Cl2 (2.0 
mL) was added Me2Zn (18 mg, 0.19 mmol) in anhydrous CH2Cl2 (1.0 mL). The reaction mixture 
was stirred at 0 ºC for 1 h, cooled to -30 ºC and added a cold solution of Et2Zn (47 mg, 0.38 
mmol) and trifluoroethanol (28 µl, 0.38 mmol) in anhydrous dichloromethane (5.0 mL). Then, 
diethyl aluminum chloride (1 M in hexanes, 0.011 mL, 0.011 mmol) and CH2I2 (0.10 g, 0.38 
mmol) was added at this temperature. The reaction mixture was stirred overnight, quenched with 
saturated NH4Cl and extracted with dichloromethane (3×10 mL). The combined organic layers 
were washed with water and brine and dried (MgSO4). The product was concentrated and 
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purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 151 as a white semisolid 
(37 mg, 76%): IR (ATR) 3172.7, 3057.2, 3023.6, 2949.0, 2932.3, 2909.9, 2872.6, 1452.2, 1437.2, 
1187.4, 1122.2, 1109.2, 1077.5, 769.9, 751.2, 721.4, 695.3 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
7.97-7.88 (m, 4 H), 7.49-7.43 (m, 6 H), 7.24-7.22 (m, 2 H), 7.17-7.15 (m, 3 H), 3.61-3.59 (m, 1 
H), 2.98-2.90 (m, 2 H), 2.77-2.75 (m, 1 H), 1.78-1.73 (m, 1 H), 1.24 (d, 1 H, J = 6.8 Hz), 0.99 (d, 
1 H, J = 6.4 Hz), 0.84 (t, 9 H, J = 8.0 Hz), 0.44 (q, 6 H, J = 8.0 Hz), 0.20 (s, 1 H), 0.17 (s, 1 H); 
13
C NMR (125 MHz, CDCl3) δ 142.0, 134.0, 133.2 (dd, J = 58, 129 Hz), 132.3 (dd, J = 7, 4 Hz) 
131.8 (dd, J = 2, 8 Hz), 128.4 (d, J = 15 Hz), 128.4, 128.3, 125.8, 51.2, 38.0 (d, J = 3 Hz), 33.5, 
32.3, 30.5, 23.5 (d, J = 5 Hz), 7.5, 4.1, -1.2; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C33H36NOSiP 
502.2679, found 502.2686. 
 
N-(1-(3-(Dimethyl(phenyl)silyl)bicyclo[1.1.0]butan-1-yl)-3-phenylpropyl)-P,P-diphenyl-
phosphinic amide (152). To a cooled solution of amide 145 (50.0 mg, 0.10 mmol) in anhydrous 
CH2Cl2 (2.0 mL) was added Me2Zn (19 mg, 0.20 mmol) in anhydrous CH2Cl2 (1.0 mL). The 
reaction mixture was stirred at 0 ºC for 1 h, cooled to -30 ºC and added a cold solution of Et2Zn 
(50 mg, 0.41 mmol) and trifluoroethanol (29 µl, 0.41 mmol) in anhydrous dichloromethane (5.0 
mL). Then, diethyl aluminum chloride (1 M in hexanes, 0.012 mL, 0.012 mmol) and CH2I2 (0.11 
g, 0.41 mmol) was added at this temperature. The reaction mixture was stirred overnight, 
quenched with saturated NH4Cl and extracted with dichloromethane (3×10 mL). The combined 
organic layers were washed with water and brine and dried (MgSO4). The product was 
concentrated and purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 )  to afford 152 as 
a white semisolid (45 mg, 86%): IR (ATR) 2950.9, 2941.6, 2923.0, 2917.4, 2867.0, 2857.7, 
 89 
2852.1, 3167.2, 1437.2, 1187.4, 1122.2, 1111.0, 1092.4, 827.7, 812.8, 747.5, 725.1, 699.0 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.92-7.82 (m, 4 H), 7.50-7.48 (m, 2 H), 7.44-7.42 (m, 6 H), 7.25-
7.22 (m, 5 H), 7.19-7.17 (m, 1 H), 7.11-7.09 (m, 2 H), 3.59-3.54 (m, 1 H), 2.92-2.88 (m, 1 H), 
2.72 (dd, 1 H, J = 6.8, 10.0 Hz), 2.64-2.58 (m, 1 H), 1.64-1.61 (m, 1 H), 1.38 (d, 1 H, J = 6.8 Hz), 
1.11 (d, 1 H, J = 6.8 Hz), 0.34 (s, 1 H), 0.30 (s, 1 H), 0.26 (s, 3 H), 0.22 (s, 3 H); HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C33H37NOSiP 522.2382, found 522.2382 
. 
 
P,P-Diphenyl-N-(3-phenyl-1-(3-(trimethylsilyl)bicyclo[1.1.0]butan-1-yl)propyl)phosphinic 
amide (153). To a cooled solution of amide 146 (43.0 mg, 0.10 mmol) in anhydrous CH2Cl2 (2.0 
mL) was added Me2Zn (19 mg, 0.20 mmol) in anhydrous CH2Cl2 (1.0 mL). The reaction mixture 
was stirred at 0 ºC for 1 h, cooled to -30 ºC and added a cold solution of Et2Zn (49 mg, 0.40 
mmol) and trifluoroethanol (29 µl, 0.40 mmol) in anhydrous dichloromethane (5.0 mL). Then, 
diethyl aluminum chloride (1 M in hexanes, 0.012 mL, 0.012 mmol) and CH2I2 (0.11 g, 0.40 
mmol) was added at this temperature. The reaction mixture was stirred overnight, quenched with 
saturated NH4Cl and extracted with dichloromethane (3×10 mL). The combined organic layers 
were washed with water and brine and dried (MgSO4). The product was concentrated and 
purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford 153 as a yellowish 
semisolid (34 mg, 75%): IR (ATR) 3176.0, 3054.9, 3023.2, 2946.8, 2922.5, 2861.0, 2853.6, 
1437.0, 1246.9, 1185.4, 1122.0, 1109.0, 1092.2, 835.0, 747.4, 723.2, 695.2 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 8.02-7.93 (m, 4 H), 7.55-7.49 (m, 6 H), 7.29-7.28 (m, 2 H), 7.22-7.20 (m, 3 H), 
3.68-3.65 (m, 1 H), 3.07-2.97 (m, 2 H), 2.83-2.76 (m, 1 H), 1.86-1.77 (m, 2 H), 1.33 (d, 1 H, J = 
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6.8 Hz), 1.04 (d, 1 H, J = 6.8 Hz), 0.26 (s, 1 H), 0.24 (s, 1 H), 0.00 (s, 9 H); 
13
C NMR (100 MHz, 
CDCl3) δ 143.0, 133.6 (d, J = 10 Hz), 133.0 (d, J = 10 Hz), 132.8, 129.5 (d, J = 10 Hz), 129.4 
(overlap), 129.3, 126.8, 51.9, 39.1, 34.0, 33.3, 31.1, 25.1 (d, J = 7 Hz), 1.9, 0.0; HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C28H35NOSiP 460.2226, found 460.2222. 
 
 
N-(1-(3-(Dimethyl(thiophen-2-yl)silyl)bicyclo[1.1.0]butan-1-yl)-3-phenylpropyl)-P,P-
diphenylphosphinic amide (154). To a cooled solution of amide 147 (50.0 mg, 0.10 mmol) in 
anhydrous CH2Cl2 (2.0 mL) was added Me2Zn (19 mg, 0.20 mmol) in anhydrous CH2Cl2 (1.0 
mL). The reaction mixture was stirred at 0 ºC for 1 h, cooled to -30 ºC and added a cold solution 
of Et2Zn (50 mg, 0.41 mmol) and trifluoroethanol (29 µl, 0.41 mmol) in anhydrous 
dichloromethane (5.0 mL). Then, diethyl aluminum chloride (1 M in hexanes, 0.012 mL, 0.012 
mmol) and CH2I2 (0.11 g, 0.41 mmol) was added at this temperature. The reaction mixture was 
stirred overnight, quenched with saturated NH4Cl and extracted with dichloromethane (3×10 
mL). The combined organic layers were washed with water and brine and dried (MgSO4). The 
product was concentrated and purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to 
afford 154 as a white semisolid (48 mg, 92%): 
1
H NMR (400 MHz, CDCl3) δ 7.95-7.85 (m, 4 H), 
7.53-7.50 (m, 2 H), 7.48-7.43 (m, 6 H), 7.27-7.26 (m, 2 H), 7.21-7.13 (m, 4 H), 7.06 (dd, 1 H, J 
= 3.2, 4.8 Hz), 3.68-3.59 (m, 1 H), 2.98-2.89 (m, 1 H), 2.73 (dd, 1 H, J = 7.2, 10.0 Hz), 2.68-2.60 
(m, 1 H), 1.70-7.62 (m, 2 H), 1.47 (d, 1 H, J = 6.8 Hz), 1.19 (d, 1 H, J = 6.8 Hz), 0.39 (s, 1 H), 
0.35 (s, 4 H, overlap), 0.32 (s, 3 H). 
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N-Allyl-P,P-diphenyl-N-(3-phenyl-1-(3-(triethylsilyl)bicyclo[1.1.0]butan-1-yl) propyl) 
phosphinic amide (167). Amide 151 (15 mg, 0.030 mmol), allyl bromide (36 mg, 0.30 mmol) 
and Bu4NHSO4 (5 mg, 0.015 mmol) were dissolved in PhMe (1.0 mL) and treated with a 50 % 
NaOH solution (1.0 mL). The reaction mixture was vigorously stirred at room temperature for 
1.5 h, diluted with water, and extracted (3x) with EtOAc. The combined organic layers were 
washed with water and brine, dried (Na2SO4) and concentrated. The residue was purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford the product 167 (15 mg, 93%) as a 
yellowish oil: 
1
H NMR (400 MHz, CDCl3) δ 7.96-7.87 (m, 4 H), 7.48-7.44 (m, 6 H), 7.29-7.27 
(m, 2 H), 7.18-7.16 (m, 3 H), 6.01-5.97 (m, 1 H), 4.95 (s, 1 H), 4.92 (d, 1 H, J = 7.2 Hz), 4.00-
3.96 (m, 1 H), 3.82-3.77 (m, 2 H), 3.15-3.06 (m, 1 H), 2.50-2.43 (m, 1 H), 2.09-2.05 (m, 1 H), 
1.45-1.38 (m, 1 H), 1.25 (d, 1 H, J = 6.4 Hz), 1.12 (d, 1 H, J = 6.8 Hz), 0.82 (d, 9 H, J = 8.0 Hz), 
0.43 (s, 1 H), 0.42 (q, 6 H, J = 8.0 Hz), 0.27 (s, 1 H) 0.02 (s, 1 H).  
 
N-(1-(3-(tert-Butyldimethylsilyl)bicyclo[1.1.0]butan-1-yl)-3-phenylpropyl)-P,P-diphenyl-N-
(prop-2-yn-1-yl)phosphinic amide (168). Amide 150 (0.015 g, 0.030 mmol), propargyl 
bromide (36 mg, 0.29 mmol) and Bu4NHSO4 (0.0051 g, 0.015 mmol) were dissolved in PhMe 
(1.0 mL) and treated with a 50 % NaOH solution (1.0 mL). The reaction mixture was vigorously 
stirred at room temperature for 1.5 h, diluted with water, and extracted (3x) with EtOAc. The 
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combined organic layers were washed with water and brine, dried (Na2SO4), and concentrated. 
The residue was purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford the 
product 168 (14 mg, 91%) as a colorless oil: 
1
H NMR (400 MHz, CDCl3) δ 8.03-7.91 (m, 4 H), 
7.54-7.44 (m, 6 H), 7.29-7.23 (m, 2 H), 7.20-7.18 (m, 3 H), 4.15-4.11 (m, 1 H), 3.91-3.85 (m, 2 
H), 3.25-3.16 (m, 1 H), 2.48-2.41 (m, 1 H), 2.31-2.26 (m, 1 H), 2.17 (s, 1 H), 1.36 (d, 1 H, J = 
6.8 Hz), 1.33-1.30  (m, 1 H), 1.17 (d, 1 H, J = 6.8 Hz), 0.88 (s, 9 H), 0.47 (s, 1 H), 0.34 (s, 1 H), -
0.12 (s, 3 H), 0.35 (s, 3 H);
 13
C NMR (100 MHz, CDCl3) δ 142.4, 133.0 (d, J = 10 Hz), 132.8 (d, 
J = 9 Hz), 131.8 (d, J = 8 Hz), 128.5 (d, J = 9 Hz), 128.3, 125.8, 82.6, 71.2, 56.8, 34.9, 33.7, 33.1, 
32.1, 31.9, 26.4, 19.7, 17.8, -1.6, -6.0, -6.8; HRMS (ESI) m/z calcd. for C36H39NOSiP (M+H) 
560.2539, found 560.2554. 
 
N-(1-(3-(Dimethyl(phenyl)silyl)bicyclo[1.1.0]butan-1-yl)-3-phenylpropyl)-P,P-diphenyl-N-
(prop-2-yn-1-yl)phosphinic amide (169). Amide 152 (0.015 g, 0.029 mmol), propargyl 
bromide (34 mg, 0.29 mmol) and Bu4NHSO4 (0.005 g, 0.014 mmol) were dissolved in PhMe 
(1.0 mL) and treated with a 50 % NaOH solution (1.0 mL). The reaction mixture was vigorously 
stirred at room temperature for 1.5 h, diluted with water, and extracted (3x) with EtOAc. The 
combined organic layers were washed with water and brine, dried (Na2SO4), and concentrated. 
The residue was purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford the 
product 169 (14 mg, 85%) as a colorless oil: IR (ATR) 3304.6, 3299.0, 3291.6, 3282.3, 3054.9, 
3023.2, 2948.6, 2924.4, 2851.7, 1716.6, 1692.4, 1601.1, 1591.7, 1468.7, 1459.4, 1453.8, 1437.0, 
1248.8, 1181.7, 1120.2, 1107.1, 1081.0, 1071.7, 1047.5, 829.4, 767.9, 751.1, 725.0 cm
-1
; 
1
H 
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NMR (400 MHz, CDCl3) δ 8.03-7.98 (m, 2 H), 7.95-7.90 (m, 2 H), 7.53-7.41 (m, 6 H), 7.39-7.37 
(m, 2 H), 7.26-7.23 (m, 5 H), 7.10-7.08 (m, 1 H), 7.06-7.03 (m, 2 H), 4.14-4.07 (m, 1 H), 3.87-
3.76 (m, 2 H), 3.19-3.11 (m, 1 H), 2.34-2.16 (m, 2 H), 2.13 (s, 1 H), 1.39 (d, 1 H, J = 6.4 Hz), 
1.27 (d, 1 H, J = 6.4 Hz), 1.13-1.09 (m, 1 H), 0.56 (s, 1 H), 0.45 (s, 1 H), 0.19 (s, 3 H), 0.15 (s, 3 
H);
 13
C NMR (100 MHz, CDCl3) δ 142.1, 138.5, 133.0 (d, J = 10 Hz),132.7, 132.5, 132.2 (d, J = 
9 Hz), 132.1 (d, J = 10 Hz), 131.3 (d, J = 21 Hz), 129.2, 128.7, 128.6 (d, J = 10 Hz), 128.5, 
128.0, 125.9, 82.7 (d, J = 7 Hz), 71.4, 56.8 (d, J = 3 Hz), 35.0, 33.6 (d, J = 4 Hz), 33.1, 32.3 (d, J 
= 6 Hz), 21.9 (d, J = 2 Hz), 0.0, -2.1, -2.5; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C34H43NOSiP 
540.2852, found 540.2854. 
 
P,P-Diphenyl-N-(3-phenyl-1-(3-(trimethylsilyl)bicyclo[1.1.0]butan-1-yl)propyl)-N-(prop-2-
yn-1-yl)phosphinic amide (170). Amide 153 (0.015 g, 0.033 mmol), propargyl bromide (39 mg, 
0.33 mmol) and Bu4NHSO4 (0.006 g, 0.016 mmol) were dissolved in PhMe (1.0 mL) and treated 
with a 50 % NaOH solution (1.0 mL). The reaction mixture was vigorously stirred at room 
temperature for 1.5 h, diluted with water, and extracted (3x) with EtOAc. The combined organic 
layers were washed with water and brine, dried (Na2SO4) and concentrated. The residue was 
purified by chromatography on SiO2 (EtOAc : hexanes = 4 :1 ) to afford the product 170 (11 mg, 
65%) as a yellowish oil: 
1
H NMR (400 MHz, CDCl3) δ 8.11-8.06 (m, 2 H), 8.04-7.99 (m, 2 H), 
7.60-7.53 (m, 6 H), 7.34-7.32 (m, 2 H), 7.28-7.25 (m, 3 H), 4.21-4.19 (m, 1 H), 3.98-3.93 (m, 2 
H), 3.35-3.28 (m, 1 H), 2.54-2.49 (m, 1 H), 2.41-2.33 (m, 1 H), 2.25 (s, 1 H), 1.45 (d, 1 H, J = 
6.8 Hz), 1.40-1.35 (m, 1 H), 1.25 (d, 1 H, J = 6.4 Hz), 0.52 (s, 1 H), 0.43 (s, 1 H), 0.00 (s, 9 H); 
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13
C NMR (100 MHz, CDCl3) δ 143.5, 134.0 (dd, J = 9, 10 Hz), 133.7, 133.5, 133.0 (dd, J = 3, 8 
Hz), 132.8, 132.4, 132.2, 129.6, 129.5, 129.4, 126.9, 83.7 (d, J = 7 Hz), 72.3, 57.9 (d, J = 2 Hz), 
35.4, 34.8 (d, J = 5 Hz), 34.2, 33.3 (d, J = 6 Hz), 32.8, 22.4 (d, J = 3 Hz), 1.3, 0.0. 
 
 
N-(4-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-P,P-diphenyl-N-(3-phenyl-1-(3-(trimethyl-
silyl)bicyclo[1.1.0]butan-1-yl)propyl)phosphinic amide (173). Amide 153 (0.040 g, 0.087 
mmol), propargyl bromide (69 mg, 0.26 mmol) and Bu4NHSO4 (0.015 g, 0.044 mmol) were 
dissolved in PhMe (1.0 mL) and treated with a 50 % NaOH solution (1.0 mL). The reaction 
mixture was vigorously stirred at room temperature overnight, diluted with water, and extracted 
(3x) with EtOAc. The combined organic layers were washed with water and brine, dried 
(Na2SO4), and concentrated. The residue was purified by chromatography on SiO2 (EtOAc : 
hexanes = 3 :1 ) to afford the product 173 (40 mg, 71%) as a yellowish oil: 
1
H NMR (400 MHz, 
CDCl3) δ 8.06 (ddd, 4 H, J = 7.2, 12.0, 25.2 Hz), 7.60-7.50 (m, 6 H), 7.36-7.32 (m, 2 H), 7.27-
7.23 (m, 3 H), 4.27 (s, 2 H), 4.25-4.21 (m, 1 H), 4.00-3.93 (m, 2 H), 3.26 (dt, 1 H, J = 4.0, 12.8 
Hz), 2.56 (dt, 1 H, J = 4.8, 13.2 Hz), 2.46-2.33 (m, 1 H), 1.44 (d, 1 H, J = 6.8 Hz), 1.23 (d, 1 H, J 
= 6.4 Hz), 0.96 (s, 9 H), 0.51 (s, 1 H), 0.44 (s, 1 H), 0.14 (s, 6 H), 0.00 (s, 9 H). 
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(Z)-2-(6-(Diphenylphosphoryl)-5-phenethyl-2-(trimethylsilyl)-6-azaspiro[3.4]oct-1-en-8-
ylidene)acetaldehyde (174). To 1 mL anhydrous THF was added TBAF (0.12 mL, 0.12 mmol, 1 
M solution in THF) and TBS protected alcohol 173 (40 mg, 0.062 mmol). The mixture was then 
stirred at 0 ºC for 1 h and concentrated. The product was purified by chromatography to afford 
the primary alcohol (32 mg, 98%) without further characterization. To a solution of primary 
alcohol (10 mg, 0.019 mmol) was added 2,6-lutidine (0.011 mL, 0.095 mmol). The mixture was 
cooled to 0 ºC, added Dess-Martin periodinane (16 mg, 0.038 mmol) and stirred at this 
temperature for 8 h. The reaction was quenched by a 1:1 solution of saturated Na2S2O3 and 
NaHCO3 solution and extracted with EtOAc for 3 times. The combined organic layer was 
washed with brine and dried (MgSO4). The product was concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 :1) afford the product as a colorless oil (6.9 mg, 
69 %): 
1
H NMR (400 MHz, CDCl3) δ 9.64 (d, 2 H, J = 6.4 Hz), 7.95-7.87 (m, 4 H), 7.55-7.45 (m, 
6 H), 7.24-7.22 (m, 2 H), 7.18-7.14 (m, 1 H), 7.06-7.04 (m, 2 H), 6.34 (s, 1 H), 6.06 (br d, J = 
6.0 Hz), 4.39 (ddq, 2 H, J = 2.4, 8.8, 18.0 Hz), 3.77 (q, 1 H, J = 6.8 Hz), 2.91 (d, 1 H, J = 13.2 
Hz), 2.65 (m, 1 H), 2.54 (d, 1 H, J = 13.2 Hz), 2.54 (s, 1 H), 2.35 (m, 1 H), 1.71 (m, 1 H), 0.10 (s, 
9 H); 
13
C NMR (100 MHz, CDCl3) δ 190.4, 170.0, 159.7, 143.7, 141.7, 132.5 (dd, J = 9, 10 Hz), 
132.1 (dd, J = 3, 14 Hz), 128.8 (dd, J = 13, 15 Hz), 128.4, 128.2, 126.0, 118.7, 65.1, 62.7, 49.9, 
48.6, 35.5, 32.9, -2.4. 
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P,P-Diphenyl-N-(1-(trimethylsilyl)pent-1-yn-3-yl)phosphinic amide (176). To a solution of 
lithium bistrimethylsilyl amide (0.408 g, 2.4 mmol) in anhydrous hexanes (5 mL) was added 
trimethylsilyl acetylene (0.355 g, 3.6 mmol). The mixture was stirred at -78 ºC for 15 min and 
added a solution of imine adduct (0.50 g, 1.21 mmol) in THF (4.0 mL). The reaction was stirred 
at room temperature for 6 h and quenched by NH4Cl. The mixture was extracted with EtOAc, 
washed with brine, and dried (Na2SO4). The organic layers were concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 4 : 1 ) to afford the product 176 as a yellowish 
solid (0.336 g, 78%): 
1
H NMR (400 MHz, CDCl3) δ 7.86-7.80 (m, 2 H), 7.71-7.65 (m, 2 H), 
7.33-7.23 (m, 6 H), 3.72-3.69 (m, 1 H), 3.23 (t, 1 H, J = 9.6 Hz), 1.69-1.59 (m, 1 H), 1.57-1.54 
(m, 1 H), 0.84 (t, 3 H, J = 8.4 Hz ), 0.00 (s, 9 H); HRMS (ESI) m/z: [M + H]
+ 
Calcd for 
C20H27NOSiP 356.1600, found 356.1603. 
 
P,P-Diphenyl-N-(1-(3-(trimethylsilyl)bicyclo[1.1.0]butan-1-yl)propyl)phosphinic amide 
(177). To a cooled solution of 176 (0.33 g, 0.93 mmol) in anhydrous CH2Cl2 (15 mL) was added 
Me2Zn (0.18 g, 1.8 mmol) in anhydrous CH2Cl2 (5 mL). The reaction mixture was stirred at 0 ºC 
for 1 hour, cooled to -30 ºC and treated with a cold solution of Et2Zn (0.46 g, 3.7 mmol) in 
anhydrous CH2Cl2 (2 mL). Then, CH2I2 (1.0 g, 3.7 mmol) were slowly added in this temperature. 
The reaction mixture was stirred overnight, quenched with sat. NH4Cl, and extracted with 
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CH2Cl2 (3×10 mL). The combined organic layers were washed with water and brine and dried 
(MgSO4). The product was concentrated and purified by chromatography on SiO2 (EtOAc : 
hexanes = 4 : 1) to afford the product as a white solid (0.22 g, 62 %): 
1
H NMR (400 MHz, 
CDCl3) δ 7.91-7.83 (m, 4 H), 7.42-7.36 (m, 6 H), 3.46 (m, 1 H), 2.83 (t, 1 H, J = 8.4 Hz), 1.45 (p, 
2 H, J = 6.8 Hz), 1.23 (d, 1 H, J = 9.2 Hz), 1.02 (t, 3 H, J = 6.8 Hz), 0.99 (d, 1 H, J = 9.2 Hz), 
1.15 (d, 2 H, J = 6.4 Hz), -0.05 (s, 9 H); 
13
C NMR (100 MHz, CDCl3) δ 134.2, 133.8, 132.9, 
132.5, 132.4, 132.0, 131.9, 131.6, 128.4, 128.3, 128.2, 52.4, 32.8, 30.2, 29.0 (d, J = 4 Hz), 24.0 
(d, J = 7 Hz), 10.7, -1.01; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C22H31NOSiP 384.1913, found 
384.1918; IR(ATR) 3176, 3055, 2954, 2926, 2870, 1437, 1247, 1187, 1122, 1107, 1060, 1010, 
997, 954, 835, 749, 721, 695 cm
-1
. 
 
 
N-(4-((tert-Butyldimethylsilyl)oxy)but-2-yn-1-yl)-P,P-diphenyl-N-(1-(3-(trimethylsilyl)-
bicyclo[1.1.0]butan-1-yl)propyl)phosphinic amide (178). Amide (0.10 g, 0.26 mmol), TBS-
protected propargyl bromide (0.21 g, 0.78 mmol) and Bu4NHSO4 (0.044 g, 0.13 mmol) were 
dissolved in toluene (3.0 mL) and treated with a 50 % aq NaOH solution (3.0 mL). The reaction 
mixture was vigorously stirred at rt overnight, diluted with water, and extracted (3x) with EtOAc. 
The combined organic layers were washed with water, brine, dried (Na2SO4), and concentrated. 
The product was purified by chromatography on SiO2 (EtOAc : hexanes = 4 : 1) to afford the 
product 178 as a yellowish oil (78 mg, 53%): 
1
H NMR (400 MHz, CDCl3) δ 8.09 (ddd, 2 H, J = 
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1.2, 8.0, 12.0 Hz), 7.93 (ddd, 2 H, J = 1.2, 8.0, 12.0 Hz), 7.53-7.45 (m, 6 H), 4.28 (t, 2 H, J = 1.6 
Hz), 4.10 (ddt, 1 H, J = 1.6, 8.8, 18.4 Hz), 3.83 (ddt, 1 H, J = 2.0, 8.8, 18.4 Hz), 3.65 (dt, 1 H, J 
= 2.8, 8.8 Hz), 2.05 (m, 1 H), 1.39 (d, 1 H, J = 6.8 Hz), 1.16 (d, 1 H, J = 6.8 Hz), 1.14-1.08 (m, 1 
H), 1.08 (t, 3 H, J = 6.4 Hz), 0.93 (s, 9 H), 0.45 (s, 1 H), 0.37 (s, 1 H), 0.12 (s, 6 H), -0.06 (s, 9 
H); 
13C NMR (125 MHz, CDCl3) δ 132.9 (dd, J = 10.0, 20.0 Hz), 132.0 (dd, J = 126, 33 Hz), 
131.8 (dd, J = 11, 2.5 Hz), 128.3 (dd, J = 1.3, 12.5 Hz), 83.1 (d, J = 6.3 Hz), 81.2, 57.9, 51.7, 
34.0, 32.1 (d, J = 6.3 Hz), 31.7, 25.8, 24.3 (d, J = 5 Hz), 21.5 (d, J = 2.5 Hz), 18.3, 11.4, -1.2, -
5.2 (d, J = 7.5 Hz); HRMS (ESI) m/z: [M + H]
+ 
Calcd for C32H49NO2Si2P 566.3040, found 
566.3046; IR(ATR) 2950, 2926, 2896, 2874, 2855, 1461, 1437, 1371, 1361, 1340, 1249, 1206, 
1139, 1118, 1103, 1068, 913, 831, 775, 749, 721, 695 cm
-1
. 
 
 
(Z)-2-(6-(Diphenylphosphoryl)-5-ethyl-2-(trimethylsilyl)-6-azaspiro[3.4]oct-1-en-8-ylidene)-
acetaldehyde (179) To 1 mL anhydrous THF was added TBAF (0.28 mL, 0.28 mmol, 1 M 
solution in THF) and 178 (78 mg, 0.14 mmol). The mixture was then stirred at 0 ºC for 1 h and 
concentrated. The product was purified by chromatography on SiO2 (EtOAc : hexanes = 3:1) to 
afford the corresponding propargyl alcohol (60 mg, 96%) without further purification: 
1
H NMR 
(400 MHz, CDCl3) δ 8.09-8.01 (m, 4 H), 7.60-7.54 (m, 6 H), 4.48-4.36 (m, 1 H), 4.32 (s, 2 H), 
4.14 (dd, 1 H, J = 15.2, 24.0 Hz), 3.90 (dd, 1 H, J = 15.2, 24.0 Hz), 3.62 (t, 1 H, J = 12.8 Hz), 
2.04 (dt, 1 H, J = 14.0, 9.6 Hz), 1.47 (d, 1 H, J = 8.8 Hz), 1.25 (d, 1 H, J = 8.8 Hz), 1.21-1.15 (m, 
1 H), 1.17 (t, 3 H, J = 4.0 Hz), 0.58 (s, 1 H), 0.47(s, 1 H), 0.00 (s, 9 H). To a solution of 
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propargyl alcohol (60 mg, 0.13 mmol) was added 2,6-lutidine (0.078 mL, 0.66 mmol). The 
mixture was cooled to 0 ºC, treated with Dess-Martin periodinane (113 mg, 0.27 mmol) and 
stirred at this temperature for 8 h. The reaction was quenched by a 1:1 solution of saturated 
Na2S2O3 and NaHCO3 and extracted with EtOAc for 3 times. The combined organic layer was 
washed with brine and dried (MgSO4). The product was concentrated and purified by 
chromatography on SiO2 (EtOAc : hexanes = 3:1) to afford 179 as a colorless oil (48 mg, 80%): 
1
H NMR (400 MHz, CDCl3) δ 9.63 (d, 1 H, J = 6.4 Hz), 7.96-7.86 (m, 4 H), 7.51-7.45 (m, 6 H), 
6.31 (s, 1 H), 6.03 (br d, 1 H, J = 6.4 Hz), 4.37 (ddd, 1 H, J = 2.0, 9.2, 13.2 Hz), 4.32 (ddd, 1 H, J 
= 2.0, 9.2, 13.2 Hz), 3.6 (q, 1 H, J = 7.2 Hz), 2.8 (d, 1 H, J = 12.8 Hz), 2.52 (d, 1 H, J = 12.8 Hz), 
1.48-1.40 (m, 2 H), 0.80 (t, 3 H, J = 7.2 Hz), 0.10 (s, 9 H); 
13
C NMR (100 MHz, CDCl3) δ 190.6, 
170.8 (d, J = 5 Hz), 159.4, 144.0, 132.7, 132.6 (dd, J = 17, 9 Hz), 132.1 (dd, J = 17, 3 Hz), 131.4, 
128.8 (dd, J = 20, 12 Hz), 118.6, 66.6, 62.7 (d, J = 3 Hz), 50.1, 48.8 (d, J = 4 Hz), 26.5 (d, J = 5 
Hz), 11.0, -2.3; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C26H33NO2SiP 450.2018, found 450.2007; 
IR(ATR) 3059, 2956, 2934, 2928, 2878, 2872, 2855, 1676, 1614, 1590, 1437, 1247, 1184, 1122, 
1107, 1072, 911, 839, 751, 725, 693, 677 cm
-1
. 
 
 
((Z)-8-((Z)-2-(2-(2,4-Dinitrophenyl)hydrazono)ethylidene)-5-ethyl-2-(trimethylsilyl)-6-
azaspiro[3.4]oct-1-en-6-yl)diphenylphosphine oxide (181) To solution of the aldehyde 179 (40 
mg, 0.089 mmol) in methanol (1 mL) was added (2,4-dinitrophenyl)hydrazine (18 mg, 0.089 
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mmol). The mixture was stirred at room temperature overnight. The product is concentrated and 
purified by chromatography to afford the hydrazone 181 as a yellow oil (42 mg, 75%). An 
orange color crystal was obtained by slowly crystallizing a solution of 181 in dichloromethane 
and hexanes: 
1
H NMR (400 MHz, CDCl3) δ 11.5 (s, 1 H), 9.13 (d, 1 H, J = 2.4 Hz), 8.31 (dd, 1 
H, J = 9.6, 2.0 Hz), 7.99-7.88 (m, 5 H), 7.57-7.48 (m, 6 H), 7.15 (d, 1 H, J = 10.8 Hz), 6.39-6.35 
(m, 2 H), 4.25 (dd, 1 H, J = 16.0, 8.0 Hz), 4.13 (dd, 1 H, J = 16.0, 8.0 Hz), 3.61 (q, 1 H, J = 6.0 
Hz), 2.91 (d, 1 H, J = 12.8 Hz), 2.58 (d, 1 H, J = 12.8 Hz), 1.46 (m, 2 H), 0.82 (t, 1 H, J = 7.2 
Hz), 0.14 (s, 9 H); HRMS (ESI) m/z: [M + Na]
+ 
Calcd for C32H36N5O5NaSiP 652.2121 found 
652.2118; IR(ATR) 3122, 3116, 3111, 3103, 3100, 3090, 3083, 3075, 3055, 2956, 2924, 2874, 
2854, 1616, 1590, 1437, 1422, 1333, 1310, 1247, 1183, 1122, 1107, 1077, 1070, 1025, 1008, 997, 
911, 902, 839, 753, 723, 692, 677 cm
-1
. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(4-chlorophenyl)methyl)-4-methylbenzenesulfonamide (157a).
53
 
To a -78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was added a 
1.6 M solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. 
Then, a 1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. 
After 1 hr, sulfonyl imine (1.5 g, 5.0 mmol) in THF (2 x 3.5 mL) was added. The reaction 
mixture was then gradually warmed to rt. After 30 min, the reaction mixture was quenched with 
NaHCO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried (MgSO4), filtered and concentrated in vacuo. Purification by 
chromatography on SiO2 (EtOAc : hexanes = 1 : 4) afforded 157a as a white solid (1.06 g, 61%): 
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1
H NMR (300 MHz, CDCl3) δ 7.60 (d, 2 H, J = 8.1 Hz), 7.20-7.13 (m, 4 H), 7.03 (d, 2 H, J = 8.4 
Hz), 5.28 (d, 2 H, J = 6.6 Hz), 4.73 (d, 2 H, J = 6.9 Hz), 2.40 (s, 3 H), 1.46 (dd, 1 H, J = 3.0, 6.0 
Hz), 1.26-1.22 (m, 2 H), 0.62 (s, 1 H), 0.53 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 143.6, 
138.03, 137.8, 133.5, 129.6, 128.6, 128.4, 127.3, 57.5, 32.6, 31.5, 21.6, 14.1, 1.9; HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C18H19NO2SCl 348.0825, found 348.0829. 
 
  
N-(Bicyclo[1.1.0]butan-1-yl(furan-2-yl)methyl)-4-methylbenzenesulfonamide (157b)
53
. To a 
-78 °C solution of tribromo cyclopropane  (2.5 g, 10 mmol) in Et2O (100 mL) was added a 1.6 M 
solution of MeLi in ether dropwise (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. 
Then, a 1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. 
After 1 hr, sulfonyl imine (1.2 g, 5.0 mmol) in THF (2 x 3.5 mL) was added. The reaction 
mixture was then gradually warmed to rt. After 30 min, the reaction mixture was quenched with 
NaHCO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried (MgSO4), filtered and concentrated in vacuo. Purification by 
chromatography on SiO2 (EtOAc : hexanes = 1 : 4) afforded 157b as a yellowish solid (1.14 g, 
75%): 
1
H NMR (400 MHz, CDCl3) δ 7.67 (d, 2 H, J = 8.0 Hz), 7.22 (d, 2 H, J = 8.0 Hz), 7.16 (d, 
1 H, J = 0.8 Hz), 6.17 (dd, 1 H, J = 1.6, 2.8 Hz), 6.05 (d, 1 H, J = 2.8 Hz), 5.16 (d, 1 H, J = 8.0 
Hz), 4.91 (d, 1 H, J = 8.0 Hz), 2.40 (s, 3 H), 1.44-1.42 (m, 3 H), 0.58 (s, 2 H); 
13
C NMR (100 
MHz, CDCl3) δ 152.3, 143.3, 142.2, 137.9, 129.5, 127.2, 110.2, 107.3 ,52.1, 32.4, 32.0, 21.6, 
12.9, 2.0; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C16H18NO3S 304.1007, found 304.1033. 
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N-(Bicyclo[1.1.0]butan-1-yl(3,5-dimethoxyphenyl)methyl)-4-methylbenzenesulfonamide 
(157c).
53
 To a -78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was 
added a 1.6 M solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in 
vacuo. Then, a 1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -
78 °C. After 1 hr, sulfonyl imine (1.6 g, 5.0 mmol) in THF (2 x 3.5 mL) was added. The reaction 
mixture was then gradually warmed to rt. After 30 min, the reaction mixture was quenched with 
NaHCO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried (MgSO4), filtered and concentrated in vacuo. Purification by 
chromatography on SiO2 (EtOAc : hexanes = 1 : 4) afforded 157c as a yellowish solid (1.23 g, 
66%): 
1
H NMR (400 MHz, CDCl3) δ 7.64 (d, 2 H, J = 8.0 Hz), 7.18 (d, 2 H, J = 8.0 Hz), 6.25 (s, 
1 H), 6.22 (s, 2 H), 5.45 (d, 1 H, J = 6.8 Hz), 4.69 (d, 1 H, J = 7.2 Hz), 3.66 (s, 6 H), 2.38 (s, 3 
H), 1.50-1.49 (m, 1 H), 1.35-1.30 (m, 1 H), 1.30 (s, 1 H), 0.60 (s, 1 H), 0.54 (s, 1 H); 
13
C NMR 
(100 MHz, CDCl3) δ 160.8, 143.3, 141.9, 138.0, 129.5, 127.3, 105.1, 99.6, 58.0, 55.3, 32.4, 31.9, 
21.6, 14.1, 1.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C20H24NO4S 374.1426 found 374.1398. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(2-chlorophenyl)methyl)-4-methylbenzenesulfonamide (157d). 
To a -78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was added a 
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1.6 M solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. 
Then, a 1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. 
After 1 hr, sulfonyl imine (1.5 g, 5.0 mmol) in THF (2 x 3.5 mL) was added. The reaction 
mixture was then gradually warmed to rt. After 30 min, the reaction mixture was quenched with 
NaHCO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried (MgSO4), filtered and concentrated in vacuo. Purification by 
chromatography on SiO2 (EtOAc : hexanes = 1 : 4) afforded 157d as a white solid (0.45 g, 25%): 
1
H NMR (400 MHz, CDCl3) δ 7.65 (d, 2 H, J = 8.4 Hz), 7.23-7.19 (m, 2 H), 7.15 (d, 2 H, J = 8.0 
Hz), 7.10-7.07 (m, 2 H), 5.60 (d, 1 H, J = 7.2 Hz), 5.28 (d, 1 H, J = 7.2 Hz), 2.36 (s, 3 H), 1.44 
(dd, 1 H, J = 2.8, 6.0 Hz), 1.38 (s, 1 H), 1.19 (dd, 1 H, J =  2.8, 6.4 Hz), 0.61 (s, 1 H), 0.48 (s, 1 
H); 
13
C NMR (100 MHz, CDCl3) δ 143.4, 137.3, 136.6, 132.4, 129.6, 129.5, 128.8, 128.6, 127.3, 
126.8, 54.9, 33.4, 30.7, 21.6, 13.8, 2.3; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C18H19NO2SCl 
348.0825, found 348.0847. 
 
  
N-(1-(Bicyclo[1.1.0]butan-1-yl)-2-methylpropyl)-4-methylbenzenesulfonamide (157e).
53
 To a 
-78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was added a 1.6 M 
solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. Then, a 
1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. After 1 hr, 
sulfonyl imine (1.1 g, 5.0 mmol) in THF (5 mL) was added. The reaction mixture was then 
gradually warmed to rt. After 30 min, the reaction mixture was quenched with NaHCO3 (20 mL). 
The aqueous layer was extracted with Et2O (3 x 50 mL). The combined organic fractions were 
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dried (MgSO4), filtered and concentrated in vacuo. Purification by chromatography on SiO2 
(EtOAc : hexanes = 1 : 4) afforded 157e as a yellowish solid (1.01 g, 72%): 
1
H NMR (400 MHz, 
CDCl3) δ 7.75 (d, 2 H, J = 8.0 Hz), 7.32 (d, 2 H, J = 8.0 Hz), 4.63 (d, 1 H, J = 8.8 Hz), 3.43 (dd, 
1 H, J = 5.6, 8.8 Hz), 2.46 (s, 3 H), 1.85 (ds, 1 H, J = 5.6, 6.8 Hz), 1.43 (d, 1 H, J = 2.8 Hz), 0.93 
(s, 1 H), 0.92 (dd, 6 H, J = 5.6, 6.8 Hz), 0.62 (s, 1 H), 0.41 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) 
δ 143.3, 138.5, 129.6, 126.9, 58.6, 34.6, 33.6, 28.9, 21.6, 18.9, 18.7, 11.6, -0.2; HRMS (ESI) m/z: 
[M + H]
+ 
Calcd for C15H22NO2S 280.1371, found 280.1394. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(cyclopropyl)methyl)-4-methylbenzenesulfonamide (157f). To a -
78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was added a 1.6 M 
solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. Then, a 
1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. After 1 hr, 
sulfonyl imine (1.1 g, 5.0 mmol) in THF (5 mL) was added. The reaction mixture was then 
gradually warmed to rt. After 30 min, the reaction mixture was quenched with NaHCO3 (20 mL). 
The aqueous layer was extracted with Et2O (3 x 50 mL). The combined organic fractions were 
dried (MgSO4), filtered and concentrated in vacuo. Purification by chromatography on SiO2 
(EtOAc : hexanes = 1 : 4) afforded 157f as a yellowish solid (0.46 g, 33%): 
1
H NMR (400 MHz, 
CDCl3) δ 7.54 (d, 2 H, J = 8.0 Hz), 7.06 (d, 2 H, J = 8.0 Hz), 4.61 (d, 1 H, J = 6.8 Hz), 2.97 (t, 1 
H, J = 7.2 Hz), 2.2 (s, 3 H), 1.33 (dd, 1 H, J = 2.8, 6.0 Hz), 1.13 (dd, 1 H, J = 2.8, 6.0 Hz), 1.03 
(s, 1 H), 0.62-0.57 (m, 1 H), 0.25 (s, 1 H), 0.22-0.16 (m, 2 H), 0.14 (s, 1 H), 0.05-0.00 (m, 2 H); 
13
C NMR (100 MHz, CDCl3) δ 142.6, 137.9, 128.9, 126.6, 57.0, 30.9 (d, J = 3.0 Hz), 20.9, 15.0, 
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11.5, 2.2, 2.1, 0.0; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C15H20NO2S 278.1215, found 278.1217; 
IR (ATR) 3288, 3258, 3252, 3247, 3239, 3003, 2997, 2917, 2898, 2878, 2867, 1597, 1456, 1435, 
1405, 1398, 1387, 1320, 1316, 1305, 1286, 1156, 1133, 1094, 1016, 986, 958, 908, 885, 809 cm
-
1
. 
 
N-(1-(Bicyclo[1.1.0]butan-1-yl)-2-((4-methoxybenzyl)oxy)ethyl)-4-methylbenzenesulfon-
amide (157g). To a -78 °C solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) 
was added a 1.6 M solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed 
in vacuo. Then, a 1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -
78 °C. After 1 hr, sulfonyl imine (1.7 g, 5.0 mmol) in THF (5 mL) was added. The reaction 
mixture was then gradually warmed to rt. After 30 min, the reaction mixture was quenched with 
NaHCO3 (20 mL). The aqueous layer was extracted with Et2O (3 x 50 mL). The combined 
organic fractions were dried (MgSO4), filtered and concentrated in vacuo. Purification by 
chromatography on SiO2 (EtOAc : hexanes = 1 : 4) afforded 157g as a yellowish solid (1.07 g, 
55%): 
1
H NMR (400 MHz, CDCl3) δ 7.64 (d, 2 H, J = 8.0 Hz), 7.16 (d, 2 H, J = 8.0 Hz), 7.06 (d, 
2 H, J = 8.4 Hz), 6.79 (d, 2 H, J = 8.4 Hz), 4.91 (d, 1 H, J = 7.6 Hz), 4.23 (s, 2 H), 3.75-3.62 (m, 
1 H), 3.74 (s, 3 H), 3.37 (dd, 1 H, J = 4.8, 9.6 Hz), 3.30 (dd, 1 H, J = 4.8, 9.6 Hz), 2.33 (s, 3 H), 
1.42 (dd, 1 H, J = 2.8, 6.0 Hz), 1.13 (dd, 1 H, J = 2.8, 6.0 Hz), 1.29 (s, 1 H), 0.39 (s, 1 H), 0.32 (s, 
1 H); 
13
C NMR (100 MHz, CDCl3) δ 159.3, 143.2, 138.0, 129.7, 129.5, 129.3, 127.2, 113.8, 72.8, 
71.3, 55.3, 52.8, 31.4, 31.3, 21.5, 11.1, 1.7; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C21H26NO4S 
388.1583, found 388.1580; IR (ATR) 3279, 3271, 2924, 2863, 1610, 1512, 1456, 1452, 1439, 
1420, 1405, 1322, 1301, 1243, 1156, 1087, 1031, 967 cm
-1
. 
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N-(1-(Bicyclo[1.1.0]butan-1-yl)ethyl)-4-methylbenzenesulfonamide (157h). To a -78 °C 
solution of tribromo cyclopropane (2.5 g, 10 mmol) in Et2O (100 mL) was added a 1.6 M 
solution of MeLi in ether (6.3 mL, 10 mmol). After 1 h, MeBr was removed in vacuo. Then, a 
1.7 M solution of t-BuLi in pentane (12 mL, 20 mmol) was added dropwise at -78 °C. After 1 hr, 
sulfonyl imine (1.0 g, 5.0 mmol) in THF (5 mL) was added. The reaction mixture was then 
gradually warmed to rt. After 30 min, the reaction mixture was quenched with NaHCO3 (20 mL). 
The aqueous layer was extracted with Et2O (3 x 50 mL). The combined organic fractions were 
dried (MgSO4), filtered, and concentrated in vacuo. Purification by chromatography on SiO2 
(EtOAc : hexanes = 1 : 4) afforded 157h as a yellowish solid (0.50 g, 40%): 
1
H NMR (300 MHz, 
CDCl3) δ 7.79 (d, 2 H, J = 8.1 Hz), 7.32 (d, 2 H, J = 8.1 Hz), 4.55 (d, 1 H, J = 7.2 Hz), 3.83 (p, 1 
H, J = 7.2 Hz), 2.45 (s, 3 H), 1.51 (dd, 1 H, J = 3.0, 6.0 Hz), 1.31-1.27 (m, 2 H), 1.16 (d, 3 H, J = 
7.2 Hz), 0.44 (s, 1 H), 0.41 (s, 1 H);
 13
C NMR (100 MHz, CDCl3) δ 141.5, 136.7, 127.9, 125.5, 
48.2, 30.6, 28.2, 19.9, 18.8, 12.0, 0.0; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C13H18NO2S 
252.1058, found 252.1030; IR (ATR) 2954, 2947, 2924, 2867, 2852, 1597, 1448, 1420, 1411, 
1377, 1322, 1303, 1288, 1154, 1107, 1083, 1044, 1033, 1020, 969, 951, 911, 889, 863, 815, 802 
cm
-1
. 
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N-(Bicyclo[1.1.0]butan-1-yl(4-chlorophenyl)methyl)-N-(2-cyclopropylideneethyl)-4-methyl-
benzenesulfonamide (263a). A solution of 157a (219 mg, 0.63 mmol) in THF (3 mL) was 
added to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF (3 
mL). After stirring at rt for 20 min the solution was transferred via cannula over a solution of 
tosylate (100 mg, 0.420 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) in THF (2 mL) previously 
stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water 
and extracted with ether. The combined organic layers were dried, filtered and concentrated and 
the crude product was purified by chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) to 
give 263a as a colorless oil (148 mg, 85%): 
1
H NMR (300 MHz, CDCl3) δ 7.59 (d, 2 H, J = 8.1 
Hz), 7.22-7.18 (m, 4 H), 7.13 (d, 2 H, J = 8.7 Hz), 5.61 (d, 1 H, J = 2.8, 6.3 Hz), 5.21 (d, 1 H, J = 
6.6 Hz), 2.4 (s, 3 H), 1.55 (dd, 1 H, J = 3.0, 6.3 Hz), 1.47 (s, 1 H), 1.24 (dd, 1 H, J = 3.0, 6.3 Hz), 
0.98-0.94 (m, 4 H), 0.69 (s, 1 H), 0.57 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) δ 143.1, 138.6, 
138.1, 133.3, 129.4, 129.2, 128.5, 127.4, 125.2, 115.6, 62.0, 47.9, 34.2, 32.0, 21.6, 12.1, 3.8, 2.4, 
1.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C23H25NO2SCl 414.1295, found 414.1282; IR (ATR) 
2978, 2926, 2867, 1596, 1489, 1435, 1405, 1335, 1305, 1288, 1156, 1117, 1090, 1027, 1012, 951, 
910, 897, 848, 813, 762, 746, 731 cm
-1
. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(furan-2-yl)methyl)-N-(2-cyclopropylideneethyl)-4-methyl 
benzenesulfonamide (263b). A solution of 157b (190 mg, 0.63 mmol) in THF (3 mL) was 
added to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF (3 
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mL). After stirring at rt for 20 min the solution was transferred via cannula over a solution of 
tosylate (100 mg, 0.420 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) in THF (2 mL) previously 
stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water 
and extracted with ether. The combined organic layers were dried, filtered and concentrated and 
the crude product was purified by chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) to 
give 263b as a colorless oil (129 mg, 83%): 
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, 2 H, J = 8.0 
Hz), 7.22-7.19 (m, 3 H), 6.25-6.22 (m, 1 H), 6.17 (d, 1 H, J = 3.3 Hz), 5.58 (tt, 1 H,  J = 2.1, 6.3 
Hz), 5.52 (s, 1 H), 4.15 (dd, 2 H, J = 1.2, 6.6 Hz), 2.39 (s, 3 H), 1.60-1.57 (m, 2 H), 1.49 (dd, 1 H, 
J = 1.8, 5.4 Hz), 0.98-0.94 (m, 4 H), 0.66 (s, 1 H), 0.60 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 
152.4, 142.9, 141.9, 138.4, 129.3, 127.5, 124.6, 115.5, 110.3, 108.5, 56.8, 47.1, 33.8, 32.6, 21.6, 
11.2, 3.3, 2.3, 1.8; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C21H24NO3S 370.1477, found 370.1493; 
IR (ATR) 2975, 2924, 2880, 2865, 2852, 1596, 1495, 1435, 1398, 1387, 1379, 1362, 1340, 1325, 
1308, 1290, 1273, 1159, 1133, 1118, 1098, 1090, 1070, 1033, 1008, 928, 915, 893, 884 cm
-1
. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(3,5-dimethoxyphenyl)methyl)-N-(2-cyclopropylideneethyl)-4-
methylbenzenesulfonamide (263c). A solution of 157c (235 mg, 0.63 mmol) in THF (3 mL) 
was added to an ice-cooled suspension of NaH (17.9 mg, 0.67 mmol, 90% in mineral oil) in THF 
(3 mL). After stirring at rt for 20 min the solution was transferred via cannula over a solution of 
tosylate (100 mg, 0.420 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) in THF (2 mL) previously 
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stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water 
and extracted with ether. The combined organic layers were dried, filtered and concentrated and 
the crude product was purified by  chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) 
to give 263c as a colorless oil (168 mg, 91%); 
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, 2 H, J = 
8.4 Hz), 7.62 (d, 2 H, J = 8.4 Hz), 6.30 (s, 3 H), 5.65 (m, 1 H), 5.27 (s, 1 H), 4.19 (d, 2 H, J = 6.4 
Hz), 3.66 (s, 6 H), 2.39 (s, 3 H), 1.60 (dd, 1 H, J = 2.8, 6.0 Hz), 1.53 (s, 1 H), 1.34 (dd, 1 H, J = 
2.8, 6.0 Hz), 0.98-0.96 (m, 4 H), 0.71 (s, 1 H), 0.60 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 
160.6, 142.9, 141.8, 138.6, 129.3, 127.4, 124.9, 115.7, 106.1, 99.3, 62.5, 55.2, 47.8, 33.9, 32.4, 
21.5, 12.1, 3.8, 2.3, 1.8; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C25H30NO4S 440.1896, found 
440.1895; IR (ATR) 2930, 2837, 1596, 1458, 1443, 1428, 1335, 1322, 1316, 1303, 1290, 1204, 
1154, 1096, 1066, 1059, 1027, 1020, 1001, 925, 908, 897, 880, 837, 813 cm
-1
. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(2-chlorophenyl)methyl)-N-(2-cyclopropylideneethyl)-4-
methylbenzenesulfonamide (263d). A solution of 157d (219 mg, 0.63 mmol) in THF (3 mL) 
was added to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF 
(3 mL). After stirring at rt for 20 min the solution was transferred via cannula over a solution of 
tosylate (100 mg, 0.420 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) in THF (2 mL) previously 
stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water 
and extracted with ether. The combined organic layers were dried, filtered and concentrated and 
the crude product was purified by  chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) 
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to give 263d as a colorless oil (162 mg, 93%): 
1
H NMR (400 MHz, CDCl3) δ 7.62 (d, 2 H, J = 
8.0 Hz), 7.51-7.48 (m, 1 H), 7.51-7.48 (m, 1 H), 7.27-7.25 (m, 1 H), 7.18-7.12 (m, 4 H), 5.68 (s, 
2 H), 4.40 (dd, 1 H, J = 1.2, 16.0 Hz), 4.29 (dd, 1 H, J = 6.8, 16.0 Hz), 2.37 (s, 3 H), 1.63 (dd, 1 
H, J = 2.4, 6.4 Hz), 1.55 (s, 1 H), 1.13 (dd, 1 H, J = 2.8, 6.0 Hz), 0.98-0.92 (m, 4 H), 0.69 (s, 1 
H), 0.54 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 142.9, 138.1, 137.3, 132.9, 129.8, 129.5, 129.2, 
128.6, 127.5, 126.7, 125.1, 115.6, 59.9, 48.8, 35.6, 31.2, 21.6, 11.9, 3.7, 2.4, 1.9; HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C23H25NO2SCl 414.1295, found 414.1294; IR (ATR) 3024, 1597, 1481, 
1421, 1321, 1141, 1098, 1025, 1012, 916, 887, 805, 717, 736, 748, 763 cm
-1
. 
 
 
N-(1-(Bicyclo[1.1.0]butan-1-yl)-2-methylpropyl)-N-(2-cyclopropylideneethyl)-4-methyl 
benzenesulfonamide (263e). A solution of 157e (176 mg, 0.63 mmol) in THF (3 mL) was added 
to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF (3 mL). 
After stirring at rt for 20 min the solution was transferred via cannula over a solution of tosylate 
(100 mg, 0.420 mmol) and Pd(PPh3)4 (22.0 mg, 0.021 mmol) in THF (2 mL) previously stirred 
for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water and 
extracted with ether. The combined organic layers were dried, filtered and concentrated and the 
crude product was purified by chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) to 
give 263e as a colorless oil (131 mg, 90%): 
1
H NMR (400 MHz, CDCl3) δ 7.69 (d, 2 H, J = 8.0 
Hz), 7.23 (d, 2 H, J = 8.0 Hz), 5.79 (bs, 1 H), 4.13 (dd, 1 H, J = 7.6, 15.6 Hz), 4.02 (dd, 1 H, J = 
6.4, 16.0 Hz), 3.85 (d, 1 H, J = 10.4 Hz), 2.40 (s, 3 H), 1.90-1.87 (m, 1 H), 1.55-1.53 (m, 1 H), 
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1.03 (bs, 4 H), 0.99 (d, 1 H, J = 6.4 Hz), 0.97-0.94 (m, 1 H), 0.88 (dd, 1 H, J = 6.8, 11.2 Hz), 
0.80 (d, 1 H, J = 6.8 Hz), 0.35 (s, 1 H), 0.15 (s, 1 H); 
13
C NMR (125 MHz, CDCl3) δ 142.6, 
139.2, 129.2, 127.5, 124.4, 115.9, 64.2, 46.2, 31.1, 30.9, 29.8, 21.5, 21.1, 20.5, 11.4, 5.1, 2.4, 1.7; 
HRMS (ESI) m/z: [M + H]
+ 
Calcd for C20H28NO2S 346.1841, found 346.1842; IR (ATR) 2977, 
2973, 2956, 2924, 2870, 1733, 1724, 1719, 1596, 1493, 1465, 1458, 1448, 1437, 1387, 1333, 
1303, 1286, 1154, 1117, 1090, 1020, 1012, 1001, 975, 960, 926, 904, 887, 811 cm
-1
. 
 
 
N-(Bicyclo[1.1.0]butan-1-yl(cyclopropyl)methyl)-N-(2-cyclopropylideneethyl)-4-methyl-
benzenesulfonamide (263f). A solution of 157f (175 mg, 0.63 mmol) in THF (3 mL) was added 
to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF (3 mL). 
After stirring at rt for 20 min the solution was transferred via cannula over a solution of tosylate 
(100 mg, 0.420 mmol) and Pd(PPh3)4 (22.0 mg, 0.021 mmol) in THF (2 mL) previously stirred 
for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water and 
extracted with ether. The combined organic layers were dried, filtered and concentrated and the 
crude product was purified by chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) to 
give 263f as a colorless oil (110 mg, 76%): 
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, 2 H, J = 8.0 
Hz), 7.09 (d, 2 H, J = 8.0 Hz), 5.71 (bs, 1 H), 4.08-4.05 (m, 2 H), 3.26 (d, 1 H, J = 9.6 Hz), 2.4 (s, 
3 H), 1.55 (dd, 1 H, J = 2.8, 6.0 Hz), 1.42 (s, 1 H), 1.06 (dd, 1 H, J = 2.8, 6.0 Hz), 0.87-0.80 (m, 
5 H), 0.37-0.33 (m, 2 H), 0.29-0.22 (m, 3 H), 0.02-0.00 (m, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 
142.7, 139.1, 129.3, 127.4, 124.1, 116.6, 64.1, 46.3, 33.3, 31.2, 21.5, 13.8, 11.3, 5.7, 3.4, 2.4, 1.8; 
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HRMS (ESI) m/z: [M + H]
+ 
Calcd for C20H26NO2S 344.1684, found 344.1672; IR (ATR) 3001, 
2997, 2977, 2951, 2921, 2869, 1597, 1456, 1435, 1396, 1379, 1333, 1305, 1288, 1154, 1131, 
1118, 1092, 1021, 1007, 979, 962, 939, 925, 897, 859, 813, 772 cm
-1
. 
 
 
N-(1-(Bicyclo[1.1.0]butan-1-yl)-2-((4-methoxybenzyl)oxy)ethyl)-N-(2-cyclopropylidene-
ethyl)-4-methylbenzenesulfonamide (263g). A solution of 157g (244 mg, 0.63 mmol) in THF 
(3 mL) was added to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) 
in THF (3 mL). After stirring at rt for 20 min the solution was transferred via cannula over a 
solution of tosylate (100 mg, 0.420 mmol) and Pd(PPh3)4 (22.0 mg, 0.021 mmol) in THF (2 mL) 
previously stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured 
into water and extracted with ether. The combined organic layers were dried, filtered and 
concentrated and the crude product was purified by  chromatography on SiO2 (Et2O : hexanes = 
1 : 100 to 1 : 20) to give the product 263g as a colorless oil (118 mg, 62%): 
1
H NMR (300 MHz, 
CDCl3) δ 7.63 (d, 2 H, J = 8.1 Hz), 7.13 (d, 2 H, J = 8.1 Hz), 7.08 (d, 2 H, J = 8.4 Hz), 6.79 (d, 2 
H, J = 8.7 Hz), 5.69 (m, 1 H), 4.31-4.19 (m, 3 H), 4.06 (d, 2 H, J = 6.6 Hz), 3.74 (s, 3 H), 3.49 
(dd, 1 H, J = 6.0, 9.6 Hz), 3.37 (dd, 1 H, J = 8.4, 9.6 Hz), 2.32 (s, 3 H), 1.48-1.43 (m, 2 H), 1.01 
(dd, 1 H, J = 3.0, 6.3 Hz), 0.95-0.89 (m, 4 H), 0.38 (s, 1 H), 0.29 (s, 1 H); 
13
C NMR (100 MHz, 
CDCl3) δ 159.4, 142.9, 138.6, 130.1, 129.5, 129.4, 127.5, 124.7, 116.4, 113.9, 72.7, 70.4, 57.8, 
55.4, 46.6, 32.7, 31.0, 21.6, 8.9, 3.2, 2.4, 1.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C26H32NO4S 
454.2052, found 454.2061; IR (ATR) 2917, 2885, 2863, 2848, 1717, 1707, 1700, 1605, 1584, 
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1512, 1497, 1465, 1458, 1437, 1405, 1361, 1333, 1303, 1286, 1273, 1249, 1158, 1098, 1090, 
1029, 1007 cm
-1
. 
 
 
N-(1-(Bicyclo[1.1.0]butan-1-yl)ethyl)-N-(2-cyclopropylideneethyl)-4-methylbenzene-
sulfonamide (263h). A solution of 157h (158 mg, 0.63 mmol) in THF (3 mL) was added to an 
ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in mineral oil) in THF (3 mL). After 
stirring at rt for 20 min the solution was transferred via cannula over a solution of tosylate (100 
mg, 0.42 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) in THF (2 mL) previously stirred for 15 
min at rt. The reaction mixture was allowed to stir for 3 h at rt, poured into water and extracted 
with ether. The combined organic layers were dried, filtered and concentrated and the crude 
product was purified by  chromatography on SiO2 (Et2O : hexanes = 1 : 100 to 1 : 20) to give 
263h as a colorless oil (60 mg, 45%): 
1
H NMR (300 MHz, CDCl3) δ 7.73 (d, 2 H, J = 8.4 Hz), 
7.13 (d, 2 H, J = 8.7 Hz), 5.88-5.83 (m, 1 H), 4.37 (q, 1 H, J = 6.9 Hz), 4.22 (dd, 1 H, J = 7.2, 
15.9 Hz), 4.12 (ddt, 1 H, J = 1.5, 5.7, 15.9 Hz), 2.44 (s, 3 H), 1.56 (dd, 1 H, J = 3.0, 6.3 Hz), 
1.29-1.26 (m, 1 H), 1.23 (dd, 1 H, J = 3.0, 6.3 Hz), 1.13 (d, 3 H, J = 6.9 Hz), 1.09-1.05 (m, 4 H), 
0.48 (d, 2 H, J = 3.6 Hz); 
13
C NMR (100 MHz, CDCl3) δ 142.8, 139.0, 129.4, 127.3, 124.2, 
116.6, 54.7, 45.6, 34.3, 30.3, 21.6, 17.9, 11.8, 2.4, 2.2, 1.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for 
C18H24NO2S 318.1528, found 318.1514; IR (ATR) 3049, 3038, 3031, 3018, 2977, 2949, 2928, 
2880, 2874, 1597, 1493, 1450, 1437, 1390, 1357, 1333, 1303, 1288, 1150, 1120, 1096, 1066, 
1019, 1003, 988, 958, 887, 872, 857, 813, 770 cm
-1
. 
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N-(2-Cyclopropylideneethyl)-4-methyl-N-((3-methylbicyclo[1.1.0]butan-1-yl)(phenyl) 
methyl)benzenesulfonamide (263i). A solution of tosyl amide 72
53
 (206 mg, 0.63 mmol) in 
THF (3 mL) was added to an ice-cooled suspension of NaH (22.4 mg, 0.84 mmol, 90% in 
mineral oil) in THF (3 mL). After stirring at rt for 20 min the solution was transferred via 
cannula over a solution of tosylate (100 mg, 0.42 mmol) and Pd(PPh3)4 (22.2 mg, 0.021 mmol) 
in THF (2 mL) previously stirred for 15 min at rt. The reaction mixture was allowed to stir for 3 
h at rt, poured into water and extracted with ether. The combined organic layers were dried, 
filtered and concentrated and the crude product was purified by chromatography on SiO2 (Et2O : 
hexanes = 1 : 100 to 1 : 20) to give 263i as a colorless oil (155 mg, 94%): 
1
H NMR (300 MHz, 
CDCl3) δ 7.59 (d, 2 H, J = 8.1 Hz), 7.22-7.18 (m, 4 H), 7.13 (d, 2 H, J = 8.7 Hz), 5.61 (d, 1 H, J 
= 2.8, 6.3 Hz), 5.21 (d, 1 H, J = 6.6 Hz), 2.4 (s, 3 H), 1.55 (dd, 1 H, J = 3.0, 6.3 Hz), 1.47 (s, 1 H), 
1.24 (dd, 1 H, J = 3.0, 6.3 Hz), 0.98-0.94 (m, 4 H), 0.69 (s, 1 H), 0.57 (s, 1 H); 
13
C NMR (75 
MHz, CDCl3) δ 143.1, 138.6, 138.1, 133.3, 129.4, 129.2, 128.5, 127.4, 125.2, 115.6, 62.0, 47.9, 
34.2, 32.0, 21.6, 12.1, 3.8, 2.4, 1.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C23H25NO2SCl 
414.1295, found 414.1282; IR (ATR) 2919, 2852, 1493, 1452, 1407, 1374, 1333, 1303, 1288, 
1156, 1137, 1118, 1090, 1020, 1010, 1003, 975, 895, 813 cm
-1
. 
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N-(Bicyclo[1.1.0]butan-1-yl(phenyl)methyl)-N-(2-cyclopropylideneethyl)-4-methylbenzene-
sulfonamide (263)
53
 To a 0 °C solution of tosyl amide 157
53
 (80 mg, 0.26 mmol), alcohol (68 
mg, 0.77 mmol), and 1,1'-(azodicarbonyl) dipiperidine (73 mg, 0.28 mmol) was added tri-butyl 
phosphine (0.068 mL, 0.26 mmol). After 24 h, the mixture was added another portion of 1,1'-
(azodicarbonyl) dipiperidine (73 mg, 0.28 mmol) and tri-butyl phosphine (0.068 mL, 0.26 mmol). 
After 30 h, the reaction mixture was added 15 mL hexanes. The solid was filtered and the filtrate 
was concentrated and purified by column chromatography (EtOAc : hexanes = 1:19 to 1:9) to 
yield 263 as a colorless oil slowly crystallized in freezer (89 mg, 92%): 
1
H NMR (400 MHz, 
CDCl3) δ 7.59 (d, 2 H, J = 11.2 Hz), 7.26-7.14 (m, 7 H), 5.61 (tt, 1 H, J = 8.4, 2.8 Hz), 5.35 (s, 1 
H), 4.21 (d, 1 H, J = 8.8 Hz), 2.39 (s, 3 H), 1.58 (dd, 1 H, J = 8.8, 4.0 Hz), 1.49 (bs, 1 H), 1.27 
(dd, 1 H, J = 8.8, 4.0 Hz), 0.98-0.92 (m, 4 H), 0.70 (s, 1 H), 0.56 (s, 1 H); 
13
C NMR (100 MHz, 
CDCl3) δ 141.1, 131.6, 136.9, 127.5, 126.5, 126.0, 125.6, 123.3, 113.9, 60.7, 46.1, 32.3, 30.2, 
19.7, 10.5, 1.8, 0.5. 
 
 
1-Allyl-2-phenyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268) To a 
solution of 263 (10 mg, 0.026 mmol) in 0.5 mL dioxane was added tris(dibenzylideneacetone) 
dipalladium powder (3.0 mg, 2.6 µmol) and triisopropyl phosphite (3.0 mg, 0.01 mmol). The 
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solution was degassed and then heated at 110 °C in the oil bath. After 3h, the mixture was 
concentrated and purified by chromatography (EtOAc : hexanes = 1:20) to afford 268 as a 
colorless semisolid (6.5 mg, 65%): 
1
H NMR (400 MHz, CDCl3) δ 7.54 (d, 2 H, J = 8.0 Hz), 
7.33-7.20 (m, 7 H), 5.49-5.39 (m, 1 H), 4.98 (d, 1 H, J = 10.8 Hz), 4.95 (s, 1 H), 4.42 (s, 1 H), 
3.66 (d, 1 H, J = 9.6 Hz), 3.43 (dd, 1 H, J = 9.6, 4.8 Hz), 2.44 (s, 3 H), 2.34 (dd, 1 H, J = 14.8, 
8.0 Hz), 1.94 (dd, 1 H, J = 15.2, 4.8 Hz), 1.46 (d, 1 H, J = 4.8 Hz), 0.95-0.87 (m, 2 H), 0.54 (p, 1 
H, J = 4.4 Hz), 0.46 (p, 1 H, J = 4.4 Hz);
13
C NMR (100 MHz, CDCl3) δ 143.5, 138.1, 134.9, 
129.3, 128.3, 127.8, 127.5, 127.2, 117.3, 66.6, 51.0, 37.6, 35.2, 24.1, 21.6, 21.4, 3.9, 3.0; HRMS 
(ESI) m/z: [M + H]
+ 
Calcd for C23H24NO2S 378.1528, found 378.1517; IR (ATR) 3068, 3033, 
2997, 2971, 2954, 2926, 2867, 2846, 1597, 1491, 1454, 1437, 1361, 1346, 1338, 1301, 1290, 
1161, 1090, 1023, 1012, 997, 919, 837, 813, 703 cm
-1
.
 
 
1-Allyl-2-(4-chlorophenyl)-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268a) 
To a solution of 263a (20 mg, 0.048 mmol) in 0.90 mL dioxane was added 
bis(dibenzylideneacetone)palladium (2.8 mg, 4.8 µmol, 56 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphine (1.6 mg, 9.7 µmol, 35 µL in 45 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1:100 to 1:20) to 
afford 268a as a colorless oil (14.2 mg, 71%): 
1
H NMR (300 MHz, CDCl3) δ 7.61 (d, 2 H, J = 
8.4 Hz), 7.34-7.27 (m, 7 H), 5.62-5.55 (m, 1 H), 5.02 (s, 1 H), 4.97 (s, 1 H), 4.44 (s, 1 H), 3.68 (d, 
1 H, J = 9.6 Hz), 3.45 (dd, 1 H, J = 5.1, 9.6 Hz), 2.48 (s, 3 H), 2.33 (dd, 1 H, J = 8.4, 15.6 Hz), 
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1.98 (dd, 1 H, J = 3.3, 15.6 Hz), 1.50 (d, 1 H, J = 4.8 Hz), 0.93 (t, 1 H, J = 7.2 Hz), 0.62-0.56 (m, 
1 H), 0.53-0.47 (m, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 143.7, 136.8, 134.7, 132.9, 132.6, 
129.4, 129.1, 128.2, 127.7, 117.5, 66.0, 50.9, 37.4, 35.1, 24.2, 21.6, 21.3, 3.9, 2.9; HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C23H25NO2SCl 414.1295, found 414.1277; IR (ATR) 3068, 2990, 2975, 
2954, 2926, 2913, 2880, 2869, 1637, 1597, 1491, 1469, 1448, 1437, 1424, 1411, 1346, 1303, 
1292, 1163, 1089, 1059, 1025, 1014, 999, 982, 928, 919, 893, 839, 829, 822, 813, 725, 710 cm
-1
. 
 
 
1-Allyl-2-(furan-2-yl)-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268b). To 
a solution of 263b (20 mg, 0.054 mmol) in 0.50 mL dioxane was added 
bis(dibenzylideneacetone)palladium (3.1 mg, 5.4 µmol, 62 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphine (1.8 mg, 11 µmol, 39 µL in 45 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1:100 to 1:20) to 
afford 268b as a colorless oil (13.0 mg, 65%): 
1
H NMR (400 MHz, CDCl3) δ 7.59 (d, 2 H, J = 
8.0 Hz), 7.25 (d, 2 H, J = 8.0 Hz), 7.20 (s, 1 H), 6.23 (s, 2 H), 5.53-5.51 (m, 1 H), 4.93 (s, 1 H), 
4.89 (s, 1 H), 4.47 (s, 1 H), 3.60 (d, 1 H, J = 9.6 Hz), 3.46 (dd, 1 H, J = 4.8, 9.6 Hz), 2.42 (s, 3 H), 
2.26 (dd, 1 H, J = 8.0, 15.2 Hz), 2.05 (dd, 1 H, J = 6.0, 15.2 Hz), 1.50 (d, 1 H, J = 4.8 Hz), 1.10-
1.06 (m, 1 H),  0.9-0.85 (m, 1 H),  0.72-0.65 (m, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 150.5, 
143.1, 142.0, 134.5, 134.2, 129.2, 127.9, 117.1, 110.1, 109.9, 60.1, 50.5, 36.2, 35.1, 23.3, 21.5, 
20.7, 4.3, 3.6; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C21H24NO3S 370.1477, found 370.1492; IR 
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(ATR) 2993, 2951, 2921, 2865, 2850, 1801, 1793, 1784, 1778, 1774, 1760, 1752, 1733, 1728, 
1719, 1702, 1685, 1638, 1597, 1493, 1465, 1458, 1448, 1437, 1348, 1305, 1288, 1223, 1182, 
1161, 1092, 1031, 1012, 917, 885, 837, 813, 800,734, 708 cm
-1
. 
 
 
1-Allyl-2-(3,5-dimethoxyphenyl)-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] 
(268c). To a solution of 263c (20 mg, 0.045 mmol) in 0.90 mL dioxane was added 
bis(dibenzylideneacetone)palladium (2.6 mg, 4.5 µmol, 53 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphine (1.5 mg, 9.1 µmol, 33 µL in 45 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
the product 268c as a colorless oil (8.4 mg, 42%): 
1
H NMR (300 MHz, CDCl3) δ 7.63 (d, 2 H, J 
= 8.1 Hz), 7.31 (d, 2 H, J = 10.2 Hz), 6.49 (d, 2 H, J = 2.1 Hz), 6.35 (t, 1 H, J = 2.1 Hz), 5.65-
5.52 (m, 1 H), 5.03, (d, 1 H, J = 9.6 Hz), 4.98 (s, 1 H), 4.42 (s, 1 H), 3.79 (s, 6 H), 3.67 (d, 1 H, J 
= 9.6 Hz), 3.50 (dd, 1 H, J = 4.8, 9.6 Hz), 2.47 (s, 3 H), 2.41 (dd, 1 H, J = 8.4, 15.3 Hz), 1.99 (dd, 
1 H, J = 5.1, 15.3 Hz), 1.49 (d, 1 H, J = 5.1 Hz), 1.04-1.01 (m, 1 H), 0.99-0.92 (m, 1 H), 0.61-
0.51 (m, 2 H); 
13
C NMR (100 MHz, CDCl3) δ 160.0, 143.5, 140.5, 134.9, 133.1, 129.3, 128.2, 
117.4, 106.2, 99.2, 66.7, 55.2, 51.0, 37.7, 35.3, 24.1, 21.6, 21.4, 4.1, 3.2; HRMS (ESI) m/z: [M + 
H]
+ 
Calcd for C25H30NO4S 440.1896, found 440.1902; IR (ATR) 2993, 2954, 2932, 2874, 2850, 
2837, 1748, 1637, 1596, 1493, 1458, 1428, 1402, 1346, 1305, 1292, 1260, 1202, 1152, 1090, 
1059, 1029, 1014, 993, 939, 925, 889, 839, 815, 738 cm
-1
. 
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1-Allyl-2-isopropyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268e). To a 
solution of 263e (20 mg, 0.058 mmol) in 0.90 mL dioxane was added 
bis(dibenzylideneacetone)palladium (3.4 mg, 5.8 µmol, 67 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphine (1.9 mg, 12 µmol, 42 µL in 45 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
268e as a colorless oil (6.2 mg, 31%): 
1
H NMR (400 MHz, CDCl3) δ 7.82 (d, 2 H, J = 8.0 Hz), 
7.36 (d, 2 H, J = 8.0 Hz), 5.38-5.27 (m, 1 H), 4.87 (d, 1 H, J = 10.4 Hz), 4.77 (d, 1 H, J = 16.8 
Hz), 3.86 (dd, 1 H, J = 6.8, 12.8 Hz), 3.49 (d, 1 H, J = 9.2 Hz), 3.21 (dd, 1 H, J = 3.2, 12.8 Hz), 
2.47 (s, 3 H), 2.08-1.99 (m, 1 H), 2.01 (d, 2 H, J = 7.6 Hz), 1.36 (dd, 1 H, J = 3.2, 6.8 Hz), 1.10 
(d, 3 H, J = 6.8 Hz), 0.97-0.91 (m, 2 H), 0.79-0.75 (m, 1 H), 0.75 (d, 3 H, J = 6.4 Hz), 0.68-0.64 
(m, 1 H); 
13
C NMR (125 MHz, CDCl3) δ 143.3, 136.3, 135.2, 129.6, 128.1, 116.9, 72.0, 51.5, 
39.3, 39.2, 29.1, 28.4, 27.1, 21.5, 19.9, 5.2, 4.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for 
C20H28NO2S 346.1841, found 346.1855; IR (ATR) 2956, 2923, 2885, 2878, 2870, 2848, 2099, 
2093, 1653, 1646, 1637, 1596, 1512, 1508, 1489, 1465, 1458, 1450, 1420, 1363, 1340, 1303, 
1286, 1260, 1236, 1160, 1122, 1090, 1051, 1021, 995, 977, 911 cm
-1
. 
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1-Allyl-2-cyclopropyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268f) To 
a solution of 263f (20 mg, 0.058 mmol) in 0.90 mL dioxane was added 
bis(dibenzylideneacetone)palladium (3.3 mg, 5.8 µmol, 67 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphite (2.7 mg, 12 µmol, 71 µL in 38 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
268f as a colorless oil (10.8 mg, 54%): 
1
H NMR (400 MHz, CDCl3) δ 7.74 (d, 2 H, J = 8.0 Hz), 
7.26 (d, 2 H, J = 8.0 Hz), 5.68-5.60 (m, 1 H), 4.99 (s, 1 H), 4.95 (d, 1 H, J = 9.2 Hz), 3.64 (dd, 1 
H, J = 4.4, 9.6 Hz), 3.56 (d, 1 H, J = 9.6 Hz), 2.88 (d, 1 H, J = 9.2 Hz), 2.49 (dd, 1 H, J = 8.0, 
15.2 Hz), 2.41 (s, 3 H), 2.08 (dd, 1 H, J = 5.6, 15.2 Hz), 1.44 (d, 1 H, J = 4.4 Hz), 0.94-0.90 (m, 
2 H), 0.82-0.77 (m, 1 H), 0.75-0.70 (m, 1 H), 0.58-0.54 (m, 1 H), 0.45-0.41 (m, 1 H), 0.37-0.32 
(m, 1 H), 0.19-0.17 (m, 2 H);
 13
C NMR (100 MHz, CDCl3) δ 143.0, 137.9, 135.3, 129.2, 127.6, 
117.2, 67.5, 51.1, 37.0, 51.1, 37.0, 36.1, 23.7, 21.7, 20.8, 11.5, 6.1, 4.3, 3.5, 2.6; HRMS (ESI) 
m/z: [M + H]
+ 
Calcd for C20H26NO2S 344.1684, found 344.1667; IR (ATR) 3008, 3005, 2997, 
2971, 2951, 2926, 2917, 2889, 2872, 2859, 2850, 2121, 2114, 2106, 2101, 2091, 2073, 1638, 
1597, 1491, 1458, 1448, 1439, 1431, 1342, 1299, 1288, 1258, 1225, 1159, 1118, 1103, 1090, 
1061, 1042, 1025, 1008, 993, 964, 945, 934, 921, 902, 872, 856, 841, 833, 811 cm
-1
. 
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1-Allyl-2-(((4-methoxybenzyl)oxy)methyl)-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-
cyclopropane] (268g). To a solution of 263g (20 mg, 0.044 mmol) in 0.50 mL dioxane was 
added bis(dibenzylideneacetone)palladium (2.5 mg, 4.4 µmol, 51 µL in 50 mg/mL solution in 
dioxane) and triisopropyl phosphite (2.0 mg, 8.8 µmol, 54 µL in 38 mg/mL solution in dioxane). 
The solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
268g as a colorless oil (13.0 mg, 65%): 
1
H NMR (400 MHz, CDCl3) δ 7.72 (d, 2 H, J = 8.0 Hz), 
7.34 (d, 2 H, J = 8.0 Hz), 7.23 (d, 2 H, J = 8.8 Hz), 6.91 (d, 2 H, J = 8.4 Hz), 5.54-5.44 (m, 1 H), 
4.85 (d, 1 H, J = 4.4 Hz), 4.82 (s, 1 H), 4.53 (d, 1 H, J = 11.6 Hz), 4.33 (d, 1 H, J = 11.6 Hz), 
4.06 (dd, 1 H, J = 2.0, 6.8 Hz), 3.85 (s, 3 H), 3.66 (dd, 2 H, J = 8.8, 16.0 Hz), 3.44 (d, 1 H, J = 
9.6 Hz), 3.30 (dd, 1 H, J = 4.8, 9.6 Hz), 2.61 (dd, 1 H, J = 8.0, 14.8 Hz), 2.48 (s, 3 H), 2.02 (dd, 2 
H, J = 5.6, 14.8 Hz), 1.33 (d, 1 H, J = 5.2 Hz), 0.85-0.81 (m, 1 H), 0.76-0.71 (m, 2 H), 0.66-0.62 
(m, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 159.2, 143.5, 135.1, 132.9, 130.6, 129.5, 129.2, 128.1, 
116.6, 113.7, 72.8, 70.5, 61.6, 55.3, 51.3, 36.4, 36.0, 24.5, 21.6, 21.6, 4.2, 3.7; HRMS (ESI) m/z: 
[M + H]
+ 
Calcd for C26H32NO4S 454.2052, found 454.2064; IR (ATR) 2971, 2954, 2947, 2926, 
2923, 2883, 2876, 2869, 2857, 2852, 2101, 1653, 1646, 1638, 1610, 1597, 1586, 1512, 1491, 
1463, 1458, 1441, 1420, 1342, 1303, 1243, 1159, 1090, 1029, 1012, 913, 815, 708 cm
-1
. 
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1-Allyl-2-methyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (268h). To a 
solution of 263h (20 mg, 0.063 mmol) in 0.90 mL dioxane was added 
bis(dibenzylideneacetone)palladium (3.6 mg, 6.3 µmol, 72 µL in 50 mg/mL solution in dioxane) 
and triisopropyl phosphite (2.9 mg, 12.6 µmol, 77 µL in 38 mg/mL solution in dioxane). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
268h as a colorless oil (6.4 mg, 32%): 
1
H NMR (400 MHz, CDCl3) δ 7.72 (d, 2 H, J = 8.4 Hz), 
7.35 (d, 2 H, J = 7.6 Hz), 5.63-5.55 (m, 1 H), 4.96 (d, 1 H, J = 5.2 Hz), 4.92 (s, 1 H), 3.50 (d, 1 H, 
J = 9.6 Hz), 3.37 (dd, 1 H, J = 6.4, 12.4 Hz), 3.25 (dd, 1 H, J = 4.4, 9.2 Hz), 2.48 (s, 3 H), 2.32 
(dd, 1 H, J = 7.2, 15.2 Hz), 2.12 (dd, 1 H, J = 6.4, 15.2 Hz), 1.35 (d, 1 H, J = 6.4 Hz), 1.35-1.33 
(m, 1 H), 0.99 (dt, 1 H, J = 4.4, 4.8 Hz), 0.90 (dt, 1 H, J = 4.4, 5.2 Hz), 0.77 (dt, 1 H, J = 4.4, 5.2 
Hz), 0.69 (dt, 1 H, J = 4.0, 4.8 Hz);
 13
C NMR (100 MHz, CDCl3) δ 143.2, 134.9, 133.8, 129.4, 
127.8, 116.8, 59.3, 50.9, 35.8, 35.0, 23.2, 21.6, 20.2, 16.0, 3.9, 3.2; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C18H23NO2S 318.1528, found 318.1531; IR (ATR) 2977, 2960, 2926, 2887, 2878, 
2867, 2857, 2850, 2110, 2097, 2084, 1653, 1638, 1597, 1514, 1491, 1458, 1452, 1420, 1376, 
1344, 1303, 1288, 1260, 1236, 1161, 1109, 1092, 1074, 1029, 1020, 1007, 966, 913, 844, 815 
cm
-1
. 
 
 123 
 
1-(2-Methylallyl)-2-phenyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] 
(268i). To a solution of 263i (20 mg, 0.051 mmol) in 0.90 mL toluene was added 
bis(dibenzylideneacetone)palladium (2.9 mg, 5.1 µmol, 58 µL in 50 mg/mL solution in toluene) 
and triisopropyl phosphite (2.4 mg, 10 µmol, 62 µL in 38 mg/mL solution in toluene). The 
solution was carefully degassed and then heated at 130 °C in microwave. After 30 mins, the 
mixture was concentrated and purified by chromatography (EtOAc : hexanes = 1 : 20) to afford 
268i as a colorless oil (12.2 mg, 61%): 
1
H NMR (400 MHz, CDCl3) δ 7.66 (d, 2 H, J = 7.2 Hz), 
7.40-7.25 (m, 7 H), 4.79 (s, 1 H), 4.70 (s, 1 H), 4.50 (s, 1 H), 3.73 (d, 1 H, J = 9.6 Hz), 3.52 (dd, 
1 H, J = 4.8, 9.2 Hz), 2.49 (s, 3 H), 2.42 (d, 1 H, J = 15.2 Hz), 1.80 (d, 1 H, J = 16.0 Hz), 1.52 (d, 
1 H, J = 4.8 Hz), 1.35 (s, 3 H), 0.94-0.90 (m, 2 H), 0.58-0.52 (m, 1 H), 0.45-0.40 (m, 1 H); 
13
C 
NMR (100 MHz, CDCl3) δ 143.5, 142.7, 138.5, 132.2, 129.4, 128.3, 127.7, 127.4, 127.0, 113.8, 
65.3, 50.8, 39.3, 36.2, 26.2, 22.1, 21.5, 21.0, 3.6, 2.8; HRMS (ESI) m/z: [M + H]
+ 
Calcd for 
C24H28NO2S 394.1841, found 394.1840; IR (ATR) 2956, 2921, 2852, 1722, 1648, 1597, 1493, 
1450, 1377, 1348, 1303, 1290, 1163, 1090, 1075, 1051, 1023, 1014, 898, 891, 839, 816, 738, 708, 
699 cm
-1
. 
 
1-Allyl-2-phenyl-3-tosyl-3-azabicyclo[3.1.0]hexane (274). To a solution of 269 (20 mg, 0.056 
mmol) in 0.5 mL dioxane was added bis(dibenzylideneacetone)palladium (1.6 mg, 2.8 µmol, 62 
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µL in 26 mg/mL solution in dioxane) and triisopropylphosphine (0.93 mg, 5.7 µmol, 28 µL in 33 
mg/mL solution in dioxane). The solution was degassed and then heated at 130 °C in the 
microwave reactor. After 45 mins, the mixture was concentrated and purified by chromatography 
(EtOAc : hexanes = 1:100 to 1:20) to afford the product as a colorless oil (16.8 mg, 84%): 
1
H 
NMR (400 MHz, CDCl3) δ 7.59 (d, 2 H, J = 8.0 Hz), 7.33-7.27 (m, 5 H), 7.26-7.22 (m, 2 H), 
5.57-5.50 (m, 1 H), 4.95 (s, 1 H), 4.91 (d, 1 H, J = 8.0 Hz), 4.20 (s, 1 H), 3.73 (d, 1 H, J = 9.2 
Hz), 3.43 (dd, 1 H, J = 9.2, 4.4 Hz), 2.44 (s, 3 H), 2.33 (dd, 1 H, J = 14.8, 8.0 Hz), 1.84 (dd, 1 H, 
J = 15.2, 5.2 Hz), 1.38 (q, 1 H, J = 4.0 Hz), 1.05 (t, 1 H, J = 4.4 Hz), 0.39 (t, 1 H, J = 6.4 Hz); 
13
C NMR (100 MHz, CDCl3) δ 143.5, 138.7, 134.3, 132.7, 129.4, 128.2, 128.0, 127.6, 127.4, 
117.7, 66.9, 52.4, 35.3, 21.6, 19.3, 11.9; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C21H22NO2S 
352.1371, found 352.1353; IR (ATR) 3062, 3029, 2997, 2971, 2965, 2958, 2921, 2880, 2869, 
2861, 2854, 1638, 1597, 1493, 1452, 1435, 1349, 1303, 1290, 1161, 1107, 1092, 1040, 1027, 
1016, 915, 815, 772 cm
-1
. 
 
 
2-Phenyl-1-propyl-3-tosyl-3-azaspiro[bicyclo[3.1.0]hexane-6,1'-cyclopropane] (282). To a 
0 °C suspension of platinum oxide (6.0 mg, 26 µmol) in 5 ml THF hydrogenated with H2 under 
room temperature for 15 mins. After this, a solution of 268 (0.20 g, 0.53 mmol) was added 
dropwise, and the mixture was stirred at this temperature for 30 mins. The mixture was 
concentrated and purified by chromatography on SiO2 (EtOAc : hexanes = 1 : 20) to afford 282 
as a colorless oil (0.176 g, 88%): 
1
H NMR (300 MHz, CDCl3) δ 7.54-7.50 (m, 2 H), 7.26-7.08 
(m, 7 H), 4.29 (s, 1 H), 7.58 (d, 1 H, J = 9.3 Hz), 3.35 (dd, 1 H, J = 4.5, 7.8 Hz), 2.36 (s, 3 H), 
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1.53-1.48 (m, 1 H), 1.32-1.25 (m, 1 H), 1.11-1.19 (m, 3 H), 0.88-0.75 (m, 2 H), 0.67 (dt, 3 H, J = 
1.5, 6.9 Hz), 0.45-0.43 (m, 1 H), 0.37-0.33 (s, 1 H); 
13
C NMR (100 MHz, CDCl3) δ 143.5, 138.3, 
132.8, 129.3, 128.2, 127.8, 127.5, 127.1, 67.0, 51.0, 38.0, 32.7, 24.3, 21.6, 21.0, 19.4, 14.0, 3.9, 
3.1; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C23H28NO2S 382.1841, found 382.1871; IR (ATR) 
3061, 2965, 2912, 2901, 2867, 2846, 1491, 1439, 1411, 1336, 1326, 1308, 1291, 1095, 1021, 
1009, 921, 823, 810, 791 cm
-1
. 
 
6-Methyl-1-phenyl-6a-propyl-2-tosyl-1,3,3a,6a-tetrahydrocyclopenta[c]pyrrol-4(2H)-one 
(283). To a solution of 282 (40 mg, 0.1 mmol) in xylenes was added chloro-(1,5-
cyclooctadiene)rhodium(I) dimmer (2.6 mg, 5.2 µmol) and DPPP (4.4 mg, 10 µmol) and 
degassed by bubbling CO through the solution. The resulting reaction mixture was heated at 
130 °C for 3 h under CO atmosphere (CO : N2 = 1:1 balloon). The mixture was then purified by 
chromatography on SiO2 (acetone : hexanes = 2 : 5) to afford 283 as a colorless oil (24 mg, 56%): 
1
H NMR (400 MHz, CDCl3) δ 7.40 (d, 2 H, J = 8.0 Hz), 7.17-7.16 (m, 5 H), 7.05 (d, 2 H, J = 7.2 
Hz), 5.92 (s, 1 H), 4.09-4.08 (m, 1 H), 4.00 (dd, 1 H, J = 2.0, 10.0 Hz), 3.40-3.35 (m, 2 H), 2.69 
(d, 1 H, J = 8.4 Hz), 2.42 (s, 3 H), 1.74-1.70 (m, 1 H), 1.65-1.61 (m, 1 H), 1.27-1.14 (m, 1 H), 
1.05 (s, 3 H), 1.03-0.94 (m, 1 H), 0.93 (s, 3 H, J = 7.2 Hz); 
13
C NMR (100 MHz, CDCl3) δ 206.8, 
180.0, 143.6, 136.7, 133.3, 129.3, 128.6, 128.1, 128.1, 128.0, 72.0, 63.2, 52.5, 49.0, 37.5, 21.5, 
18.0, 15.6, 14.4; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C24H28NO3S 410.1790, found 410.1774; 
IR (ATR) 3057, 2969, 2962, 2926, 2919, 2854, 1700, 1614, 1597, 1469, 1454, 1363, 1351, 1312, 
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1299, 1199, 1184, 1159, 1128, 1111, 1090, 1033, 1023, 1014, 1007, 988, 904, 874, 865, 856, 833, 
824, 811, 785, 759 cm
-1
. 
 
 
6a-Allyl-6-methyl-1-phenyl-2-tosyl-1,3,3a,6a-tetrahydrocyclopenta[c]pyrrol-4(2H)-one 
(289). To a solution of 268 (10 mg, 26 µmol) in xylenes (1 mL) was added chloro-(1,5-
cyclooctadiene)rhodium(I) dimmer (0.66 mg, 1.3 µmol) and degassed by bubbling CO through 
the solution for 5 mins. The resulting reaction mixture was heated at 130 °C for 6 h under CO 
atmosphere (CO balloon). The mixture was then purified by chromatography on SiO2 (EtOAc : 
hexanes = 1:100 to 1:20) to afford 289 as a colorless oil (5.9 mg, 55%): 
1
H NMR (400 MHz, 
CDCl3) δ 7.42 (dd, 2 H, J = 1.6, 6.8 Hz), 7.29-7.19 (m, 5 H), 7.07 (dd, 1 H, J = 1.6, 6.8 Hz), 5.94 
(d, 1 H, J = 1.2 Hz), 5.48-5.40 (m, 1 H), 5.16-5.08 (m, 2 H), 4.14 (s, 1 H), 4.01 (dd, 1 H, J = 1.6, 
10.0 Hz), 3.34 (dd, 1 H, J = 8.4, 9.6 Hz), 2.72 (dd, 1 H, J = 1.6, 8.4 Hz), 2.52-2.41 (m, 2 H), 2.43 
(s, 3 H), 1.09 (d, 3 H, J = 1.2 Hz); 
13
C NMR (100 MHz, CDCl3) δ 206.4, 179.2, 143.7, 136.6, 
133.6, 132.9, 132.0, 129.3, 128.6, 128.2, 128.1, 128.0, 120.5, 71.0, 62.5, 52.7, 48.9, 39.5, 21.6, 
15.6; HRMS (ESI) m/z: [M + H]
+ 
Calcd for C24H26NO3S 408.1633, found 408.1602; IR (ATR) 
2951, 2921, 2867, 2848, 2060, 2048, 1702, 1612, 1597, 1491, 1467, 1454, 1374, 1349, 1303, 
1292, 1199, 1184, 1163, 1090, 1021, 1008, 925, 867, 839, 816 cm
-1
. 
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APPENDIX A 
X-RAY DATA FOR 153 
Table 11. Crystal data and structural refinement for 153. 
Identification code yan1 
Chemical formula C28H34NOPSi 
Formula weight 459.62 
Temperature 100(2) K 
Wavelength 1.54178 Å 
Crystal size 0.020 x 0.090 x 0.130 mm 
Crystal habit colorless plate 
Crystal system monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions a = 10.5991(3) Å α = 90° 
 
b = 20.9441(7) Å β = 92.369(2)° 
 
c = 23.2304(8) Å γ = 90° 
Volume 5152.5(3) Å
3
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Z 8 
Density (calculated) 1.185 Mg/cm
3
 
Absorption coefficient 1.532 mm
-1
 
Theta range for data collection 3.81 to 63.30° 
Index ranges -12<=h<=12, -24<=k<=23, -26<=l<=26 
Reflections collected 48198 
Independent reflections 8292 [R(int) = 0.0702] 
Coverage of independent 
reflections 98.7% 
Absorption correction multi-scan 
Max. and min. transmission 0.9700 and 0.8257 
Structure solution technique direct methods 
Structure solution program SHELXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-97 (Sheldrick, 2008) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 8292 / 0 / 590 
Goodness-of-fit on F2 1.823 
Δ/σmax 0.003 
Final R indices 6063 data; I>2σ(I) R1 = 0.0885, wR2 = 0.2198 
 
all data R1 = 0.1165, wR2 = 0.2325 
 129 
Weighting scheme 
w=1/[σ2(Fo
2
)+(0.0780P)
2
+0.0000P] 
where P=(Fo
2
+2Fc
2
)/3 
Largest diff. peak and hole 1.639 and -0.475 eÅ
-3
 
R.M.S. deviation from mean 0.109 eÅ
-3
 
 
Table 12. Atomic coordinates and equivalent isotropic displacement parameters for 153.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
x/a y/b z/c U(eq) (Å2) 
P1 0.63098(8) 0.35474(5) 0.16016(4) 0.0223(3) 
Si1 0.71943(13) 0.27991(7) 0.42326(5) 0.0459(4) 
O1 0.5100(2) 0.38306(13) 0.17764(13) 0.0327(7) 
N1 0.7486(3) 0.36560(16) 0.20672(13) 0.0262(8) 
C1 0.7372(4) 0.36273(19) 0.26955(17) 0.0291(9) 
C2 0.8089(4) 0.41808(19) 0.29670(18) 0.0315(10) 
C3 0.7530(4) 0.4826(2) 0.2794(2) 0.0485(13) 
C4 0.9015(4) 0.5758(2) 0.2743(2) 0.0461(12) 
C5 0.9652(5) 0.6271(3) 0.2985(3) 0.0640(17) 
C6 0.9510(7) 0.6413(3) 0.3541(4) 0.117(4) 
C7 0.8733(9) 0.6053(4) 0.3869(4) 0.148(5) 
C8 0.8093(7) 0.5538(4) 0.3625(3) 0.092(3) 
C9 0.8214(4) 0.5386(2) 0.3053(2) 0.0394(11) 
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x/a y/b z/c U(eq) (Å2) 
C10 0.7777(4) 0.2987(2) 0.29237(18) 0.0331(10) 
C11 0.7045(5) 0.2380(2) 0.2964(2) 0.0474(12) 
C12 0.7733(4) 0.2659(2) 0.34990(19) 0.0365(10) 
C13 0.8963(4) 0.2753(2) 0.3200(2) 0.0427(11) 
C14 0.6090(6) 0.2137(4) 0.4410(3) 0.107(3) 
C15 0.6392(12) 0.3569(5) 0.4285(3) 0.220(8) 
C16 0.8538(5) 0.2801(3) 0.4748(2) 0.0657(17) 
C17 0.6282(4) 0.4436(2) 0.0728(2) 0.0421(12) 
C18 0.6735(5) 0.4745(2) 0.0249(2) 0.0468(13) 
C19 0.7837(5) 0.4539(2) 0.0010(2) 0.0483(13) 
C20 0.8470(5) 0.4006(2) 0.0234(2) 0.0511(13) 
C21 0.7981(4) 0.3688(2) 0.06988(18) 0.0367(10) 
C22 0.6892(4) 0.39029(18) 0.09599(17) 0.0266(9) 
C23 0.4968(4) 0.2491(2) 0.1210(2) 0.0403(11) 
C24 0.4807(5) 0.1855(2) 0.1063(2) 0.0563(15) 
C25 0.5782(6) 0.1438(2) 0.1127(2) 0.0560(15) 
C26 0.6933(5) 0.1643(2) 0.1349(2) 0.0481(13) 
C27 0.7110(4) 0.2280(2) 0.15021(19) 0.0367(10) 
C28 0.6119(4) 0.27079(19) 0.14344(17) 0.0299(9) 
P1' 0.13267(9) 0.39080(5) 0.16437(5) 0.0268(3) 
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x/a y/b z/c U(eq) (Å2) 
Si1' 0.23006(13) 0.45270(7) 0.42797(5) 0.0428(4) 
O1' 0.0113(2) 0.36346(13) 0.18246(13) 0.0337(7) 
C1' 0.2402(4) 0.37907(19) 0.27303(19) 0.0303(10) 
N1' 0.2509(3) 0.37751(16) 0.21042(16) 0.0327(8) 
C2' 0.3074(4) 0.3203(2) 0.2984(2) 0.0391(11) 
C3' 0.2408(5) 0.2582(2) 0.2798(3) 0.0668(18) 
C4' 0.3956(5) 0.1733(3) 0.2600(3) 0.0581(15) 
C5' 0.4571(5) 0.1170(3) 0.2735(3) 0.0711(19) 
C6' 0.4304(5) 0.0846(3) 0.3215(3) 0.0663(18) 
C7' 0.3439(5) 0.1084(3) 0.3574(3) 0.0611(15) 
C8' 0.2844(5) 0.1653(2) 0.3445(2) 0.0482(13) 
C9' 0.3088(4) 0.1983(2) 0.2956(2) 0.0402(12) 
C10' 0.2856(4) 0.4412(2) 0.29765(18) 0.0311(10) 
C11' 0.2163(4) 0.5025(2) 0.30443(19) 0.0411(11) 
C12' 0.2847(4) 0.4716(2) 0.35617(19) 0.0340(10) 
C13' 0.4076(4) 0.4618(2) 0.3255(2) 0.0383(11) 
C14' 0.2071(11) 0.5287(5) 0.4714(4) 0.087(4) 
C15' 0.3416(9) 0.4042(6) 0.4709(4) 0.098(5) 
C16' 0.0748(8) 0.4122(5) 0.4216(4) 0.073(3) 
C14" 0.104(2) 0.5029(11) 0.4388(10) 0.097(7) 
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x/a y/b z/c U(eq) (Å2) 
C15" 0.3607(13) 0.4741(7) 0.4767(6) 0.045(4) 
C16" 0.2213(18) 0.3612(9) 0.4356(8) 0.076(6) 
C17' 0.1331(4) 0.2996(2) 0.0805(3) 0.0568(15) 
C18' 0.1763(5) 0.2699(3) 0.0310(3) 0.0713(19) 
C19' 0.2713(5) 0.2952(3) 0.0013(2) 0.0591(15) 
C20' 0.3260(5) 0.3527(2) 0.0190(2) 0.0546(14) 
C21' 0.2812(4) 0.3828(2) 0.0671(2) 0.0402(11) 
C22' 0.1860(4) 0.35678(19) 0.09854(18) 0.0309(10) 
C23' 0.0044(4) 0.5002(2) 0.1290(2) 0.0395(11) 
C24' 0.9938(5) 0.5651(2) 0.1172(2) 0.0546(14) 
C25' 0.0992(6) 0.6043(2) 0.1279(2) 0.0562(16) 
C26' 0.2101(6) 0.5812(2) 0.1489(2) 0.0506(14) 
C27' 0.2214(5) 0.5155(2) 0.16020(18) 0.0402(11) 
C28' 0.1180(4) 0.47554(19) 0.15061(18) 0.0310(10) 
 
Table 13.  Bond lengths (Å) for 153. 
P1-O1 1.485(3) P1-N1 1.633(3) 
P1-C22 1.798(4) P1-C28 1.810(4) 
Si1-C16 1.823(5) Si1-C15 1.829(7) 
Si1-C12 1.843(5) Si1-C14 1.872(7) 
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N1-C1 1.471(5) N1-H1B 0.88 
C1-C10 1.499(6) C1-C2 1.510(6) 
C1-H1A 1.0 C2-C3 1.522(6) 
C2-H2A 0.99 C2-H2B 0.99 
C3-C9 1.492(6) C3-H3A 0.99 
C3-H3B 0.99 C4-C5 1.376(8) 
C4-C9 1.378(6) C4-H4A 0.95 
C5-C6 1.340(10) C5-H5A 0.95 
C6-C7 1.372(11) C6-H6A 0.95 
C7-C8 1.383(9) C7-H7A 0.95 
C8-C9 1.376(7) C8-H8A 0.95 
C10-C13 1.472(6) C10-C11 1.494(6) 
C10-C12 1.505(6) C11-C12 1.531(6) 
C11-H11A 0.99 C11-H11B 0.99 
C12-C13 1.515(6) C13-H13A 0.99 
C13-H13B 0.99 C14-H14A 0.98 
C14-H14B 0.98 C14-H14C 0.98 
C15-H15A 0.98 C15-H15B 0.98 
C15-H15C 0.98 C16-H16A 0.98 
C16-H16B 0.98 C16-H16C 0.98 
C17-C22 1.387(6) C17-C18 1.391(7) 
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C17-H17A 0.95 C18-C19 1.383(7) 
C18-H18A 0.95 C19-C20 1.392(7) 
C19-H19A 0.95 C20-C21 1.386(6) 
C20-H20A 0.95 C21-C22 1.400(6) 
C21-H21A 0.95 C23-C28 1.382(6) 
C23-C24 1.386(6) C23-H23A 0.95 
C24-C25 1.355(8) C24-H24A 0.95 
C25-C26 1.374(8) C25-H25A 0.95 
C26-C27 1.392(6) C26-H26A 0.95 
C27-C28 1.385(6) C27-H27A 0.95 
P1'-O1' 1.485(3) P1'-N1' 1.638(3) 
P1'-C22' 1.799(4) P1'-C28' 1.809(4) 
Si1'-C14" 1.72(2) Si1'-C15" 1.808(13) 
Si1'-C15' 1.824(9) Si1'-C12' 1.832(4) 
Si1'-C16' 1.851(8) Si1'-C14' 1.906(9) 
Si1'-C16" 1.927(19) C1'-N1' 1.464(6) 
C1'-C10' 1.493(6) C1'-C2' 1.528(6) 
C1'-H1'A 1.0 N1'-H1'B 0.88 
C2'-C3' 1.533(6) C2'-H2'A 0.99 
C2'-H2'B 0.99 C3'-C9' 1.486(6) 
C3'-H3'A 0.99 C3'-H3'B 0.99 
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C4'-C9' 1.368(7) C4'-C5' 1.376(8) 
C4'-H4'A 0.95 C5'-C6' 1.347(9) 
C5'-H5'A 0.95 C6'-C7' 1.359(8) 
C6'-H6'A 0.95 C7'-C8' 1.375(7) 
C7'-H7'A 0.95 C8'-C9' 1.363(7) 
C8'-H8'A 0.95 C10'-C13' 1.486(6) 
C10'-C11' 1.490(6) C10'-C12' 1.501(6) 
C11'-C12' 1.522(6) C11'-H11C 0.99 
C11'-H11D 0.99 C12'-C13' 1.525(6) 
C13'-H13C 0.99 C13'-H13D 0.99 
C14'-H14D 0.98 C14'-H14E 0.98 
C14'-H14F 0.98 C15'-H15D 0.98 
C15'-H15E 0.98 C15'-H15F 0.98 
C16'-H16D 0.98 C16'-H16E 0.98 
C16'-H16F 0.98 C14"-H14G 0.98 
C14"-H14H 0.98 C14"-H14I 0.98 
C15"-H15G 0.98 C15"-H15H 0.98 
C15"-H15I 0.98 C16"-H16G 0.98 
C16"-H16H 0.98 C16"-H16I 0.98 
C17'-C22' 1.379(6) C17'-C18' 1.399(8) 
C17'-H17B 0.95 C18'-C19' 1.352(8) 
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C18'-H18B 0.95 C19'-C20' 1.391(8) 
C19'-H19B 0.95 C20'-C21' 1.385(7) 
C20'-H20B 0.95 C21'-C22' 1.382(6) 
C21'-H21B 0.95 C23'-C28' 1.385(6) 
C23'-C24' 1.391(6) C23'-H23B 0.95 
C24'-C25' 1.400(8) C24'-H24B 0.95 
C25'-C26' 1.344(8) C25'-H25B 0.95 
C26'-C27' 1.405(7) C26'-H26B 0.95 
C27'-C28' 1.390(6) C27'-H27B 0.95 
 
Table 14. Bond angles (°) for 153. 
O1-P1-N1 114.07(16) O1-P1-C22 113.02(18) 
N1-P1-C22 102.29(17) O1-P1-C28 110.88(17) 
N1-P1-C28 110.68(18) C22-P1-C28 105.27(18) 
C16-Si1-C15 107.9(5) C16-Si1-C12 110.2(2) 
C15-Si1-C12 111.4(3) C16-Si1-C14 109.6(3) 
C15-Si1-C14 110.0(5) C12-Si1-C14 107.8(3) 
C1-N1-P1 124.0(3) C1-N1-H1B 118.0 
P1-N1-H1B 118.0 N1-C1-C10 110.7(3) 
N1-C1-C2 108.8(3) C10-C1-C2 114.1(3) 
N1-C1-H1A 107.7 C10-C1-H1A 107.7 
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C2-C1-H1A 107.7 C1-C2-C3 112.8(3) 
C1-C2-H2A 109.0 C3-C2-H2A 109.0 
C1-C2-H2B 109.0 C3-C2-H2B 109.0 
H2A-C2-H2B 107.8 C9-C3-C2 114.5(4) 
C9-C3-H3A 108.6 C2-C3-H3A 108.6 
C9-C3-H3B 108.6 C2-C3-H3B 108.6 
H3A-C3-H3B 107.6 C5-C4-C9 122.0(5) 
C5-C4-H4A 119.0 C9-C4-H4A 119.0 
C6-C5-C4 119.6(6) C6-C5-H5A 120.2 
C4-C5-H5A 120.2 C5-C6-C7 120.5(6) 
C5-C6-H6A 119.7 C7-C6-H6A 119.7 
C6-C7-C8 119.7(7) C6-C7-H7A 120.1 
C8-C7-H7A 120.1 C9-C8-C7 120.9(6) 
C9-C8-H8A 119.6 C7-C8-H8A 119.6 
C8-C9-C4 117.2(5) C8-C9-C3 120.5(5) 
C4-C9-C3 122.2(5) C13-C10-C11 97.2(4) 
C13-C10-C1 132.8(4) C11-C10-C1 130.0(4) 
C13-C10-C12 61.2(3) C11-C10-C12 61.4(3) 
C1-C10-C12 134.7(4) C10-C11-C12 59.6(3) 
C10-C11-H11A 117.8 C12-C11-H11A 117.8 
C10-C11-H11B 117.8 C12-C11-H11B 117.8 
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H11A-C11-H11B 114.9 C10-C12-C13 58.4(3) 
C10-C12-C11 59.0(3) C13-C12-C11 93.9(4) 
C10-C12-Si1 140.4(3) C13-C12-Si1 135.1(3) 
C11-C12-Si1 131.0(3) C10-C13-C12 60.5(3) 
C10-C13-H13A 117.7 C12-C13-H13A 117.7 
C10-C13-H13B 117.7 C12-C13-H13B 117.7 
H13A-C13-H13B 114.8 Si1-C14-H14A 109.5 
Si1-C14-H14B 109.5 H14A-C14-H14B 109.5 
Si1-C14-H14C 109.5 H14A-C14-H14C 109.5 
H14B-C14-H14C 109.5 Si1-C15-H15A 109.5 
Si1-C15-H15B 109.5 H15A-C15-H15B 109.5 
Si1-C15-H15C 109.5 H15A-C15-H15C 109.5 
H15B-C15-H15C 109.5 Si1-C16-H16A 109.5 
Si1-C16-H16B 109.5 H16A-C16-H16B 109.5 
Si1-C16-H16C 109.5 H16A-C16-H16C 109.5 
H16B-C16-H16C 109.5 C22-C17-C18 121.0(5) 
C22-C17-H17A 119.5 C18-C17-H17A 119.5 
C19-C18-C17 120.0(4) C19-C18-H18A 120.0 
C17-C18-H18A 120.0 C18-C19-C20 120.2(5) 
C18-C19-H19A 119.9 C20-C19-H19A 119.9 
C21-C20-C19 119.0(5) C21-C20-H20A 120.5 
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C19-C20-H20A 120.5 C20-C21-C22 121.7(4) 
C20-C21-H21A 119.2 C22-C21-H21A 119.2 
C17-C22-C21 118.0(4) C17-C22-P1 119.0(3) 
C21-C22-P1 122.9(3) C28-C23-C24 120.4(5) 
C28-C23-H23A 119.8 C24-C23-H23A 119.8 
C25-C24-C23 120.4(5) C25-C24-H24A 119.8 
C23-C24-H24A 119.8 C24-C25-C26 120.2(4) 
C24-C25-H25A 119.9 C26-C25-H25A 119.9 
C25-C26-C27 120.2(5) C25-C26-H26A 119.9 
C27-C26-H26A 119.9 C28-C27-C26 119.9(4) 
C28-C27-H27A 120.1 C26-C27-H27A 120.1 
C23-C28-C27 118.9(4) C23-C28-P1 119.3(3) 
C27-C28-P1 121.8(3) O1'-P1'-N1' 113.48(17) 
O1'-P1'-C22' 113.22(18) N1'-P1'-C22' 103.24(18) 
O1'-P1'-C28' 111.06(18) N1'-P1'-C28' 109.87(19) 
C22'-P1'-C28' 105.43(19) C14"-Si1'-C15" 109.5(9) 
C14"-Si1'-C15' 138.4(8) C15"-Si1'-C15' 48.2(6) 
C14"-Si1'-C12' 106.0(8) C15"-Si1'-C12' 104.7(5) 
C15'-Si1'-C12' 113.3(3) C14"-Si1'-C16' 66.5(8) 
C15"-Si1'-C16' 145.0(6) C15'-Si1'-C16' 110.1(5) 
C12'-Si1'-C16' 109.8(3) C14"-Si1'-C14' 45.3(8) 
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C15"-Si1'-C14' 64.7(6) C15'-Si1'-C14' 105.6(6) 
C12'-Si1'-C14' 110.7(3) C16'-Si1'-C14' 107.0(5) 
C14"-Si1'-C16" 123.6(10) C15"-Si1'-C16" 103.2(7) 
C15'-Si1'-C16" 55.2(7) C12'-Si1'-C16" 108.5(6) 
C16'-Si1'-C16" 60.4(7) C14'-Si1'-C16" 140.8(7) 
N1'-C1'-C10' 111.3(3) N1'-C1'-C2' 108.2(4) 
C10'-C1'-C2' 114.6(3) N1'-C1'-H1'A 107.5 
C10'-C1'-H1'A 107.5 C2'-C1'-H1'A 107.5 
C1'-N1'-P1' 123.8(3) C1'-N1'-H1'B 118.1 
P1'-N1'-H1'B 118.1 C1'-C2'-C3' 111.8(4) 
C1'-C2'-H2'A 109.2 C3'-C2'-H2'A 109.2 
C1'-C2'-H2'B 109.2 C3'-C2'-H2'B 109.2 
H2'A-C2'-H2'B 107.9 C9'-C3'-C2' 115.7(4) 
C9'-C3'-H3'A 108.4 C2'-C3'-H3'A 108.4 
C9'-C3'-H3'B 108.4 C2'-C3'-H3'B 108.4 
H3'A-C3'-H3'B 107.4 C9'-C4'-C5' 121.0(6) 
C9'-C4'-H4'A 119.5 C5'-C4'-H4'A 119.5 
C6'-C5'-C4' 120.5(6) C6'-C5'-H5'A 119.8 
C4'-C5'-H5'A 119.8 C5'-C6'-C7' 119.6(5) 
C5'-C6'-H6'A 120.2 C7'-C6'-H6'A 120.2 
C6'-C7'-C8' 120.0(6) C6'-C7'-H7'A 120.0 
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C8'-C7'-H7'A 120.0 C9'-C8'-C7' 121.3(5) 
C9'-C8'-H8'A 119.3 C7'-C8'-H8'A 119.3 
C8'-C9'-C4' 117.7(5) C8'-C9'-C3' 121.9(5) 
C4'-C9'-C3' 120.4(5) C13'-C10'-C11' 97.4(4) 
C13'-C10'-C1' 132.8(4) C11'-C10'-C1' 129.7(4) 
C13'-C10'-C12' 61.4(3) C11'-C10'-C12' 61.2(3) 
C1'-C10'-C12' 134.6(4) C10'-C11'-C12' 59.8(3) 
C10'-C11'-H11C 117.8 C12'-C11'-H11C 117.8 
C10'-C11'-H11D 117.8 C12'-C11'-H11D 117.8 
H11C-C11'-H11D 114.9 C10'-C12'-C11' 59.1(3) 
C10'-C12'-C13' 58.8(3) C11'-C12'-C13' 94.4(4) 
C10'-C12'-Si1' 138.3(3) C11'-C12'-Si1' 130.7(3) 
C13'-C12'-Si1' 134.9(3) C10'-C13'-C12' 59.8(3) 
C10'-C13'-H13C 117.8 C12'-C13'-H13C 117.8 
C10'-C13'-H13D 117.8 C12'-C13'-H13D 117.8 
H13C-C13'-H13D 114.9 Si1'-C14'-H14D 109.5 
Si1'-C14'-H14E 109.5 H14D-C14'-H14E 109.5 
Si1'-C14'-H14F 109.5 H14D-C14'-H14F 109.5 
H14E-C14'-H14F 109.5 Si1'-C15'-H15D 109.5 
Si1'-C15'-H15E 109.5 H15D-C15'-H15E 109.5 
Si1'-C15'-H15F 109.5 H15D-C15'-H15F 109.5 
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H15E-C15'-H15F 109.5 Si1'-C16'-H16D 109.5 
Si1'-C16'-H16E 109.5 H16D-C16'-H16E 109.5 
Si1'-C16'-H16F 109.5 H16D-C16'-H16F 109.5 
H16E-C16'-H16F 109.5 Si1'-C14"-H14G 109.5 
Si1'-C14"-H14H 109.5 H14G-C14"-H14H 109.5 
Si1'-C14"-H14I 109.5 H14G-C14"-H14I 109.5 
H14H-C14"-H14I 109.5 Si1'-C15"-H15G 109.5 
Si1'-C15"-H15H 109.5 H15G-C15"-H15H 109.5 
Si1'-C15"-H15I 109.5 H15G-C15"-H15I 109.5 
H15H-C15"-H15I 109.5 Si1'-C16"-H16G 109.5 
Si1'-C16"-H16H 109.5 H16G-C16"-H16H 109.5 
Si1'-C16"-H16I 109.5 H16G-C16"-H16I 109.5 
H16H-C16"-H16I 109.5 C22'-C17'-C18' 119.5(5) 
C22'-C17'-H17B 120.2 C18'-C17'-H17B 120.2 
C19'-C18'-C17' 121.4(5) C19'-C18'-H18B 119.3 
C17'-C18'-H18B 119.3 C18'-C19'-C20' 119.9(5) 
C18'-C19'-H19B 120.1 C20'-C19'-H19B 120.1 
C21'-C20'-C19' 118.6(5) C21'-C20'-H20B 120.7 
C19'-C20'-H20B 120.7 C22'-C21'-C20' 121.9(5) 
C22'-C21'-H21B 119.0 C20'-C21'-H21B 119.0 
C17'-C22'-C21' 118.6(4) C17'-C22'-P1' 117.6(4) 
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C21'-C22'-P1' 123.7(3) C28'-C23'-C24' 119.9(5) 
C28'-C23'-H23B 120.1 C24'-C23'-H23B 120.1 
C23'-C24'-C25' 118.7(5) C23'-C24'-H24B 120.7 
C25'-C24'-H24B 120.7 C26'-C25'-C24' 122.3(5) 
C26'-C25'-H25B 118.9 C24'-C25'-H25B 118.9 
C25'-C26'-C27' 119.1(5) C25'-C26'-H26B 120.5 
C27'-C26'-H26B 120.5 C28'-C27'-C26' 120.0(5) 
C28'-C27'-H27B 120.0 C26'-C27'-H27B 120.0 
C23'-C28'-C27' 120.1(4) C23'-C28'-P1' 119.8(3) 
C27'-C28'-P1' 120.1(3) 
  
 
Table 15. Torsion angles (°) for 153. 
O1-P1-N1-C1 38.6(4) C22-P1-N1-C1 161.0(3) 
C28-P1-N1-C1 -87.2(3) P1-N1-C1-C10 98.3(4) 
P1-N1-C1-C2 -135.6(3) N1-C1-C2-C3 64.5(5) 
C10-C1-C2-C3 -171.4(4) C1-C2-C3-C9 179.9(4) 
C9-C4-C5-C6 0.9(9) C4-C5-C6-C7 -0.2(13) 
C5-C6-C7-C8 0.2(16) C6-C7-C8-C9 -0.8(15) 
C7-C8-C9-C4 1.4(11) C7-C8-C9-C3 179.4(8) 
C5-C4-C9-C8 -1.4(8) C5-C4-C9-C3 179.4(4) 
C2-C3-C9-C8 -74.6(7) C2-C3-C9-C4 103.4(5) 
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N1-C1-C10-C13 98.6(5) C2-C1-C10-C13 -24.6(6) 
N1-C1-C10-C11 -84.7(5) C2-C1-C10-C11 152.2(4) 
N1-C1-C10-C12 -171.9(4) C2-C1-C10-C12 65.0(6) 
C13-C10-C11-C12 51.5(3) C1-C10-C11-C12 126.1(5) 
C11-C10-C12-C13 117.6(4) C1-C10-C12-C13 123.1(6) 
C13-C10-C12-C11 -117.6(4) C1-C10-C12-C11 119.3(6) 
C13-C10-C12-Si1 124.1(6) C11-C10-C12-Si1 118.3(6) 
C1-C10-C12-Si1 1.0(9) C10-C11-C12-C13 -49.1(3) 
C10-C11-C12-Si1 132.0(5) C16-Si1-C12-C10 116.3(5) 
C15-Si1-C12-C10 3.3(8) C14-Si1-C12-C10 124.1(6) 
C16-Si1-C12-C13 -23.6(5) C15-Si1-C12-C13 96.1(7) 
C14-Si1-C12-C13 -143.1(5) C16-Si1-C12-C11 154.8(4) 
C15-Si1-C12-C11 -85.5(7) C14-Si1-C12-C11 35.3(5) 
C11-C10-C13-C12 -51.7(3) C1-C10-C13-C12 125.8(5) 
C11-C12-C13-C10 49.6(3) Si1-C12-C13-C10 -131.6(5) 
C22-C17-C18-C19 -2.6(7) C17-C18-C19-C20 2.5(8) 
C18-C19-C20-C21 -0.2(7) C19-C20-C21-C22 -2.1(7) 
C18-C17-C22-C21 0.4(6) C18-C17-C22-P1 176.8(4) 
C20-C21-C22-C17 2.0(7) C20-C21-C22-P1 -174.3(4 
O1-P1-C22-C17 7.2(4) N1-P1-C22-C17 -115.9 
C28-P1-C22-C17 128.4(3) O1-P1-C22-C21 176.5(3) 
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N1-P1-C22-C21 60.4(4) C28-P1-C22-C21 -55.3(4) 
C28-C23-C24-C25 -1.2(8) C23-C24-C25-C26 1.1(9) 
C24-C25-C26-C27 -0.7(8) C25-C26-C27-C28 0.4(7) 
C24-C23-C28-C27 0.8(7) C24-C23-C28-P1 178.1(4) 
C26-C27-C28-C23 -0.5(7) C26-C27-C28-P1 -177.7(4) 
O1-P1-C28-C23 31.1(4) N1-P1-C28-C23 158.7(3) 
C22-P1-C28-C23 -91.5(4) O1-P1-C28-C27 151.7(3) 
N1-P1-C28-C27 -24.1(4) C22-P1-C28-C27 85.7(4) 
C10'-C1'-N1'-P1' -99.3(4) C2'-C1'-N1'-P1' 133.9(3) 
O1'-P1'-N1'-C1' -38.3(4) C22'-P1'-N1'-C1' 161.3(3) 
C28'-P1'-N1'-C1' 86.7(4) N1'-C1'-C2'-C3' -65.7(5) 
C10'-C1'-C2'-C3' 169.4(4) C1'-C2'-C3'-C9' 171.9(5) 
C9'-C4'-C5'-C6' 1.8(8) C4'-C5'-C6'-C7' -1.3(9) 
C5'-C6'-C7'-C8' -0.1(9) C6'-C7'-C8'-C9' 1.0(8) 
C7'-C8'-C9'-C4' -0.6(7) C7'-C8'-C9'-C3' 177.0(5) 
C5'-C4'-C9'-C8' -0.8(7) C5'-C4'-C9'-C3' 178.5(5) 
C2'-C3'-C9'-C8' 95.0(6) C2'-C3'-C9'-C4' -87.4(6) 
N1'-C1'-C10'-C13' -97.6(5) C2'-C1'-C10'-C13' 25.6(7) 
N1'-C1'-C10'-C11' 86.1(5) C2'-C1'-C10'-C11' -150.8(4) 
N1'-C1'-C10'-C12' 172.6(4) C2'-C1'-C10'-C12' -64.2(6) 
C13'-C10'-C11'-C12' -51.5(3) C1'-C10'-C11'-C12' 125.8(5) 
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C13'-C10'-C12'-C11' 117.9(4) C1'-C10'-C12'-C11' 118.8(5) 
C11'-C10'-C12'-C13' -117.9(4) C1'-C10'-C12'-C13' 123.3(5) 
C13'-C10'-C12'-Si1' -124.1(5) C11'-C10'-C12'-Si1' 118.1(5) 
C1'-C10'-C12'-Si1' -0.7(8) C10'-C11'-C12'-C13' 49.3(3) 
C10'-C11'-C12'-Si1' -129.3(5) C14"-Si1'-C12'-C10' 109.9(9) 
C15"-Si1'-C12'-C10' 134.3(6) C15'-Si1'-C12'-C10' 83.9(6) 
C16'-Si1'-C12'-C10' -39.6(6) C14'-Si1'-C12'-C10' 157.6(6) 
C16"-Si1'-C12'-C10' 24.7(8) C14"-Si1'-C12'-C11' -23.0(9) 
C15"-Si1'-C12'-C11' -138.7(6) C15'-Si1'-C12'-C11' 170.9(6) 
C16'-Si1'-C12'-C11' 47.3(6) C14'-Si1'-C12'-C11' -70.6(6) 
C16"-Si1'-C12'-C11' 111.7(7) C14"-Si1'-C12'-C13' 159.0(9) 
C15"-Si1'-C12'-C13' 43.3(7) C15'-Si1'-C12'-C13' -7.2(7) 
C16'-Si1'-C12'-C13' -130.7(6) C14'-Si1'-C12'-C13' 111.3(6) 
C16"-Si1'-C12'-C13' -66.4(7) C11'-C10'-C13'-C12' 51.4(3) 
C1'-C10'-C13'-C12' -125.8(5) C11'-C12'-C13'-C10' -49.5(3) 
Si1'-C12'-C13'-C10' 129.0(5) C22'-C17'-C18'-C19' 1.8(9) 
C17'-C18'-C19'-C20' -1.7(9) C18'-C19'-C20'-C21' 0.1(8) 
C19'-C20'-C21'-C22' 1.3(8) C18'-C17'-C22'-C21' -0.4(7) 
C18'-C17'-C22'-P1' -176.9(4) C20'-C21'-C22'-C17' -1.1(7) 
C20'-C21'-C22'-P1' 175.1(4) O1'-P1'-C22'-C17' -17.3(4) 
N1'-P1'-C22'-C17' 105.8(4) C28'-P1'-C22'-C17' 138.9(4) 
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O1'-P1'-C22'-C21' 166.4(3) N1'-P1'-C22'-C21' -70.5(4) 
C28'-P1'-C22'-C21' 44.8(4) C28'-C23'-C24'-C25' -0.3(7) 
C23'-C24'-C25'-C26' 0.2(8) C24'-C25'-C26'-C27' 0.5(8) 
C25'-C26'-C27'-C28' -1.2(7) C24'-C23'-C28'-C27' -0.3(7) 
C24'-C23'-C28'-P1' -178.6(4) C26'-C27'-C28'-C23' 1.1(7) 
C26'-C27'-C28'-P1' 179.4(3) O1'-P1'-C28'-C23' -32.5(4) 
N1'-P1'-C28'-C23' -158.9(3) C22'-P1'-C28'-C23' 90.4(4) 
O1'-P1'-C28'-C27' 149.2(3) N1'-P1'-C28'-C27' 22.8(4) 
C22'-P1'-C28'-C27' -87.8(4) 
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APPENDIX B 
X-RAY DATA FOR 181 
Table 16. Crystal data and structure refinement for 181. 
Identification code  yan4a 
Empirical formula  C23 H25 N O2 S 
Formula weight  379.50 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 7.8396(2) Å a= 89.908(2)°. 
 b = 8.6125(4) Å b= 81.344(2)°. 
 c = 16.8418(5) Å g = 62.948(2)°. 
Volume 998.30(6) Å
3
 
Z 2 
Density (calculated) 1.262 Mg/m
3
 
Absorption coefficient 1.570 mm-1 
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F(000) 404 
Crystal size 0.21 x 0.16 x 0.12 mm
3
 
Theta range for data collection 2.66 to 71.73°. 
Index ranges -9<=h<=9, -9<=k<=10, -20<=l<=20 
Reflections collected 11041 
Independent reflections 3610 [R(int) = 0.0231] 
Completeness to theta = 71.73° 92.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8340 and 0.7340 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 3610 / 0 / 244 
Goodness-of-fit on F
2
 2.394 
Final R indices [I>2sigma(I)] R1 = 0.0643, wR2 = 0.2729 
R indices (all data) R1 = 0.0654, wR2 = 0.2738 
Largest diff. peak and hole 0.507 and -1.260 e.Å
-3 
 
Table 17. Atomic coordinates and equivalent  isotropic displacement parameters for 181.  
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 x (104) y (104) z (104) U(eq) (Å
2
x 10
3
) 
S 4631(1) 3660(1) 3400(1) 18(1) 
N 6302(3) 4018(3) 2842(1) 16(1) 
O(1) 3497(3) 5202(3) 3939(1) 23(1) 
C(1) 7815(4) 2533(4) 2279(2) 15(1) 
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O(2) 3707(3) 3106(3) 2869(1) 25(1) 
C(2) 9474(4) 3012(4) 2094(2) 17(1) 
C(3) 8992(4) 4827(4) 1876(2) 20(1) 
C(4) 7728(5) 6249(5) 1414(2) 29(1) 
C(5) 9925(5) 5598(5) 1273(2) 30(1) 
C(6) 9098(4) 4454(4) 2734(2) 20(1) 
C(7) 7213(4) 4878(4) 3277(2) 19(1) 
C(8) 11484(4) 1529(4) 1807(2) 20(1) 
C(9) 12183(4) 194(4) 2416(2) 25(1) 
C(10) 12573(5) -1459(5) 2307(3) 34(1) 
C(11) 7981(5) 519(4) 1178(2) 23(1) 
C(12) 7437(5) 159(5) 478(2) 27(1) 
C(13) 6017(5) 1477(5) 134(2) 25(1) 
C(14) 5134(4) 3159(4) 496(2) 23(1) 
C(15) 5660(4) 3534(4) 1198(2) 20(1) 
C(16) 7107(4) 2209(4) 1540(2) 18(1) 
C(17) 6211(4) 2187(4) 4720(2) 21(1) 
C(18) 7284(5) 777(4) 5141(2) 24(1) 
C(19) 8012(4) -943(4) 4817(2) 24(1) 
C(20) 7637(5) -1207(4) 4058(2) 28(1) 
C(21) 6545(5) 182(4) 3633(2) 24(1) 
C(22) 5857(4) 1882(4) 3967(2) 20(1) 
C(23) 9193(5) -2480(5) 5267(2) 31(1) 
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Table 18.  Bond lengths [Å] for 181. 
S-O(2)  1.436(2) 
S-O(1)  1.437(2) 
S-N  1.641(2) 
S-C(22)  1.764(3) 
N-C(1)  1.492(3) 
N-C(7)  1.495(3) 
C(1)-C(16)  1.512(4) 
C(1)-C(2)  1.525(4) 
C(1)-H(1A)  1.0000 
C(2)-C(3)  1.491(4) 
C(2)-C(8)  1.514(4) 
C(2)-C(6)  1.539(4) 
C(3)-C(6)  1.487(4) 
C(3)-C(4)  1.487(4) 
C(3)-C(5)  1.491(4) 
C(4)-C(5)  1.528(4) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.502(4) 
C(6)-H(6A)  1.0000 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.506(4) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.320(5) 
C(9)-H(9A)  0.9500 
C(10)-H(10A)  0.9500 
C(10)-H(10B)  0.9500 
C(11)-C(16)  1.390(4) 
C(11)-C(12)  1.392(4) 
C(11)-H(11A)  0.9500 
C(12)-C(13)  1.381(5) 
C(12)-H(12A)  0.9500 
C(13)-C(14)  1.383(5) 
C(13)-H(13A)  0.9500 
C(14)-C(15)  1.394(4) 
C(14)-H(14A)  0.9500 
C(15)-C(16)  1.391(4) 
C(15)-H(15A)  0.9500 
C(17)-C(18)  1.390(4) 
C(17)-C(22)  1.389(4) 
C(17)-H(17A)  0.9500 
C(18)-C(19)  1.399(5) 
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C(18)-H(18A)  0.9500 
C(19)-C(20)  1.394(5) 
C(19)-C(23)  1.509(4) 
C(20)-C(21)  1.388(5) 
C(20)-H(20A)  0.9500 
C(21)-C(22)  1.395(4) 
C(21)-H(21A)  0.9500 
C(23)-H(23A)  0.9800 
C(23)-H(23B)  0.9800 
C(23)-H(23C)  0.9800 
 
Table 19.  Bond angles [°] for 181. 
O(2)-S-O(1) 119.88(14) 
O(2)-S-N 107.66(12) 
O(1)-S-N 105.68(13) 
O(2)-S-C(22) 107.38(15) 
O(1)-S-C(22) 108.83(14) 
N-S-C(22) 106.73(13) 
C(1)-N-C(7) 110.6(2) 
C(1)-N-S 116.71(19) 
C(7)-N-S 115.56(18) 
N-C(1)-C(16) 113.8(2) 
N-C(1)-C(2) 103.6(2) 
C(16)-C(1)-C(2) 114.0(2) 
N-C(1)-H(1A) 108.4 
C(16)-C(1)-H(1A) 108.4 
C(2)-C(1)-H(1A) 108.4 
C(3)-C(2)-C(8) 120.2(2) 
C(3)-C(2)-C(1) 118.0(2) 
C(8)-C(2)-C(1) 116.9(2) 
C(3)-C(2)-C(6) 58.8(2) 
C(8)-C(2)-C(6) 122.1(2) 
C(1)-C(2)-C(6) 107.3(2) 
C(6)-C(3)-C(4) 137.5(3) 
C(6)-C(3)-C(5) 134.5(3) 
C(4)-C(3)-C(5) 61.8(2) 
C(6)-C(3)-C(2) 62.23(19) 
C(4)-C(3)-C(2) 142.4(3) 
C(5)-C(3)-C(2) 134.4(3) 
C(3)-C(4)-C(5) 59.2(2) 
C(3)-C(4)-H(4A) 117.8 
C(5)-C(4)-H(4A) 117.8 
C(3)-C(4)-H(4B) 117.8 
C(5)-C(4)-H(4B) 117.8 
H(4A)-C(4)-H(4B) 115.0 
C(3)-C(5)-C(4) 59.0(2) 
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C(3)-C(5)-H(5A) 117.9 
C(4)-C(5)-H(5A) 117.9 
C(3)-C(5)-H(5B) 117.9 
C(4)-C(5)-H(5B) 117.9 
H(5A)-C(5)-H(5B) 115.0 
C(3)-C(6)-C(7) 116.6(2) 
C(3)-C(6)-C(2) 58.99(19) 
C(7)-C(6)-C(2) 108.0(2) 
C(3)-C(6)-H(6A) 119.3 
C(7)-C(6)-H(6A) 119.3 
C(2)-C(6)-H(6A) 119.3 
N-C(7)-C(6) 104.3(2) 
N-C(7)-H(7A) 110.9 
C(6)-C(7)-H(7A) 110.9 
N-C(7)-H(7B) 110.9 
C(6)-C(7)-H(7B) 110.9 
H(7A)-C(7)-H(7B) 108.9 
C(9)-C(8)-C(2) 113.1(2) 
C(9)-C(8)-H(8A) 108.9 
C(2)-C(8)-H(8A) 108.9 
C(9)-C(8)-H(8B) 108.9 
C(2)-C(8)-H(8B) 108.9 
H(8A)-C(8)-H(8B) 107.8 
C(10)-C(9)-C(8) 124.7(3) 
C(10)-C(9)-H(9A) 117.7 
C(8)-C(9)-H(9A) 117.7 
C(9)-C(10)-H(10A) 120.0 
C(9)-C(10)-H(10B) 120.0 
H(10A)-C(10)-H(10B) 120.0 
C(16)-C(11)-C(12) 120.6(3) 
C(16)-C(11)-H(11A) 119.7 
C(12)-C(11)-H(11A) 119.7 
C(13)-C(12)-C(11) 120.5(3) 
C(13)-C(12)-H(12A) 119.8 
C(11)-C(12)-H(12A) 119.8 
C(12)-C(13)-C(14) 119.1(3) 
C(12)-C(13)-H(13A) 120.4 
C(14)-C(13)-H(13A) 120.4 
C(13)-C(14)-C(15) 121.0(3) 
C(13)-C(14)-H(14A) 119.5 
C(15)-C(14)-H(14A) 119.5 
C(16)-C(15)-C(14) 119.9(3) 
C(16)-C(15)-H(15A) 120.0 
C(14)-C(15)-H(15A) 120.0 
C(11)-C(16)-C(15) 119.0(3) 
C(11)-C(16)-C(1) 118.2(3) 
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C(15)-C(16)-C(1) 122.8(3) 
C(18)-C(17)-C(22) 119.4(3) 
C(18)-C(17)-H(17A) 120.3 
C(22)-C(17)-H(17A) 120.3 
C(17)-C(18)-C(19) 121.0(3) 
C(17)-C(18)-H(18A) 119.5 
C(19)-C(18)-H(18A) 119.5 
C(20)-C(19)-C(18) 118.2(3) 
C(20)-C(19)-C(23) 120.5(3) 
C(18)-C(19)-C(23) 121.3(3) 
C(21)-C(20)-C(19) 121.7(3) 
C(21)-C(20)-H(20A) 119.1 
C(19)-C(20)-H(20A) 119.1 
C(20)-C(21)-C(22) 118.7(3) 
C(20)-C(21)-H(21A) 120.6 
C(22)-C(21)-H(21A) 120.6 
C(17)-C(22)-C(21) 120.9(3) 
C(17)-C(22)-S 119.8(2) 
C(21)-C(22)-S 119.2(2) 
C(19)-C(23)-H(23A) 109.5 
C(19)-C(23)-H(23B) 109.5 
H(23A)-C(23)-H(23B) 109.5 
C(19)-C(23)-H(23C) 109.5 
H(23A)-C(23)-H(23C) 109.5 
H(23B)-C(23)-H(23C) 109.5
Table 20. Anisotropic displacement parameters for 181.   
The anisotropic displacement factor exponent takes the form:  -2π2[ h2a*2U11 + ...  + 2 h k a*b*U12 ] 
 U11 U22  U33 U23 U13            U12      (Å
2
x 10
3
) 
S 11(1)  19(1) 21(1)  0(1) -2(1)  -7(1) 
N 11(1)  17(1) 20(1)  -1(1) -2(1)  -6(1) 
O(1) 16(1)  21(1) 25(1)  -1(1) 0(1)  -3(1) 
C(1) 11(1)  14(1) 20(1)  1(1) -3(1)  -6(1) 
O(2) 19(1)  34(1) 27(1)  3(1) -5(1)  -17(1) 
C(2) 14(1)  16(1) 22(1)  3(1) -5(1)  -7(1) 
C(3) 12(1)  16(1) 32(2)  3(1) -4(1)  -6(1) 
C(4) 24(2)  27(2) 39(2)  12(1) -7(1)  -14(2) 
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C(5) 20(2)  29(2) 44(2)  12(2) -4(1)  -13(2) 
C(6) 14(1)  16(1) 30(2)  -2(1) -4(1)  -7(1) 
C(7) 15(1)  18(1) 26(2)  -2(1) -4(1)  -10(1) 
C(8) 14(1)  19(2) 26(2)  2(1) -2(1)  -7(1) 
C(9) 18(1)  20(2) 31(2)  3(1) -5(1)  -4(1) 
C(10) 25(2)  22(2) 51(2)  5(2) -12(2)  -7(2) 
C(11) 25(2)  18(2) 28(2)  1(1) -9(1)  -10(1) 
C(12) 32(2)  24(2) 30(2)  -2(1) -7(1)  -16(2) 
C(13) 25(2)  31(2) 25(2)  1(1) -7(1)  -17(1) 
C(14) 17(1)  30(2) 22(2)  6(1) -5(1)  -11(1) 
C(15) 19(1)  17(1) 24(2)  2(1) -5(1)  -8(1) 
C(16) 17(1)  20(2) 18(1)  3(1) -4(1)  -10(1) 
C(17) 18(1)  19(2) 25(2)  -3(1) 1(1)  -9(1) 
C(18) 22(2)  26(2) 23(2)  3(1) -3(1)  -10(1) 
C(19) 18(1)  21(2) 31(2)  5(1) 2(1)  -10(1) 
C(20) 22(2)  18(2) 39(2)  -1(1) 1(1)  -8(1) 
C(21) 24(2)  25(2) 29(2)  0(1) -2(1)  -18(1) 
C(22) 16(1)  21(2) 24(2)  4(1) -1(1)  -9(1) 
C(23) 25(2)  25(2) 38(2)  11(1) 0(1)  -8(2) 
Table 21. Hydrogen coordinates  and isotropic displacement parameters for 181. 
x(10
4
)              y(10
4
)             z(10
4
)           U(eq) (Å
2
x 10
3
) 
H(1A) 8270 1448 2576 18 
H(4A) 6891 7413 1703 35 
H(4B) 7166 5930 992 35 
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H(5A) 10693 4884 766 36 
H(5B) 10418 6368 1477 36 
H(6A) 10210 4413 2972 24 
H(7A) 7445 4403 3808 22 
H(7B) 6375 6158 3358 22 
H(8A) 11473 941 1304 24 
H(8B) 12410 2017 1680 24 
H(9A) 12356 569 2915 30 
H(10A) 12417 -1880 1815 41 
H(10B) 13010 -2228 2719 41 
H(11A) 8957 -400 1409 28 
H(12A) 8048 -1002 236 33 
H(13A) 5652 1233 -345 30 
H(14A) 4155 4071 263 27 
H(15A) 5032 4693 1444 24 
H(17A) 5724 3350 4946 25 
H(18A) 7527 984 5656 29 
H(20A) 8142 -2367 3826 33 
H(21A) 6271 -22 3124 29 
H(23A) 9317 -2055 5784 47 
H(23B) 10487 -3165 4947 47 
H(23C) 8541 -3217 5363 47 
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APPENDIX C 
X-RAY DATA FOR 268 
Table 22. Crystal data and structure refinement for 268. 
Identification code  yan5 
Empirical formula  C32 H36 N5 O5 P Si 
Formula weight  629.72 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 11.1144(18) Å a= 88.012(7)°. 
 b = 12.2142(18) Å b= 69.895(8)°. 
 c = 13.799(2) Å g = 72.721(7)°. 
Volume 1675.0(4) Å3 
Z 2 
Density (calculated) 1.249 Mg/m
3
 
Absorption coefficient 1.449 mm-1 
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F(000) 664 
Crystal size 0.09 x 0.06 x 0.02 mm
3
 
Theta range for data collection 3.80 to 67.68°. 
Index ranges -13<=h<=8, -13<=k<=13, -15<=l<=15 
Reflections collected 8530 
Independent reflections 4306 [R(int) = 0.0529] 
Completeness to theta = 67.68° 70.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9716 and 0.8806 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 4306 / 0 / 401 
Goodness-of-fit on F2 1.171 
Final R indices [I>2sigma(I)] R1 = 0.0712, wR2 = 0.1572 
R indices (all data) R1 = 0.1137, wR2 = 0.1738 
Largest diff. peak and hole 0.593 and -0.468 e.Å
-3
 
 
Table 23. Atomic coordinates  and equivalent  isotropic displacement parameters for 268.   
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor.  
 x(10
4
) y(10
4
) z(10
4
) U(eq) (Å
2
x 10
3
) 
P(1) 8395(1) 2556(1) 1993(1) 32(1) 
Si(1) 1880(1) 5984(1) 3658(1) 39(1) 
O(1) 7510(3) 2344(3) 3024(2) 35(1) 
N(1) 8101(4) 3890(3) 1619(3) 28(1) 
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C(1) 9228(5) 1568(4) -35(4) 35(1) 
O(2) 2840(3) 8836(3) 4871(3) 42(1) 
N(2) 6504(4) 7476(3) 4838(3) 33(1) 
C(2) 9055(5) 972(4) -793(4) 38(1) 
N(3) 5167(3) 8112(3) 5117(3) 31(1) 
O(3) 1218(3) 10172(3) 5932(3) 54(1) 
C(3) 7968(5) 558(4) -559(4) 38(1) 
O(4) 1851(3) 12416(3) 8314(3) 49(1) 
N(4) 2401(4) 9569(3) 5612(4) 40(1) 
C(4) 7038(5) 736(4) 430(4) 36(1) 
O(5) 3775(4) 11951(3) 8565(3) 48(1) 
N(5) 3034(4) 11819(3) 8120(3) 39(1) 
C(5) 7227(5) 1312(4) 1197(4) 34(1) 
C(6) 8304(4) 1744(4) 975(4) 27(1) 
C(7) 10457(5) 1620(4) 2729(4) 34(1) 
C(8) 11742(5) 1360(4) 2744(4) 38(1) 
C(9) 12710(5) 1712(4) 1968(4) 38(1) 
C(10) 12385(5) 2292(4) 1175(4) 36(1) 
C(11) 11093(5) 2555(4) 1156(4) 36(1) 
C(12) 10104(5) 2223(4) 1945(4) 32(1) 
C(13) 8383(6) 4528(5) -561(4) 62(2) 
C(14) 7256(5) 5189(4) 409(4) 38(1) 
C(15) 6928(4) 4428(4) 1299(3) 31(1) 
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C(16) 8129(4) 4778(4) 2319(4) 34(1) 
C(17) 6662(4) 5494(4) 2809(4) 31(1) 
C(18) 5865(4) 5120(4) 2283(4) 31(1) 
C(19) 4589(4) 6020(5) 2268(4) 34(1) 
C(20) 3725(5) 5531(4) 2922(4) 33(1) 
C(21) 4858(4) 4502(4) 3024(4) 35(1) 
C(22) 1256(5) 4748(5) 3603(4) 55(2) 
C(23) 1006(6) 7244(5) 3126(5) 71(2) 
C(24) 1682(5) 6368(5) 5011(4) 50(2) 
C(25) 6151(4) 6322(4) 3588(4) 32(1) 
C(26) 6906(5) 6660(4) 4120(4) 35(1) 
C(27) 4648(4) 9026(4) 5831(4) 27(1) 
C(28) 3298(4) 9741(4) 6096(4) 29(1) 
C(29) 2778(5) 10650(4) 6841(4) 33(1) 
C(30) 3590(5) 10869(4) 7305(4) 32(1) 
C(31) 4937(5) 10219(4) 7043(4) 33(1) 
C(32) 5449(4) 9300(4) 6317(3) 30(1) 
 
Table 24. Bond lengths [Å] for 268. 
P(1)-O(1)  1.490(3) 
P(1)-N(1)  1.665(4) 
P(1)-C(6)  1.794(5) 
P(1)-C(12)  1.799(5) 
Si(1)-C(23)  1.837(6) 
Si(1)-C(22)  1.854(5) 
Si(1)-C(24)  1.862(5) 
Si(1)-C(20)  1.864(5) 
N(1)-C(15)  1.480(5) 
N(1)-C(16)  1.491(6) 
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C(1)-C(2)  1.391(7) 
C(1)-C(6)  1.397(6) 
C(1)-H(1A)  0.9500 
O(2)-N(4)  1.244(5) 
N(2)-C(26)  1.293(6) 
N(2)-N(3)  1.379(5) 
C(2)-C(3)  1.379(6) 
C(2)-H(2A)  0.9500 
N(3)-C(27)  1.361(6) 
N(3)-H(3B)  0.8800 
O(3)-N(4)  1.231(5) 
C(3)-C(4)  1.377(7) 
C(3)-H(3A)  0.9500 
O(4)-N(5)  1.239(5) 
N(4)-C(28)  1.441(6) 
C(4)-C(5)  1.396(7) 
C(4)-H(4A)  0.9500 
O(5)-N(5)  1.231(5) 
N(5)-C(30)  1.476(6) 
C(5)-C(6)  1.385(6) 
C(5)-H(5A)  0.9500 
C(7)-C(8)  1.376(6) 
C(7)-C(12)  1.389(7) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.393(7) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.376(7) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.385(6) 
C(10)-H(10A) 0.9500 
C(11)-C(12)  1.404(7) 
C(11)-H(11A) 0.9500 
C(13)-C(14)  1.527(7) 
C(13)-H(13A) 0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(14)-C(15)  1.523(6) 
C(14)-H(14A) 0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(18)  1.530(6) 
C(15)-H(15A) 1.0000 
C(16)-C(17)  1.522(6) 
C(16)-H(16A) 0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(25)  1.347(6) 
C(17)-C(18)  1.492(6) 
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C(18)-C(19)  1.521(6) 
C(18)-C(21)  1.590(6) 
C(19)-C(20)  1.342(7) 
C(19)-H(19)  1.03(5) 
C(20)-C(21)  1.535(6) 
C(21)-H(21A) 0.9900 
C(21)-H(21B)  0.9900 
C(22)-H(22A) 0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-H(23A) 0.9800 
C(23)-H(23B)  0.9800 
C(23)-H(23C)  0.9800 
C(24)-H(24A) 0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-C(26)  1.436(6) 
C(25)-H(25A) 0.9500 
C(26)-H(26A) 0.9500 
C(27)-C(32)  1.398(6) 
C(27)-C(28)  1.419(6) 
C(28)-C(29)  1.384(6) 
C(29)-C(30)  1.360(6) 
C(29)-H(29A) 0.9500 
C(30)-C(31)  1.394(6) 
C(31)-C(32)  1.376(6) 
C(31)-H(31A) 0.9500 
C(32)-H(32A) 0.9500 
 
Table 25.  Bond angles [°] for 268. 
O(1)-P(1)-N(1) 118.55(18) 
O(1)-P(1)-C(6) 110.9(2) 
N(1)-P(1)-C(6) 103.5(2) 
O(1)-P(1)-C(12) 110.8(2) 
N(1)-P(1)-C(12) 101.9(2) 
C(6)-P(1)-C(12) 110.6(2) 
C(23)-Si(1)-C(22) 111.4(3) 
C(23)-Si(1)-C(24) 109.6(3) 
C(22)-Si(1)-C(24) 110.9(3) 
C(23)-Si(1)-C(20) 110.8(3) 
C(22)-Si(1)-C(20) 108.1(2) 
C(24)-Si(1)-C(20) 105.8(2) 
C(15)-N(1)-C(16) 105.8(3) 
C(15)-N(1)-P(1) 121.1(3) 
C(16)-N(1)-P(1) 116.0(3) 
C(2)-C(1)-C(6) 120.0(4) 
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C(2)-C(1)-H(1A) 120.0 
C(6)-C(1)-H(1A) 120.0 
C(26)-N(2)-N(3) 114.9(4) 
C(3)-C(2)-C(1) 120.6(5) 
C(3)-C(2)-H(2A) 119.7 
C(1)-C(2)-H(2A) 119.7 
C(27)-N(3)-N(2) 120.1(4) 
C(27)-N(3)-H(3B) 120.0 
N(2)-N(3)-H(3B) 120.0 
C(2)-C(3)-C(4) 120.1(5) 
C(2)-C(3)-H(3A) 119.9 
C(4)-C(3)-H(3A) 119.9 
O(3)-N(4)-O(2) 121.5(4) 
O(3)-N(4)-C(28) 118.9(4) 
O(2)-N(4)-C(28) 119.6(4) 
C(3)-C(4)-C(5) 119.4(5) 
C(3)-C(4)-H(4A) 120.3 
C(5)-C(4)-H(4A) 120.3 
O(5)-N(5)-O(4) 124.8(4) 
O(5)-N(5)-C(30) 117.6(4) 
O(4)-N(5)-C(30) 117.6(5) 
C(6)-C(5)-C(4) 121.4(5) 
C(6)-C(5)-H(5A) 119.3 
C(4)-C(5)-H(5A) 119.3 
C(5)-C(6)-C(1) 118.5(4) 
C(5)-C(6)-P(1) 118.0(4) 
C(1)-C(6)-P(1) 123.5(3) 
C(8)-C(7)-C(12) 121.1(5) 
C(8)-C(7)-H(7A) 119.4 
C(12)-C(7)-H(7A) 119.4 
C(7)-C(8)-C(9) 119.8(5) 
C(7)-C(8)-H(8A) 120.1 
C(9)-C(8)-H(8A) 120.1 
C(10)-C(9)-C(8) 119.9(5) 
C(10)-C(9)-H(9A) 120.1 
C(8)-C(9)-H(9A) 120.1 
C(9)-C(10)-C(11) 120.6(5) 
C(9)-C(10)-H(10A) 119.7 
C(11)-C(10)-H(10A) 119.7 
C(10)-C(11)-C(12) 120.0(5) 
C(10)-C(11)-H(11A) 120.0 
C(12)-C(11)-H(11A) 120.0 
C(7)-C(12)-C(11) 118.6(5) 
C(7)-C(12)-P(1) 118.5(4) 
C(11)-C(12)-P(1) 122.8(4) 
C(14)-C(13)-H(13A) 109.5 
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C(14)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B)109.5 
C(14)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C)109.5 
H(13B)-C(13)-H(13C)109.5 
C(15)-C(14)-C(13) 112.8(4) 
C(15)-C(14)-H(14A) 109.0 
C(13)-C(14)-H(14A) 109.0 
C(15)-C(14)-H(14B) 109.0 
C(13)-C(14)-H(14B) 109.0 
H(14A)-C(14)-H(14B)107.8 
N(1)-C(15)-C(14) 111.9(4) 
N(1)-C(15)-C(18) 103.5(4) 
C(14)-C(15)-C(18) 111.9(4) 
N(1)-C(15)-H(15A) 109.8 
C(14)-C(15)-H(15A) 109.8 
C(18)-C(15)-H(15A) 109.8 
N(1)-C(16)-C(17) 104.1(4) 
N(1)-C(16)-H(16A) 110.9 
C(17)-C(16)-H(16A) 110.9 
N(1)-C(16)-H(16B) 110.9 
C(17)-C(16)-H(16B) 110.9 
H(16A)-C(16)-H(16B)108.9 
C(25)-C(17)-C(18) 125.1(4) 
C(25)-C(17)-C(16) 126.6(5) 
C(18)-C(17)-C(16) 108.3(4) 
C(17)-C(18)-C(15) 103.9(4) 
C(17)-C(18)-C(19) 116.3(4) 
C(15)-C(18)-C(19) 122.0(4) 
C(17)-C(18)-C(21) 112.7(4) 
C(15)-C(18)-C(21) 117.3(4) 
C(19)-C(18)-C(21) 84.4(4) 
C(20)-C(19)-C(18) 96.4(4) 
C(20)-C(19)-H(19) 130(3) 
C(18)-C(19)-H(19) 134(3) 
C(19)-C(20)-C(21) 92.9(4) 
C(19)-C(20)-Si(1) 135.6(4) 
C(21)-C(20)-Si(1) 130.6(4) 
C(20)-C(21)-C(18) 86.2(3) 
C(20)-C(21)-H(21A) 114.3 
C(18)-C(21)-H(21A) 114.3 
C(20)-C(21)-H(21B) 114.3 
C(18)-C(21)-H(21B) 114.3 
H(21A)-C(21)-H(21B)111.4 
Si(1)-C(22)-H(22A) 109.5 
Si(1)-C(22)-H(22B) 109.5 
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H(22A)-C(22)-H(22B)109.5 
Si(1)-C(22)-H(22C) 109.5 
H(22A)-C(22)-H(22C)109.5 
H(22B)-C(22)-H(22C)109.5 
Si(1)-C(23)-H(23A) 109.5 
Si(1)-C(23)-H(23B) 109.5 
H(23A)-C(23)-H(23B)109.5 
Si(1)-C(23)-H(23C) 109.5 
H(23A)-C(23)-H(23C)109.5 
H(23B)-C(23)-H(23C)109.5 
Si(1)-C(24)-H(24A) 109.5 
Si(1)-C(24)-H(24B) 109.5 
H(24A)-C(24)-H(24B)109.5 
Si(1)-C(24)-H(24C) 109.5 
H(24A)-C(24)-H(24C)109.5 
H(24B)-C(24)-H(24C)109.5 
C(17)-C(25)-C(26) 125.4(4) 
C(17)-C(25)-H(25A) 117.3 
C(26)-C(25)-H(25A) 117.3 
N(2)-C(26)-C(25) 129.1(4) 
N(2)-C(26)-H(26A) 115.5 
C(25)-C(26)-H(26A) 115.5 
N(3)-C(27)-C(32) 120.4(4) 
N(3)-C(27)-C(28) 121.7(4) 
C(32)-C(27)-C(28) 117.8(4) 
C(29)-C(28)-C(27) 121.0(5) 
C(29)-C(28)-N(4) 116.5(4) 
C(27)-C(28)-N(4) 122.6(4) 
C(30)-C(29)-C(28) 119.0(4) 
C(30)-C(29)-H(29A) 120.5 
C(28)-C(29)-H(29A) 120.5 
C(29)-C(30)-C(31) 122.1(4) 
C(29)-C(30)-N(5) 119.3(4) 
C(31)-C(30)-N(5) 118.5(5) 
C(32)-C(31)-C(30) 118.9(5) 
C(32)-C(31)-H(31A) 120.5 
C(30)-C(31)-H(31A) 120.5 
C(31)-C(32)-C(27) 121.1(4) 
C(31)-C(32)-H(32A) 119.5 
C(27)-C(32)-H(32A) 119.5 
 
Table 26. Anisotropic displacement parameters for 268.   
The anisotropic displacement factor exponent takes the form:  -2π2[ h2a*2U11 + ...  + 2 h k a*b*U12 ] 
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 U11 U22  U33 U23 U13              U12        (Å2x 103) 
P(1) 29(1)  31(1) 26(1)  -8(1) 0(1)  -6(1) 
Si(1) 29(1)  42(1) 33(1)  -9(1) 0(1)  -3(1) 
O(1) 32(2)  35(2) 25(2)  -4(2) 5(2)  -8(1) 
N(1) 26(2)  28(2) 24(2)  -3(2) -1(2)  -6(2) 
C(1) 30(2)  32(3) 38(4)  -8(2) -5(3)  -10(2) 
O(2) 37(2)  42(2) 40(2)  -10(2) -7(2)  -9(2) 
N(2) 31(2)  28(2) 30(3)  -5(2) -2(2)  -2(2) 
C(2) 35(3)  34(3) 33(3)  -11(2) -3(3)  -4(2) 
N(3) 25(2)  33(2) 29(3)  -11(2) -4(2)  -6(2) 
O(3) 32(2)  46(2) 74(3)  -14(2) -14(2)  0(2) 
C(3) 48(3)  29(3) 36(4)  -10(2) -14(3)  -8(2) 
O(4) 40(2)  37(2) 45(3)  -12(2) 11(2)  -6(2) 
N(4) 33(2)  31(2) 47(3)  1(2) -6(2)  -8(2) 
C(4) 31(3)  38(3) 37(4)  -6(2) -7(3)  -14(2) 
O(5) 55(2)  44(2) 32(2)  -15(2) -2(2)  -13(2) 
N(5) 42(3)  32(3) 30(3)  -6(2) 3(2)  -10(2) 
C(5) 34(3)  34(3) 28(3)  -7(2) -5(2)  -9(2) 
C(6) 28(2)  21(3) 31(3)  -6(2) -9(2)  -7(2) 
C(7) 32(3)  33(3) 28(3)  -8(2) 0(2)  -7(2) 
C(8) 40(3)  39(3) 31(3)  -6(2) -9(3)  -8(2) 
C(9) 32(3)  42(3) 38(4)  -7(3) -10(3)  -10(2) 
C(10) 32(3)  35(3) 35(4)  -6(2) -4(3)  -9(2) 
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C(11) 35(3)  32(3) 30(3)  -6(2) -1(2)  -8(2) 
C(12) 32(2)  29(3) 28(3)  -11(2) -2(2)  -7(2) 
C(13) 72(4)  50(4) 34(4)  -8(3) 8(3)  -8(3) 
C(14) 39(3)  34(3) 24(3)  -11(2) 1(2)  1(2) 
C(15) 34(3)  29(3) 19(3)  -6(2) 2(2)  -8(2) 
C(16) 29(2)  31(3) 29(3)  -14(2) 3(2)  -5(2) 
C(17) 30(2)  27(3) 21(3)  1(2) 3(2)  -1(2) 
C(18) 29(2)  28(3) 25(3)  -6(2) 4(2)  -8(2) 
C(19) 29(3)  31(3) 36(3)  -6(3) -7(3)  -5(2) 
C(20) 34(3)  29(3) 34(3)  -7(2) -12(3)  -5(2) 
C(21) 30(2)  33(3) 33(3)  -8(2) -1(2)  -10(2) 
C(22) 40(3)  73(4) 36(4)  -16(3) 4(3)  -16(3) 
C(23) 68(4)  64(4) 56(5)  -6(3) -12(4)  5(3) 
C(24) 50(3)  47(3) 41(4)  -14(3) 1(3)  -17(3) 
C(25) 24(2)  33(3) 28(3)  -9(2) 1(2)  -6(2) 
C(26) 34(3)  30(3) 29(3)  -1(2) 3(2)  -8(2) 
C(27) 23(2)  25(3) 26(3)  -1(2) -2(2)  -7(2) 
C(28) 25(2)  30(3) 29(3)  -2(2) -4(2)  -11(2) 
C(29) 29(2)  27(3) 31(3)  -1(2) 1(2)  -4(2) 
C(30) 37(3)  26(3) 24(3)  -3(2) 0(2)  -9(2) 
C(31) 35(3)  32(3) 29(3)  2(2) -6(2)  -14(2) 
C(32) 24(2)  36(3) 19(3)  -8(2) 1(2)  -2(2) 
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Table 27.Hydrogen coordinates  and isotropic displacement parameters  for 268. 
 x (x10
4
) y (x10
4
)  z (x10
4
)  U(eq) (Å
2
x10
3
) 
H(1A) 9976 1856 -205 42 
H(2A) 9691 849 -1478 45 
H(3B) 4650 7928 4832 37 
H(3A) 7860 150 -1082 46 
H(4A) 6277 469 590 43 
H(5A) 6603 1410 1885 41 
H(7A) 9798 1384 3265 41 
H(8A) 11970 940 3282 46 
H(9A) 13592 1552 1985 45 
H(10A) 13053 2514 637 44 
H(11A) 10876 2961 609 43 
H(13A) 8566 5059 -1102 92 
H(13B) 8108 3930 -806 92 
H(13C) 9197 4170 -397 92 
H(14A) 7523 5813 633 45 
H(14B) 6437 5548 237 45 
H(15A) 6611 3818 1094 37 
H(16A) 8682 5257 1923 40 
H(16B) 8495 4415 2853 40 
H(19) 4400(40) 6780(40) 1910(40) 37(14) 
H(21A) 4905 3760 2723 42 
H(21B) 4891 4435 3732 42 
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H(22A) 1361 4567 2886 82 
H(22B) 304 4944 4037 82 
H(22C) 1773 4078 3856 82 
H(23A) 1108 7039 2416 106 
H(23B) 1395 7867 3126 106 
H(23C) 49 7500 3553 106 
H(24A) 2007 7028 5022 75 
H(24B) 2203 5712 5275 75 
H(24C) 730 6566 5447 75 
H(25A) 5214 6714 3804 38 
H(26A) 7829 6225 3915 42 
H(29A) 1868 11115 7025 40 
H(31A) 5493 10408 7359 39 
H(32A) 6361 8844 6143 36 
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APPENDIX D 
X-RAY DATA FOR 283 
Table 28. Crystal data and structure refinement for 283. 
Identification code  yan6 
Empirical formula  C24 H27 N O3 S 
Formula weight  409.53 
Temperature  150(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 12.1214(2) Å a= 90°. 
 b = 14.4706(2) Å b= 110.5600(10)°. 
 c = 13.0421(2) Å g = 90°. 
Volume 2141.92(6) Å
3
 
Z 4 
Density (calculated) 1.270 Mg/m
3
 
Absorption coefficient 1.537 mm-1 
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F(000) 872 
Crystal size 0.21 x 0.15 x 0.09 mm
3
 
Theta range for data collection 3.89 to 72.13°. 
Index ranges -14<=h<=14, -16<=k<=17, -15<=l<=15 
Reflections collected 15495 
Independent reflections 4034 [R(int) = 0.0171] 
Completeness to theta = 70.00° 98.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8741 and 0.7385 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 4034 / 0 / 370 
Goodness-of-fit on F2 1.659 
Final R indices [I>2sigma(I)] R1 = 0.0347, wR2 = 0.1212 
R indices (all data) R1 = 0.0360, wR2 = 0.1235 
Largest diff. peak and hole 0.311 and -0.331 e.Å
-3
 
 
Table 29. Atomic coordinates and equivalent  isotropic displacement parameters for 283.   
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor.  
 x (10
4
) y (10
4
) z (10
4
) U(eq) (Å
2
x 10
3
) 
S(1) 4751(1) 2336(1) 9149(1) 28(1) 
O(1) 1863(1) -377(1) 8502(1) 36(1) 
N(1) 3758(1) 1640(1) 8308(1) 24(1) 
C(1) 4045(1) 644(1) 8443(1) 29(1) 
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O(2) 5001(1) 1952(1) 10221(1) 43(1) 
C(2) 3059(1) 223(1) 7489(1) 24(1) 
O(3) 4314(1) 3258(1) 8914(1) 41(1) 
C(3) 1930(1) 48(1) 7721(1) 25(1) 
C(4) 965(1) 463(1) 6829(1) 25(1) 
C(5) 1371(1) 958(1) 6170(1) 22(1) 
C(6) 2717(1) 936(1) 6548(1) 20(1) 
C(7) 3322(1) 1865(1) 7117(1) 20(1) 
C(8) 622(1) 1464(1) 5169(1) 29(1) 
C(9) 3168(1) 694(1) 5617(1) 24(1) 
C(10) 2652(1) -190(1) 4982(1) 30(1) 
C(11) 3238(1) -430(1) 4159(1) 38(1) 
C(12) 1733(1) 2885(1) 7366(1) 25(1) 
C(13) 977(1) 3640(1) 7054(1) 30(1) 
C(14) 1034(1) 4230(1) 6233(1) 34(1) 
C(15) 1843(1) 4071(1) 5729(1) 36(1) 
C(16) 2606(1) 3313(1) 6037(1) 29(1) 
C(17) 2542(1) 2714(1) 6850(1) 22(1) 
C(18) 6103(1) 2723(1) 7914(1) 25(1) 
C(19) 7100(1) 2631(1) 7640(1) 28(1) 
C(20) 8047(1) 2084(1) 8270(1) 28(1) 
C(21) 7969(1) 1634(1) 9186(1) 30(1) 
C(22) 6966(1) 1703(1) 9458(1) 26(1) 
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C(23) 6036(1) 2251(1) 8817(1) 22(1) 
C(24) 9117(1) 1963(1) 7952(2) 45(1) 
 
Table 30. Bond lengths [Å] for 283. 
S(1)-O(3)  1.4277(11) 
S(1)-O(2)  1.4340(10) 
S(1)-N(1)  1.6547(10) 
S(1)-C(23)  1.7621(12) 
O(1)-C(3)  1.2154(15) 
N(1)-C(1)  1.4800(15) 
N(1)-C(7)  1.4912(13) 
C(1)-C(2)  1.5170(15) 
C(1)-H(1A)  0.984(19) 
C(1)-H(1B)  1.015(16) 
C(2)-C(3)  1.5238(16) 
C(2)-C(6)  1.5445(14) 
C(2)-H(2)  0.993(17) 
C(3)-C(4)  1.4582(16) 
C(4)-C(5)  1.3391(17) 
C(4)-H(4)  0.966(19) 
C(5)-C(8)  1.4941(15) 
C(5)-C(6)  1.5296(14) 
C(6)-C(9)  1.5362(15) 
C(6)-C(7)  1.5859(14) 
C(7)-C(17)  1.5141(14) 
C(7)-H(7)  1.003(16) 
C(8)-H(8A)  0.96(2) 
C(8)-H(8B)  0.98(3) 
C(8)-H(8C)  0.99(3) 
C(9)-C(10)  1.5336(15) 
C(9)-H(9A)  1.005(16) 
C(9)-H(9B)  0.924(18) 
C(10)-C(11)  1.5204(19) 
C(10)-H(10A) 1.00(2) 
C(10)-H(10B)  0.950(18) 
C(11)-H(11B)  1.037(19) 
C(11)-H(11C)  0.97(2) 
C(11)-H(11A) 0.93(2) 
C(12)-C(13)  1.3915(17) 
C(12)-C(17)  1.3929(17) 
C(12)-H(12)  0.926(17) 
C(13)-C(14)  1.3899(19) 
C(13)-H(13)  0.982(18) 
C(14)-C(15)  1.379(2) 
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C(14)-H(14)  0.94(2) 
C(15)-C(16)  1.3995(18) 
C(15)-H(15)  0.98(2) 
C(16)-C(17)  1.3922(17) 
C(16)-H(16)  0.945(17) 
C(18)-C(19)  1.3819(19) 
C(18)-C(23)  1.3879(17) 
C(18)-H(18)  0.945(17) 
C(19)-C(20)  1.3985(19) 
C(19)-H(19)  0.947(18) 
C(20)-C(21)  1.3924(18) 
C(20)-C(24)  1.5055(18) 
C(21)-C(22)  1.3851(18) 
C(21)-H(21)  0.980(18) 
C(22)-C(23)  1.3917(16) 
C(22)-H(22)  0.908(18) 
C(24)-H(24A) 1.01(3) 
C(24)-H(24B)  1.01(3) 
C(24)-H(24C)  0.92(3) 
 
Table 31. Bond angles [°] for 283. 
O(3)-S(1)-O(2) 120.42(7) 
O(3)-S(1)-N(1) 107.28(5) 
O(2)-S(1)-N(1) 105.41(6) 
O(3)-S(1)-C(23) 107.84(6) 
O(2)-S(1)-C(23) 108.08(6) 
N(1)-S(1)-C(23) 107.14(5) 
C(1)-N(1)-C(7) 108.55(9) 
C(1)-N(1)-S(1) 115.38(7) 
C(7)-N(1)-S(1) 117.83(8) 
N(1)-C(1)-C(2) 102.06(9) 
N(1)-C(1)-H(1A) 111.9(11) 
C(2)-C(1)-H(1A) 111.8(10) 
N(1)-C(1)-H(1B) 108.2(10) 
C(2)-C(1)-H(1B) 112.7(9) 
H(1A)-C(1)-H(1B) 110.0(13) 
C(1)-C(2)-C(3) 114.09(10) 
C(1)-C(2)-C(6) 107.36(9) 
C(3)-C(2)-C(6) 105.09(9) 
C(1)-C(2)-H(2) 112.7(9) 
C(3)-C(2)-H(2) 107.2(9) 
C(6)-C(2)-H(2) 110.1(9) 
O(1)-C(3)-C(4) 127.30(11) 
O(1)-C(3)-C(2) 125.38(11) 
C(4)-C(3)-C(2) 107.31(9) 
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C(5)-C(4)-C(3) 111.09(10) 
C(5)-C(4)-H(4) 126.6(10) 
C(3)-C(4)-H(4) 122.3(10) 
C(4)-C(5)-C(8) 125.12(11) 
C(4)-C(5)-C(6) 111.92(10) 
C(8)-C(5)-C(6) 122.94(10) 
C(5)-C(6)-C(9) 112.66(9) 
C(5)-C(6)-C(2) 103.18(9) 
C(9)-C(6)-C(2) 113.92(9) 
C(5)-C(6)-C(7) 113.53(9) 
C(9)-C(6)-C(7) 109.14(9) 
C(2)-C(6)-C(7) 104.08(8) 
N(1)-C(7)-C(17) 112.34(9) 
N(1)-C(7)-C(6) 103.84(8) 
C(17)-C(7)-C(6) 115.54(9) 
N(1)-C(7)-H(7) 109.2(8) 
C(17)-C(7)-H(7) 109.8(8) 
C(6)-C(7)-H(7) 105.7(8) 
C(5)-C(8)-H(8A) 116.2(14) 
C(5)-C(8)-H(8B) 110.2(13) 
H(8A)-C(8)-H(8B) 108(2) 
C(5)-C(8)-H(8C) 113.4(15) 
H(8A)-C(8)-H(8C) 107.5(19) 
H(8B)-C(8)-H(8C) 100(2) 
C(10)-C(9)-C(6) 115.21(10) 
C(10)-C(9)-H(9A) 107.6(9) 
C(6)-C(9)-H(9A) 107.9(9) 
C(10)-C(9)-H(9B) 110.0(10) 
C(6)-C(9)-H(9B) 108.7(11) 
H(9A)-C(9)-H(9B) 107.1(14) 
C(11)-C(10)-C(9) 111.67(11) 
C(11)-C(10)-H(10A) 109.8(11) 
C(9)-C(10)-H(10A) 113.0(11) 
C(11)-C(10)-H(10B) 111.1(10) 
C(9)-C(10)-H(10B) 108.2(10) 
H(10A)-C(10)-H(10B)102.8(14) 
C(10)-C(11)-H(11B) 109.4(11) 
C(10)-C(11)-H(11C) 109.3(11) 
H(11B)-C(11)-H(11C)106.9(16) 
C(10)-C(11)-H(11A) 113.1(13) 
H(11B)-C(11)-H(11A)105.6(16) 
H(11C)-C(11)-H(11A)112.4(18) 
C(13)-C(12)-C(17) 120.16(11) 
C(13)-C(12)-H(12) 121.2(10) 
C(17)-C(12)-H(12) 118.6(10) 
C(12)-C(13)-C(14) 120.08(12) 
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C(12)-C(13)-H(13) 120.1(9) 
C(14)-C(13)-H(13) 119.8(9) 
C(15)-C(14)-C(13) 120.07(12) 
C(15)-C(14)-H(14) 121.4(12) 
C(13)-C(14)-H(14) 118.5(12) 
C(14)-C(15)-C(16) 120.17(12) 
C(14)-C(15)-H(15) 122.1(11) 
C(16)-C(15)-H(15) 117.8(11) 
C(17)-C(16)-C(15) 119.96(12) 
C(17)-C(16)-H(16) 120.9(10) 
C(15)-C(16)-H(16) 119.1(10) 
C(16)-C(17)-C(12) 119.55(11) 
C(16)-C(17)-C(7) 118.89(11) 
C(12)-C(17)-C(7) 121.51(10) 
C(19)-C(18)-C(23) 119.27(11) 
C(19)-C(18)-H(18) 118.1(10) 
C(23)-C(18)-H(18) 122.7(10) 
C(18)-C(19)-C(20) 120.93(11) 
C(18)-C(19)-H(19) 120.4(11) 
C(20)-C(19)-H(19) 118.6(11) 
C(21)-C(20)-C(19) 118.72(11) 
C(21)-C(20)-C(24) 120.44(13) 
C(19)-C(20)-C(24) 120.82(13) 
C(22)-C(21)-C(20) 121.06(11) 
C(22)-C(21)-H(21) 117.3(10) 
C(20)-C(21)-H(21) 121.7(10) 
C(21)-C(22)-C(23) 119.04(11) 
C(21)-C(22)-H(22) 119.4(11) 
C(23)-C(22)-H(22) 121.5(11) 
C(18)-C(23)-C(22) 120.96(11) 
C(18)-C(23)-S(1) 119.63(9) 
C(22)-C(23)-S(1) 119.41(9) 
C(20)-C(24)-H(24A) 111.2(17) 
C(20)-C(24)-H(24B) 106.2(18) 
H(24A)-C(24)-H(24B)106(2) 
C(20)-C(24)-H(24C) 103(2) 
H(24A)-C(24)-H(24C)126(3) 
H(24B)-C(24)-H(24C)103(2) 
 
Table 32. Anisotropic displacement parameters for 283.   
The anisotropic displacement factor exponent takes the form:  -2π2[ h2a*2U11 + ...  + 2 h k a*b*U12 ] 
U11 U22  U33 U23 U13 U12 
S(1) 20(1)  42(1) 22(1)  -11(1) 7(1)  -2(1) 
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O(1) 42(1)  37(1) 31(1)  8(1) 16(1)  -5(1) 
N(1) 19(1)  31(1) 19(1)  -1(1) 5(1)  -1(1) 
C(1) 22(1)  33(1) 27(1)  5(1) 4(1)  2(1) 
O(2) 27(1)  85(1) 19(1)  -9(1) 9(1)  -11(1) 
C(2) 22(1)  22(1) 25(1)  3(1) 7(1)  2(1) 
O(3) 28(1)  42(1) 50(1)  -25(1) 9(1)  2(1) 
C(3) 29(1)  22(1) 25(1)  0(1) 11(1)  -3(1) 
C(4) 20(1)  26(1) 29(1)  -3(1) 10(1)  -3(1) 
C(5) 20(1)  21(1) 22(1)  -3(1) 5(1)  0(1) 
C(6) 19(1)  21(1) 20(1)  0(1) 7(1)  -1(1) 
C(7) 19(1)  24(1) 19(1)  -2(1) 8(1)  -2(1) 
C(8) 24(1)  30(1) 27(1)  3(1) 1(1)  0(1) 
C(9) 24(1)  25(1) 23(1)  -4(1) 11(1)  -3(1) 
C(10) 32(1)  28(1) 31(1)  -8(1) 12(1)  -5(1) 
C(11) 43(1)  38(1) 36(1)  -14(1) 17(1)  -2(1) 
C(12) 25(1)  25(1) 26(1)  -1(1) 11(1)  -1(1) 
C(13) 28(1)  29(1) 34(1)  -3(1) 13(1)  2(1) 
C(14) 36(1)  26(1) 38(1)  1(1) 10(1)  7(1) 
C(15) 48(1)  28(1) 36(1)  8(1) 17(1)  2(1) 
C(16) 33(1)  27(1) 31(1)  0(1) 17(1)  -3(1) 
C(17) 21(1)  22(1) 22(1)  -3(1) 7(1)  -3(1) 
C(18) 25(1)  22(1) 24(1)  -1(1) 5(1)  -4(1) 
C(19) 33(1)  29(1) 24(1)  -2(1) 12(1)  -10(1) 
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C(20) 25(1)  30(1) 32(1)  -10(1) 13(1)  -8(1) 
C(21) 23(1)  30(1) 34(1)  0(1) 8(1)  2(1) 
C(22) 25(1)  31(1) 23(1)  3(1) 7(1)  -1(1) 
C(23) 20(1)  26(1) 21(1)  -5(1) 7(1)  -3(1) 
C(24) 33(1)  59(1) 50(1)  -18(1) 25(1)  -11(1) 
 
Table 33. Hydrogen coordinates and isotropic displacement parameters for 283. 
x(10
4
) y(10
4
)  z(10
4
)    U(eq) (Å
2
x 10
3
) 
H(1A) 4824(16) 512(12) 8401(13) 37(4) 
H(1B) 4023(14) 440(12) 9180(13) 33(4) 
H(2) 3288(14) -370(12) 7238(12) 29(4) 
H(4) 149(16) 362(12) 6740(13) 38(4) 
H(7) 4013(13) 1961(10) 6875(12) 20(3) 
H(8A) 890(20) 1466(17) 4565(19) 65(6) 
H(8B) 510(20) 2103(18) 5351(19) 65(6) 
H(8C) -210(20) 1254(19) 4890(20) 76(7) 
H(9A) 4046(14) 613(11) 5946(13) 30(4) 
H(9B) 3028(15) 1190(12) 5142(14) 34(4) 
H(10A) 2692(17) -729(15) 5468(16) 50(5) 
H(10B) 1828(16) -104(11) 4628(13) 34(4) 
H(11B) 2876(16) -1036(14) 3756(15) 44(5) 
H(11C) 4066(19) -549(14) 4545(16) 47(5) 
H(11A) 3113(18) 12(16) 3614(17) 55(6) 
H(12) 1721(13) 2494(11) 7924(13) 24(3) 
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H(13) 387(15) 3749(11) 7400(13) 33(4) 
H(14) 517(18) 4734(16) 6039(16) 53(5) 
H(15) 1910(16) 4476(14) 5155(15) 43(5) 
H(16) 3145(14) 3207(11) 5674(13) 29(4) 
H(18) 5493(14) 3111(12) 7475(13) 33(4) 
H(19) 7146(15) 2925(12) 7008(14) 35(4) 
H(21) 8621(16) 1261(12) 9668(14) 38(4) 
H(22) 6938(14) 1406(12) 10062(14) 34(4) 
H(24A) 9850(30) 1880(20) 8620(20) 85(8) 
H(24B) 9000(30) 1360(20) 7530(20) 101(9) 
H(24C) 9010(30) 2400(20) 7410(30) 95(10) 
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